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Abstract 
 
Magnetic Nanocomposite Materials for Image-Guided Drug Release in Cancer 
 
Magnetic nanocomposites and nanoparticle assemblies have gained significant 
interest for biomedical applications including MRI, hyperthermia and targeted drug 
delivery. Their efficacy depends on colloidal stability, optimal magnetic properties 
and appropriate size and surface chemistry for good biodistribution.  
 
The first part of this thesis focuses on the preparation of sub 20 nm magnetic 
nanoparticles (IONP) and the modification of their surface charge for subsequent 
encapsulation or adsorption to the polymer poly n-butyl cyanoacrylate (PACA) to 
produce IONP dilute assemblies. In addition to this, IONP-dense assemblies were 
prepared using established methods, and the effect of IONP density on the magnetic 
resonance properties of the assemblies was assessed. It was found that the NMR 
response was very sensitive to the IONP density and also to the structure of the 
assembly. This suggests potential routes to novel materials with tunable MRI 
properties. 
 
The second part of the thesis focuses on the assembly of IONP into dense 
assemblies (or clusters) in organic media using a novel in situ assembly technique 
based on reducing surfactant coverage. Particular attention was paid to the kinetics 
of the assembly process and the effect of adding surfactants and/or gold 
nanoparticles to the metastable IONP assemblies was also studied.
  
 
 
 
 
CHAPTER 1 
Introduction 
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1.1 Thesis overview 
 
 
Magnetic Nanocomposite Materials for Image-Guided Drug Release in 
Cancer 
 
Magnetic iron oxide nanoparticles (IONP) and their composite materials have 
received considerable interest due to their many potential bio-applications. IONP 
prepared via non-hydrolytic thermal decomposition syntheses of iron precursors 
followed by phase transfer into aqueous media are usually preferable as the process 
provides nanoparticles with good particle size control and superior crystallinity. 
This approach also allows functionalisation of the IONP and engineering of the 
surface charge. These advantages could be used in the design of therapeutics for 
Magnetic Drug Targeting (MDT), which could be tracked in the body by MRI. For 
MDT, drugs could also be incorporated into the core of the nanocomposite, or 
adsorbed via ionic or covalent linkage onto its surface. Once transported to the site 
of interest, drug release can be facilitated by many methods such as bond 
degradation, pH cleavage, or RF irradiation producing a local temperature increase 
(hyperthermia).  
 
The first part of this thesis focuses on the preparation of sub 20 nm IONP and their 
functionalisation using both anionic and cationic surface ligands, followed by their 
combination by encapsulation or adsorption with Poly n-butyl cyanoacrylate 
(PACA) in an effort to synthesise nanocomposites for targeted drug delivery and 
heat-mediated drug release. The second part of this thesis focuses on the assembly 
of iron oxide nanoparticles into larger nanoparticle assemblies (or clusters) in 
organic media. The kinetics of the assembly process was observed over time by 
Photon Correlation Spectroscopy. The effect of adding additional surfactant on the 
assembly/disassembly of the clusters was studied. The effect of gold nanoparticles 
on the assembly kinetics and stability were also assessed. Nanoparticles of this 
type offer additional diagnostic potential due to their plasmonic properties.  
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1.2 Applications of magnetic Iron oxide nanoparticles in biomedicine 
 
The application of iron oxide nanoparticles in the biomedical sciences has been 
ongoing since the 1970s, in the areas of drug delivery, magnetic resonance 
imaging, cell recognition and thermogenic treatments. More specifically, iron 
oxide nanoparticles of magnetite (Fe3O4) and maghemite (γ-Fe2O3) have shown to 
be very promising candidates for use in the above mentioned applications, due to 
the many favorable physical and chemical properties associated with them [1, 2]. 
Iron oxide nanoparticles can be prepared via straight-forward synthetic routes, 
typically yielding small nanoparticles of < 20 nm, they exhibit low toxicity in-vivo 
and are easily excreted from the body [3]. Their excellent magnetic properties are 
key to their potential as therapeutic and diagnostic agents. Iron oxide nanoparticles 
possess a large magnetic moment and are typically superparamagnetic in nature, 
that is they do not retain any bulk magnetisation on removal of an external field 
[4]. 
 
In vivo applications of IONP can be divided into their therapeutic and diagnostic 
uses. Therapeutic applications of magnetic particles include their use in magnetic 
fluid hyperthermia [5, 6]
 
and the development of a variety of drug delivery vehicles 
for a wide range of purposes, including the development of magnetic targeted 
carriers, or MTCs for the treatment of solid tumours [7] . Diagnostically, IONP and 
their composite materials have been used in the development of a class of 
compounds known as 'Magneto-pharmaceuticals', particularly for the enhancement 
of MRI imaging and are components in a wide range of contrast agents e.g. 
Endorem or Resovist [8, 9].
 
 
1.2.1 Magnetic drug targeting and the use of magnetic carriers as potential 
drug delivery vehicles in biomedicine 
 
One of the major obstacles in drug delivery, in particular of chemotherapeutics, is 
the delivery of the drugs to a specific site in the body while minimising potential 
undesired cytotoxic effects on surrounding healthy tissue caused by administration 
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of the drug itself or by any processes that may follow e.g. heating of the tumour 
region using an applied magnetic field. 
 
Magnetic drug targeting (MDT) processes have been developed for this reason, and 
involve the delivery of the drug of interest, under the influence of a static magnetic 
field, to a particular site of interest in the body using a drug delivery vehicle 
(DDV). Iron oxide nanoparticles have shown excellent (although size dependent), 
capability to be transported through the vasculature system of the body, thus 
allowing them to be potentially concentrated at a chosen site [10]. 
 
MDT therapies offer many benefits over more conventional non-specific methods 
such as chemo- and radiotherapies, as they allow for maximum drug efficacy while 
using the lowest possible dose and, in turn, reducing the potential toxicity and side 
effects usually associated with increased drug concentration in vivo [11], although 
they are limited by the accessibility of the target area to the externally applied 
static field. Targeting can also be achieved by two other routes; passive targeting, 
where carriers are allowed to circulate freely through the vasculature system and 
biodistribution is determined by size, and active targeting, which involves direct 
control of DDV circulation by specific recognition of ligands on the delivery 
vehicle [10, 12].  
 
With magnetic drug targeting, drugs can be encapsulated into the core of a delivery 
vehicle [13, 14], or adsorbed (via ionic or covalent linkage) onto its surface [15, 
16]. The latter is more favourable as it allows for a much lower required drug dose 
while maintaining efficacy of that drug. Once transported to the site of interest, 
drug release can be facilitated via many methods such as bond degradation [17], 
pH dependent cleavage [18], irradiation [19], or the use of an elevated temperature 
(Hyperthermia) [20].  
 
Multiple systems and strategies have been investigated to meet the goals of 
selective delivery of chemotherapeutic agents, with some successfully reaching 
clinical trials in humans. The use of Magnetic Cationic Liposomes (MCLs), for 
example, has proven successful in the delivery of magnetic iron oxide 
nanoparticles to target cells by electrostatic interaction of their positive surface 
charge with an oppositely charged cell surface (particularly in the Kupfer cells of 
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the liver), making them potential mediators for successful passive drug targeting. 
In addition to this MCLs were observed to provide extended accumulation times of 
chemotherapeutic drugs at the tumour site, make them extremely promising 
candidates for intelligent drug delivery and active targeting strategies [7]. In one 
particular study by Ito et. al. [21], a ten-fold increase was observed for MCLs 
towards targeted tumour cells relative to their neutral equivalents, resulting in a 
much improved transfection efficiency and successful nucleic acid delivery to the 
site of interest in vivo. MCLs generate heat by hysteresis under the influence of an 
applied magnetic field, with temperatures of ~42°C being achieved in the affected 
tumour site. Furthermore, the temperature of the surrounding healthy tissue has 
been observed to remain in the region of 37-39°C upon heating of the cancerous 
mass, which further outlines the benefits of the use of MCL delivery vehicles in 
hyperthermia.  
 
Another widely reported type of delivery vehicle in the literature are those based 
on polymer-associated magnetic nanoparticles where the polymer is used to 
encapsulate both the magnetic colloid and any drug substances to be delivered. 
Three main methods of entrapment of drugs and other ‘model compounds’ have 
been widely reported within the literature; encapsulation, where the drug of choice 
is combined with the monomeric material [22] or pre-polymerisation/sorption 
which involves the addition of the drug after the polymerisation process is 
complete [23]. Selection of the method used usually depends on the type of drug to 
be entrapped, in addition to the polymer synthesis chosen and the structural 
properties of the polymer itself (chain length, degree of polymerisation etc). 
 
The entrapment efficiencies of loaded bioactives depend strongly on the method of 
entrapment used and also on the solubility of the drug in the polymerisation 
medium. For example, entrapment in nanospheres is favoured more for hydrophilic 
drugs [24], whereas drugs more lipophilic in nature are more successfully 
incorporated into nanocapsule structures [25]. A wide variety of bioactives 
including insulin, ovalbumin and oligonucleotides have been efficiently entrapped 
within polymer nanoparticles possessing an aqueous core for oral peptide and 
protein delivery [26]. 
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Figure 1.1: General structure of polymer nanospheres (NS), water-containing nanocapsules 
(w-NC) and oil-containing nanocapsules (o-NC) (Ref Couvreur) 
 
 
The use of these so called 'thermosensitive' polymer materials allow for successful 
inductive heating using an applied magnetic field to temperatures above the critical 
phase transition temperature, or the LCST, of the polymer, which can fall within 
the  range of approximately 30-45°C. Above this temperature, phase separation 
occurs due to the positive value of the free energy of mixing, and the result is an 
observed shrinkage or compaction of the polymer particles. A transformation in the 
structure of the polymer chains from an expanded hydrophilic structure to a more 
compact hydrophobic one is also observed at this characteristic temperature. This 
process, in turn, results in an initial rapid release of any encapsulated substances 
i.e. the drug to be delivered, followed by a more controlled release phase, making 
these stimuli-responsive polymer drug carriers attractive candidates for intelligent 
temperature-responsive drug delivery due to their attractive responses to changes in 
their environmental conditions e.g. pH, temperature or magnetic field strength 
[27]. The most commonly used  polymers reported in the literature are 
polyethylene glycol (PEG) [28] and derivatives of poly(N-isopropylacrylamide) 
(PNIPAM) [29]. 
 
Another attractive potential candidate for polymer-based magnetic carriers may 
also be a more biocompatible and biodegradeable polymer, 
poly(alkylcyanoacrylate) (PACA), with previous studies already demonstrating its 
capacity for successful loading of doxorubicin into the particle core [30]. The 
alkyl-cyanoacrylates are a family of strong, fast acting adhesives that have been 
previously exploited as effective surface and tissue adhesives in both medical and 
non-medical applications. Cyanoacrylate monomers such as methyl-2-
cyanoacrylate, ethyl-2-cyanoacryalte and n-butyl-cyanoacrylate are amongst the 
members of the cyanoacrylate family that have been used since the 1960s for the 
formulation of many commercially sold adhesive glues (e.g. Superglue) and 
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veterinary and skin-adhesive glues for use in suture-free surgeries (e.g. Vetbond 
and Indermil). 
 
 
Figure 1.2: Structures of methyl-cyanaocrylate (MCA), ethyl-cyanoacrylate (ECA) and n-
butylcyanoacrylate (nBCA) monomers. 
 
Most recently, interest in these materials has increased due to applications for the 
delivery of a wide range of therapeutics, particularly for the treatment of many 
cancers as they minimise the threat of high drug toxicity in healthy regions of 
surrounding tissue to the tumour site by confining the nanoparticles and/or drug to 
an aqueous or oily matrix within a biodegradeable polymeric carrier shell. 
 
Polymers were first introduced into the area of drug delivery by Patrick Couvreur 
in the 1970s with his research into lysosomotropic therapeutics for cancer 
chemotherapy [14]. Their many favourable properties such as biocompatibility, 
biodegradability, simple and highly reproducible syntheses, compatibility and 
entrapment efficiency with a vast range of therapeutics suggest their excellent 
potential as effective drug delivery agents. Research into their method of delivery 
has focused primarily on the oral route of administration, but recent studies are 
expanding into potential methods of ocular and transdermal administration, in 
addition to penetration of the blood-brain barrier [31]. Furthermore, polymer 
nanoparticles possess the advantage of high stability in biological media, 
protecting therapeutics in vivo against enzymatic degradation and also provide a 
feasible method for controlled drug release. Despite the extent of research 
conducted on PACA nanoparticles, no product has entered the market to date, 
although many formulations have been investigated as far as clinical phase II/III 
trials [32]. 
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1.2.2 Thermogenic use of magnetic nanoparticles and their composites in 
biomedicine (Magnetic Fluid Hyperthermia) 
 
Magnetic nanoparticles and their composite drug delivery formulations possess an 
excellent potential for uniform heating and non-invasive delivery of therapeutics 
and are widely studied as potential hyperthermic treatment agents in biomedicine. 
Magnetic Fluid Hyperthermia (MFH) has received much attention as a method for 
the treatment and control of a variety of malignant tumour types due to its 
provision of significant heating effects in the presence of an AC magnetic field 
without any significant interference from any anatomical obstructions e.g. bones. 
MFH is a technique whereby magnetic fluids (or ferrofluids as they are otherwise 
known) are coupled to an AC magnetic field and heat the tissue of interest to 
temperatures in the region of 43-55°C. The temperature to which the tumour region 
is heated depends on the hyperthermic method employed. Traditional magnetic 
hyperthermia involves heating within the 45-47ºC temperature range, whereas 
magnetic thermoablation utilises temperatures up to 55ºC. Temperatures in the 
higher range result in rapid immediate cell death. 
 
Although hyperthermic methods are frequently successful in the treatment of 
malignancies, limitations to the treatment also exist. For example, deep rooted 
tumours can sometimes be difficult to access by heat induction, and often recur in 
many patients as a result. Other alternatives for more difficult to treat 
malignancies, or cancers where secondaries are already present, include whole 
body hyperthermia (WBH), local hyperthermia and interstitial hyperthermia [6]. 
More often the entire tumour is not destroyed and secondaries can subsequently 
occur. These secondaries are most commonly observed in the vicinity of the bone 
of the pelvis or skull, where shielding of the tissue from the applied RF occurs. 
This problem often results in thermal underdosage in the target of interest and, in 
turn, regrowth of the malignant tumour. These problems are often counteracted by 
direct injection of the magnetic nanoparticles into the tumour, which can be 
effective in treating large accessible solid tumours of this type. 
 
In a typical MFH treatment, colloidal dispersions of magnetic nanoparticles are 
injected into the vasculature system of the body and are localised at the site of 
interest using a static external magnetic field. Alternating magnetic fields are then 
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utilised to generate heat energy from the nanoparticles present, via two relaxation 
mechanisms, Néel relaxation and rotational Brownian relaxation [33].  
H
(a)
(b)
 
 
Figure 1.3: Relaxational losses leading to heating in an alternating ﬁeld (H). (a) ´Neel relaxation. 
The magnetic moment (dotted arrow) originally locked along the crystal easy axis (solid arrow) 
rotates away from the crystal axis towards the external ﬁeld H.(b)Brownian mode. The whole 
particle oscillates towards the ﬁeld, with the moment locked along the crystal axis, under the effect 
of a thermal force [34]. 
 
Heat generation via Néel relaxation is due to rotation of the magnetic moments 
contained within the nanoparticle core relative to the crystal lattice (internal 
dynamics), where the magnetic moments, originally locked along the easy axis of 
the crystal, rotate away in the direction of the external field. Heat energy is 
generated as a result of these oscillations of the magnetic moments in the presence 
of the alternating magnetic field applied [35]. The time taken for these oscillations 
to occur is known as the Néel relaxation time and is represented by the following 
equation: 
 
              







Tk
KV
B
n exp0
                          Equation 1.1
 
 
where τ0 is the time constant (~10
-9
 s), K is the anisotropy constant ,V is the 
volume of the particle core,  kB is the Boltzmann constant and T is the absolute 
temperature [36]. It follows that, the frequency νN for maximal heating via Néel 
relaxation is given by Equation 1.2: 
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N
N


2
1
                         Equation 1.2 
 
Brownian motion contributions to the heating process arise due to rotation of the 
particle as a whole due to the torque exerted on the magnetic moment by the 
external AC magnetic field. The time taken for this process to occur, the 
correlation time for Brownian motion, is given by: 
 
                  Tk
V
B
H
B


3
                         
Equation 1.3
 
 
where η is the viscosity of the carrier liquid and VH represents the hydrodynamic 
volume of the particle responsible for the process [37]. The frequency required for 
maximal heating via this process is given by: 
 
                 
B
B


2
1
                          Equation 1.4 
 
The quantity of heat delivered by a magnetic nanoparticle material can be 
represented by the specific absorption rate, or SAR, of that material. This is 
essentially a measure of the heating potential of the material and may be defined by 
the following equation: 
 
Femt
T
CSAR
1


           
Equation 1.5
 
 
with C representing the specific heat capacity of the sample and ΔT/Δt being the 
initial slope of the time dependent temperature curve where the maximum value for 
SAR is observed and mFe is the iron content per gram of the iron oxide 
nanoparticle suspension. SAR values are given in Watts per kilogram (W.kg
-1
), 
with typical values for the ferrites of 50-500 W.kg
-1
 [38]. Higher SAR values are 
favourable as they are associated with lower particle concentrations to produce a 
temperature jump. 
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The SAR of magnetic nanoparticle suspensions has been demonstrated in the 
literature to exhibit strong dependence on a number of physiochemical properties 
of the nanoparticles present such as particle size, size distribution, and particle 
shape in addition to electromagnetic field parameters such as the frequency and the 
amplitude of the magnetic field applied. 
 
Ma et al. [39] demonstrated how the SAR for magnetite nanoparticles in the size 
range of 7-13 nm was attributed to the presence of Néel and Brownian rotation 
losses, and to hysteresis loss for particles in excess of ~46 nm. As these losses are 
subsequently dependent on the size of the particles present, a dependency exists 
between the core size of the particles and their SAR. It has been previously 
reported in the literature that, on decreasing the core particle size, a transition from 
ferromagnetic to superparamagnetic behaviour occurs [38], thus changing the loss 
mechanism and, in turn, the heating effect observed. Nanoparticles used for 
hyperthermia primarily exploit Néel relaxation processes over all other types, as 
even at smaller field amplitudes, superparamagnetic nanoparticles exhibit higher 
SAR than their multi-domain counterparts. In addition to this, narrow particle size 
distributions have been linked with higher SAR values as they are commonly 
associated with heat generation through Neél relaxation processes. 
 
One other physical property that has been reported to have a significant effect on 
the SAR is the surface coverage of the particles used in hyperthermic treatments. In 
one particular study for example, it was observed that γ-Fe2O3 nanoparticles coated 
with dextran of higher molecular weight values exhibited higher SAR values in 
vitro than those coated with lower molecular weight varieties [38, 40]. In a 
different study on the use of gold-coated magnetite nanoparticles (Au-IONP), it 
was observed that the temperature rise and the time required to reach the 
therapeutic temperature of 42°C was faster for Au-IONP than those without Au 
coverage. Furthermore, the SAR of Au-coated IONP have been shown to exhibit a 
4-5 fold increase in the SAR value relative to those in the absence of Au coverage 
[41]. The reported results in both of the above cases suggest that the observed 
increases in the SAR was as a result of the presence of the ligands/surface coatings 
as opposed to increases due to nanoparticle aggregation. These observations are 
very promising for advances in hyperthermia, as it provides the potential for tuning 
the surface coverage of the magnetic materials used for specific cancers. It is 
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therefore vital that control of nanoparticle properties is considered, as it has been 
observed that factors such as those mentioned above have a significant influence 
on the efficacy of the treatment.  
 
The value of the SAR of a given magnetic material is also strongly dependent on 
the frequency and amplitude of the magnetic field applied during the heating 
process. Hergt et al. [36] highlight that at low frequencies, for superparamagnetic 
nanoparticles, hysteresis losses increase with the square of the frequency and 
amplitude of the applied field. Non-specific heating of surrounding tissue during 
hyperthermia, however, places a limit on the RF frequency and field amplitude 
range that can be used to generate these losses and maximise the effects of heat-
mediated treatment of pathological cells. Non-specific heating effects associated 
with eddy currents not only in the tumour site but also in the surrounding healthy 
tissue reduce the selectivity of the treatment. In addition to this, magnetic 
resonance induced heating is greatest at the surface of the targeted tissue mass than 
in the center, resulting in what are known as thermal 'hot spots' in the tumour 
region, particularly in the region of the resonance frequency of maximum heat 
absorption. The FDA have outlined a number of limitations for acceptable SAR 
ranges in particular regions of the human body and are as follows: 
 
 0.4 W.kg-1 for whole body exposure 
 3.2 W.kg-1 average in the head/brain region 
 8.0 W.kg-1 peak in any 1 gram of exposed tissue 
 
The literature reports a wide range of studies on the determination of the optimum 
field frequency and amplitude required to optimise the hyperthermic potential, i.e. 
the SAR for a number of nanoparticle types including iron oxide nanoparticles, 
cobalt ferrites, manganese ferrites and a series of Fe doped AuNP to mention a 
few. Each nanoparticle type possesses its own characteristic field frequency and 
field amplitude at which they produce a maximum heating potential (SAR). Iron 
oxide nanoparticles, however, continue to attract more attention over other 
nanoparticle types due to their lack of toxicity and excellent biocompatibility in 
vivo. With nanoparticles of this nature, it has been reported in the literature that 
field frequencies of approximately 400 kHz with an amplitude of 10 kA.m
-1 
are the 
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most optimum in producing the highest possible SAR value of 960 W.kg
-1
 for 15 
nm single domain IONP [42]. 
 
One effect that has not gained enough interest, however, is the effect of 
aggregation or clustering of nanoparticles on SAR. In one particular study 
conducted by Jordan et. al. [6] it was deduced that, despite the dependence of SAR 
on core nanoparticle size, an increase in the particle hydrodynamic diameter due to 
aggregation in particular had no impact on the SAR of the material.  
 
1.2.3 Iron oxide nanoparticles in the development of contrast agents for MRI 
(Magnetic Resonance Imaging) 
 
The use of contrast agents in MRI applications has been extensively demonstrated 
over the last 15 years to further enhance and increase the sensitivity of generating 
image contrast between healthy and pathological tissues in vivo. MRI agents 
operate on the basis of effectively decreasing T1 and/or T2 relaxation times of the 
object or tissue under analysis. For this reason, they may be deemed “T1 agents” or 
“T2 agents”, depending on the relaxation process on which they have an effect. The 
measure of how a given agent can reduce relaxation times of the H2O proton signal 
within a given suspension is known as its relaxivity. Relaxivity can be defined as 
the “proton relaxation enhancement per unit concentration” of the material used 
and can be denoted as r1 and r2  for the T1 and T2 relaxation processes, respectively. 
Relaxivities (given the units s
-1
mM
-1
) are parameters used to quantify relaxation 
enhancements by the following relations: 
 
 
 
R1 obs = R1H2O + r1 [Fe] 
or 
                                R2 obs = R1H2O + r2 [Fe]            
Equation 1.6
 
 
where R1obs and R2obs represent the measured relaxation rates, and R1H2O and R2H2O 
the rate in the absence of any agent. Concentration independent relaxivities r1 and 
r2 are, in turn, defined as the change in longitudinal or transverse relaxation as a 
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function of iron content in the contrast medium, can then be derived by Equation 
1.7 
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Equation 1.7      
 
Contrast agents that possess higher r1 values and, as a result, lower r2/r1 ratios, are 
typically composed of individually-dispersed nanoparticles in suspension and 
generate positive (bright) contrast in the MRI image under T1 weighting conditions 
due to enhancement of the MRI signal due to reduction of T1 proton relaxation 
times. Agents exhibiting higher r2 values, and therefore higher r2/r1 ratios will 
generate a negative (dark) contrast in the MRI image under T2 weighting 
conditions due to signal suppression as a result of shortened T2 relaxation 
processes, and are typically composed of larger clustered materials as illustrated in 
Figure 1.4 below:  
 
 
 
Figure 1.4: Properties of T1- and T2-weighted contrast agents and their characteristic properties 
 
Iron oxide nanoparticle (IONP) dispersions in particular have exhibited excellent 
potential for use in MRI contrast agent development, as they are metabolised by 
the body and are easily excreted following treatment, thus avoiding the problem of 
toxicity. Current IONP formulations in use include Endorem
® 
(T2 agent, AMAG-
Pharma), Lumirem
®
(T2
*
 agent, AMAG), Resovist
®
(predominantly T2 agent, 
Bayer) and most recently VSOP-C184 (T1 agent, Ferrofarm GmbH) . Such 
formulations provide promising potential for the replacement of their Gadolinium-
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based alternatives, which have been shown to present occasional toxicity problems, 
specifically nephrogenic systemic fibrosis (NSF) of skin, joints, eyes, and internal 
organs in cancer patients with liver disease. 
 
1.3 Synthesis of iron-oxide nanoparticles 
 
The synthesis of superparamagnetic iron-oxide nanoparticles has become of 
increasing interest as their potential in many industrial, medical and biosensing 
applications continues to increase. For this reason, it is vital that the resulting 
physical, chemical, optical and magnetic properties of the nanoparticles be strongly 
considered in their preparation, as these properties determine the efficacy and 
application of the IONP. It follows that good size control is therefore crucial, as it 
provides the opportunity to engineer the resulting properties of the nanoparticles 
produced. Many methods are available for the preparation of iron-oxide 
nanoparticles including alkaline coprecipitation [43], microemulsion [44], 
pyrolysis [45] and high-temperature thermal decomposition in organic media [46]. 
For the purpose of this thesis, the coprecipitation and high temperature thermal 
decomposition methods will be further discussed.  
 
1.3.1 Alkaline coprecipitation of iron salts in aqueous medium 
 
The use of aqueous coprecipitation of iron salts has been widely employed and 
extensively reported in the literature as a simple and effective route in the 
preparation of relatively small, water dispersible iron-oxide nanoparticles. The 
procedure involves a stoichiometric mix of ferric and ferrous iron salts in aqueous 
medium as demonstrated by the following equation: 
 
Fe
2+
 + 2Fe
3+
 +8OH
-
  Fe3O4 +4H2O    
         
  
Equation 1.8 
 
Complete nanoparticle precipitation occurs within the range of pH 8 to 14 and is 
facilitated by the addition of ammonia into the reaction mixture. A ratio of 2:1 of 
iron salts (Fe
3+
: Fe
2+
) is required to avoid the formation of oxide mixtures (i.e. both 
maghemite and magnetite nanoparticles in the same suspension). In addition to 
this, control over the Fe
3+
: Fe
2+
 ratio has shown to have a significant effect on the 
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crystallisation and the magnetic properties of the nanoparticles produced [47]. 
Typically, magnetite, or Fe3O4, nanoparticles are produced via this process, but 
oxidative processes that may occur can often result in the formation of maghemite, 
or γ-Fe2O3 via Equation 1.9 [48]. 
 
2Fe3O4 + ½O2 +2H
+
 3γ-Fe2O3 + H2O         
Equation 1.9
 
 
Nanoparticles prepared by this method are also very susceptible to agglomeration, 
to reduce their surface energy. For this reason, the use of stabilisers or surfactants 
is vital to create steric repulsion between individual nanoparticles, thus inhibiting 
cluster formation. A vast range of surfactants and stabilisers have been reported in 
the literature and include fatty acids (oleic, acid, lauric acid, dodecanoic acid) [49], 
carboxylates (citric acid) [50] , phosphates [51], polymeric stabilisers(e.g. 
Polyethylene Glycol, PEG) [28] and phospholipids [52]. 
 
The coprecipitation method offers a straightforward and convenient method of 
producing iron oxide nanoparticles of a relatively small size in the presence of a 
stabilising surfactant or ligand. Despite average nanoparticle size being fairly 
reproducible between syntheses, control over nanoparticle size is very limited with 
resulting particle distributions being quite broad. For this reason, thermal 
decomposition methods in organic media have gained increasing interest as an 
option for nanoparticle production. These nanoparticles can then be transferred to 
aqueous media in order to generate water-dispersible nanoparticles for biomedical 
application. Nanoparticles of this type and their potential applications will be 
discussed in Chapters 3 and 4. 
 
1.3.2 Thermal decomposition of iron precursors in organic media  
 
The thermal decomposition process of IONP synthesis, although not fully 
understood, is proposed to proceed via a two-stage mechanism involving an initial 
nucleation stage and a subsequent growth period. Separation of these stages is vital 
for obtaining size monodispersity and a narrow size distribution, and can be 
achieved using two strategies; heterogenous nucleation and homogenous 
nucleation [53].  
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The most commonly used form of heterogenous nucleation in the literature is the 
seed-mediated process, whereby preformed nanocrystals are used as seed nuclei for 
the further growth of larger nanoparticles in the presence of a low concentration of 
additional monomers. This ensures that the nucleation stage is physically separated 
from the subsequent growth stage that follows. It is vital that the concentration of 
the monomers introduced is kept low in order to prevent further heterogenous 
nucleation processes. The growth phase of heterogenous nucleation is marked by 
the deposition of metal atoms on the surface of the preformed seed nanocrystals, 
resulting in the growth and formation of larger nanoparticles. Monodisperse single-
nanoparticle and core-shell structures have been reported to be produced by seed-
mediated processes [54], providing that the seed particles are uniform in size.  
 
Homogenous nucleation can be achieved by one of two primary methods, the ‘hot-
injection’ technique (introduction of precursor into a hot solvent) or by ‘heating 
up’ processes. The latter technique was employed in the synthesis of iron oxide 
nanoparticles for the purpose of this thesis.  Hot injection techniques are those in 
which a state of high supersaturation is induced by the rapid injection of  highly 
reactive reactants into a hot surfactant solution, resulting in a rapid homogenous 
nucleation, followed by a slower diffusion-controlled process of 'focussing' of a 
monodisperse nanoparticle size distribution . The common objective of this method 
is to generate a condition of ‘burst nucleation’, whereby the concentration of the 
precursor in the medium rapidly decreases, thus slowing down the rate of 
nucleation. This stage, in combination with the slower, more controlled growth 
phase, is critical in the formation of monodisperse nanoparticles in suspension.  
 
In the "heating up" approach the combination of the solvent, precursor and any 
additional surfactants or stabilizing ligands occurs at room temperature before 
heating up to the reflux temperature of the carrier solvent used. The precursor 
decomposes during the heating stage, and thus generates ions in solution. After the 
concentration of these ions reaches super-saturation, a short period of ‘burst 
nucleation’ occurs in which the concentration of the precursor rapidly decreases 
and subsequently inhibits the formation of further secondary nucleations. Otswald 
ripening is then believed to occur following this in a slower, more controlled 
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growth stage which is responsible for the formation of a monodisperse suspension 
of nanoparticles of uniform size.  
 
There have been very limited studies reported in the literature on the proposed 
mechanism of nanoparticle formation by heating up processes, mainly due to the 
lack of characterisation methods that could facilitate following both the nucleation 
and growth processes in real time. The one main difference of this method to the 
hot injection variety is that there is no process that induces instantaneous 
supersaturation for formation of monodisperse nanoparticle dispersions. However, 
the underlying mechanism for size control via this method is not yet fully 
understood, and cannot be simply explained using the proposed mechanism 
presented for hot injection processes.  
 
In one particular study by Kwon et. al. [54], a series of aliquots of the reaction 
solution were extracted during a thermal decomposition synthesis of iron oxide 
nanoparticles in an attempt to identify the actual mechanism of particle formation 
and to separate the synthesis into its nucleation and growth phases. The conclusion 
of the above study was that the mechanism underlying the formation of the 
nanocrystals in the heating-up process was very similar to that of the “hot 
injection” method, in that there was a sudden increase in the concentration of the 
nanocrystals, rapid narrowing of the size distribution and a high growth rate. On 
analysis of aged nanoparticle dispersions following synthesis, it was observed that 
termination of growth occurred approximately 2-3 min after the reflux temperature 
of the reaction was reached. Noticeable changes in the particle morphology was 
evident from TEM analyses in this instance, with the particles adopting a 
smoother, more 'rounded' shape when maintained at these high temperatures for a 
number of minutes following synthesis. At aging times in excess of 20 minutes, 
however, the once-spherical particles began to transform into cubed-shaped 
structures with a broader size distribution.  
 
The main advantages of nanoparticle preparation by both 'hot injection' and 
'heating up' processes is their remarkable ease and simplicity in producing particles 
of a small crystallite size with a high degree of monodispersity, in addition to 
providing the potential to engineer the size, and thus the characteristic physical, 
chemical and magnetic properties of the nanoparticles produced. Despite these 
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advantages, a number of drawbacks can be associated with conventional 
decomposition syntheses such as the use of large quantities of surfactants e.g. 
oleylamine, oleic acid used in the Sun et. al synthesis [46], which firstly, is of 
environmental concern, and, furthermore, involves coating of the IONP by large 
quantities of strongly bound surfactants. This seriously limits biomedical 
applications of the synthesised IONP. These drawbacks can be overcome by 
syntheses of the type reported by Pinna et. al [55], where the solvent, benzyl 
alcohol, simultaneously acts as both the reaction medium and the ligand during 
nanoparticle formation, instead of using a more complex mixtures of solvents and 
ligands. Critically the benzyl alcohol moieties are weakly bound and so are easily 
replaced. In addition to this, benzyl alcohol is known to be an environmentally 
friendly solvent and  is commonly used in the food industry. 
 
Thermal decomposition syntheses as reported by Pinna et. al and Sun et. al were 
utilised for IONP syntheses as described in Chapters 3 and 5 respectively, with the 
use of  those prepared by Pinna et. al. also described in Chapter 4 in the formation 
of IONP/polymer nanocomposites. 
 
1.4 Surface functionalisation and control of nanoparticle/nanocomposite 
properties 
 
Successful preparation of stable, well-dispersed iron oxide nanoparticle 
suspensions requires that the nanoparticles are coated with appropriate surfactants 
that allow the dispersion of the nanoparticles in the chosen medium. For example, 
for dispersion of nanoparticles in non-aqueous ferrofluids, long chain surfactants 
such as oleic acid can be used to stabilise IONP in organic media via 
chemisorption of the carboxylic acid head group to the nanoparticle surface, 
leaving the hydrophobic tail exposed to the solvent. Steric interactions then 
provide effective dispersion in organic media [56]. For successful dispersion in 
aqueous media, a wide variety of short/long chain surfactants [44], lipid bilayers 
[49] and copolymer moieties [57] have been reported in the literature to have been 
successfully attached to the surface of iron oxide nanoparticles. 
 
Apart from providing stability of nanoparticles in their dispersing solvent, 
surfactants are also the key element in the functionalisation of the nanoparticles 
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formed as they allow for specific engineering of surface charge of the nanoparticles 
toward a particular biomedical application. This can be useful, for example, in the 
design of therapeutics for specific targeted drug delivery, particularly if the site of 
interest possesses a specific surface charge, thus increasing the efficacy of the 
delivery vehicle used.  
 
1.5 Zeta Potential of particles and the Electrical Double Layer 
 
 
Colloidal particles dispersed in aqueous suspension are generally electrically 
charged, arising from their own natural surface charge or any surface coatings that 
may be attached to them. Each individual particle dispersed in solution is 
surrounded by a ‘fixed layer’, or ‘Stern Layer’ as it is otherwise known, that 
consists of oppositely charged ions strongly bound to the surface. Surrounding this 
layer exists a more fluid-like layer, known as the diffuse double layer, where a 
collection of ions of opposite polarities exist. Combined, these two layers comprise 
what is known as the ‘Electrical Double Layer’. In addition to this, the bulk liquid 
surrounding the particle also possesses its own characteristic electrical charge. 
When a voltage is applied to dispersion, particles are attracted to the electrode of 
the opposite polarity, along with the fixed layer and part of the diffuse double 
layer, or internal side of the "sliding surface". The difference in electrical charge 
between the dense layer of ions surrounding the particle and the bulk of the 
suspended fluid is known as the Zeta Potential. 
 
        
Figure 1.5: Schematic of the Electrical Double Layer of a particle [58] 
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The magnitude of the Zeta Potential gives an indication of the stability of the 
particles in the medium in which it is dispersed. For example, if the majority (or 
indeed all) of the particles in suspension possess a very positive or indeed very 
negative surface charge, then the probability of aggregation will decrease as the 
particles will repel each other. It follows that if a low overall charge is present, 
there will be no electrostatic repulsion forces to keep particles apart, allowing 
aggregation to occur in the absence of other repulsive interparticle interactions. 
Typically, a Zeta Potential in excess of 30 mV (positive or negative) indicates a 
stable dispersion. 
 
Four main effects, or electrokinetic effects as they are otherwise known, may occur 
during this application of an external electrical field; Electroosmosis, 
Electrophoresis, Streaming Potential (generated when a liquid is forced to flow 
past a stationary charged surface) and Sedimentation Potential (field generated 
due to sedimentation of particles from suspension).  
 
Electroosmosis involves the movement of a liquid through a capillary, membrane 
or porous material due to the application of an external electrical field. On 
application of this field, an electrical double layer of mobile ions form at the 
interface of the static surface and the liquid. The net charge in this layer is induced 
to move by the resulting Coulomb force and the resulting flow is termed 
electroosmotic flow. 
 
 
 
Figure 1.6: Schematic representation of electroosmotic flow. 
 
Electrophoresis (Electrophoretic mobility) can be defined as the movement of 
charged particles relative to the medium in which they are suspended while under 
the influence of a magnetic field. When a field is applied, charged particles move 
towards the electrode of opposite charge. Forces due to the viscosity of the solvent 
oppose such motion, and the particles move with a constant velocity once 
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equilibrium is reached. A particles velocity is dependent on a number of factors; 
the Zeta potential, the applied field, the dielectric constant of the particle and the 
viscosity of the solvent.  
 
 
 
Zeta Potential is related to electrophoretic mobility via the Henry Equation: 
 


3
)(2 kazF
U E                
Equation 1.10 
 
where UE is the electrophoretic mobility, z is the Zeta Potential, ε is the dielectric 
constant (ratio of the permittivity of a substance to the permittivity of free space), η 
is the viscosity and F (ka) is Henry’s function. Henry’s function can be further 
explained by its individual parameters where k is the Debye length (used to 
describe the ‘thickness’ of the electrical double layer and a represents the radius of 
the particle. Combined, the term can be said to represent the ratio of particle radius 
to the thickness of the double layer.  
 
Measurement of the electrophoretic mobility of a particle was initially achieved by 
visual methods, but is now addressed using the Laser Doppler Effect. This is the 
M3-PALS technique in the Malvern Zeta Sizer software. In the experiment, a laser 
beam is passed through the sample in the cell in the presence of an electrical field 
at an angle of 17º relative to the incident beam. The scattered light from the 
moving particles is shifted in frequency, ΔF, given by the following equation: 
 

 )2/(2
F
Sin
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Equation 1.11
 
 
where ν is the particle’s velocity, λ is the laser wavelength and θ is the scattering 
angle.  
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Figure 1.7: Process of light scattering in the Zeta cell, outlining the angles of the incidence and 
scattering beam, in addition to the behaviour of the ions and intensity of the scattered light on 
application of an electrical charge [58]. 
 
The scattered light is combined with a reference beam and a digital signal 
processor produces a fluctuating signal or phase plot, which is essentially a 
representation of the difference in phase between the measured beat frequency and 
the reference frequency as a function of time. The rate of fluctuation is 
proportional to the velocity of the particles, with particles of a higher level of 
mobility resulting in more frequent fluctuations than their slower counterparts. 
These fluctuations are what are responsible for the initial artefact in the resulting 
phase plot of the plot as outlined in Figure 1.8, whereas the latter part is 
determined by the surface charge of the particle and the magnitude by which the 
measured beat frequency differs from the reference frequency of 320 Hz. 
 
Particle mobility
Surface charge 
and magnitude of 
shift from 
reference beam
 
 
Figure 1.8: Sample phase plot for a particle with a negative ( - ), neutral ( - ) and positive ( - ) 
zeta potential 
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1.6 Principles of NMR 
 
 
Nuclear spin and the effect of an applied magnetic field 
 
Hydrogen nuclei (protons) possess magnetic properties known as nuclear spins that 
have magnetic characteristics. The concept of spin was first postulated by Pauli in 
the 1920’s, with the aid of Ralph Kronig, George Uhlenbeck and Samuel Goudsmit 
whom, following Pauli’s mathematical predictions, provided further information 
into its interpretation as the activity of a particle spinning on its own axis. Spin is a 
property that can be defined as a form of angular momentum that is a fundamental 
characteristic of primary particles. This angular momentum, the spin angular 
momentum, is quantised and can be represented by the following equation 
 
 
)1(  SShS
              
Equation 1.12
 
 
where h represents Planck’s constant and S is the Spin angular momentum (a non-
negative integer or half integer). It follows from this equation, that the nuclear 
angular momentum can be derived (Equation 1.13) 
 
)1(  IIP 
            
Equation 1.13
 
 
where I is defined as the nuclear spin quantum number and is expressed as 0 or ½ 
numerical values. Associated with this angular momentum is a particles’ magnetic 
moment, μ, which can also be related to the gyromagnetic ratio by the following 
equation: 
 
I 
                 
Equation 1.14
 
 
where γ is the proportionality constant otherwise known as the gyromagnetic ratio 
and is unique for a given nucleus and determines the sensitivity of that nucleus in 
NMR ,with higher γ values resulting in a greater sensitivity). It follows that, for 
nuclei of zero spin I, there is no associated magnetic moment (Equation 1.14), 
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whereas 
1
H nuclei of I =½  will possess a magnetic moment according to the same 
equation.  
 
Quantum mechanics describes that a nucleus of spin I will have 2I + 1 possible 
orientations in the presence of a magnetic field. For nuclei (e.g. 
1
H, 
13
C) that 
possess a spin of +1/2, two possible orientations (2(1/2) +1)) will exist. This is 
known as the Zeeman Effect and can be represented (in this instance for nuclei of 
spin ½) with the following diagram: 
 
B0
Bo= 0 B0 ≠ 0
Ms +1/2
ΔE=ɣћB0
Ms -1/2
 
 
Figure 1.9: Schematic representation of Zeeman equilibrium distribution of nuclear spins 
with I = ½ in the presence of a magnetic field, B0. 
 
 
In the absence of a strong applied magnetic field, all spins are randomly 
distributed, resulting in zero net magnetisation in the sample. When a magnetic 
field B0 is applied, however, spins adopt an alignment with (parallel) or against 
(anti-parallel) the applied field i.e. spins can exist in one of two states; the α-state 
or the β-state. The α-state is lower in energy and tends to possess a higher 
population of spins. The ratio of nuclear spin population in the α-state to the β-state 
is represented by the Boltzmann equation (Equation 1.15). 
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where ΔE is the difference in energy of the two states and T is the absolute 
temperature (Kelvin). The energy difference is proportional to the strength of the 
field applied and can be defined by: 
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This energy difference is low in energy due to a small population bias towards the 
lower energy α-state, and results in a small net magnetisation (M0), that aligns with 
the applied field, B0. The bulk sample magnetisation, M0 can be visually 
represented with the use of the vector model diagram for angular momentum. A 
typical diagram is constructed as shown: 
Z axis
xy plane
B0  
Figure 1.10: Vector model diagram for an assemble of 
1
H nuclei in the presence of a magnetic 
field applied along the z-axis.   
 
When a 90º pulse is applied, M0 will be rotated into the xy plane and will precess 
there for a period of time. The frequency at which the magnetisation precesses is 
called the Larmor frequency, νL, and is represented by: 
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            Equation 1.17
 
 
There are two processes that exist by which M0 can evolve as it returns to a state of 
thermal equilibrium following perturbation via an RF pulse. The first process, T1, 
or the spin-lattice relaxation time is associated with the recovery of longitudinal 
magnetisation towards equilibrium and the second is the spin-spin relaxation time, 
which represents the dephasing of the transverse component magnetisation, in the 
xy plane.  
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Spin-Lattice Relaxation time (T1) 
 
A typical T1 measurement is initiated by perturbing the magnetisation of a system 
out of equilibrium using a 180º pulse so that the magnetisation orientates itself in 
the opposite direction on the z-axis. The magnetisation is then allowed to precess 
for a time τ, after which the bulk magnetisation vector returns to complete thermal 
equilibrium. This process is exponential in duration and can be defined by: 
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            Equation 1.18
 
 
The longitudinal relaxation (T1) process may be diagrammatically illustrated as 
follows: 
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Figure 1.11:Vector model diagram illustrating the longitudinal relaxation (T1) of the bulk  
sample magnetisation, M0, following application of a 180° RF pulse. 
 
 
The subsequent application a 90º pulse generates measurable (transverse) 
magnetisation. This experiment is known as inversion recovery, it can be used to 
measure T1 by systematic variation of the inter-pulse separation. Full recovery of 
M0 back to equilibrium is only achieved when a time of 5 times T1 is allowed. 
Similarly,  in all NMR (and MRI) a recycle delay, of 5 times T1 between each 
measurement is usually applied. Alternatively, by reducing the recycle delay, the 
experiment can be T1-weighted, i.e. any spins with faster relaxation will contribute 
more to the measured signal (or they recover faster). 
 
Spin-spin relaxation time (T2) 
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If instead we use a 90º pulse to perturb the system, M0 will be rotated into the xy 
plane and all spins precess in-phase with each other. As time progresses, the 
individual nuclei undergo spontaneous relaxation by exchanging RF energy with 
the spin system, resulting in an increase in thermal energy (entropy). A loss in the 
organisation of the spins is observed as they begin to ‘fan out’, losing phase 
coherence as they do so. This leads to the eventual loss of magnetisation in the xy 
plane. T2 relaxation processes are represented by the equation below: 
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The typical dephasing of the transverse magnetisation, prior to recovery, is shown 
in the following series of vector diagrams: 
 
RelaxationRelaxation
y
z
x
y
z
x
y
z
x
y
z
x
90o
T2 T1
 
 
Figure 1.12: Vector diagram series for a typical spin-spin T2 relaxation process of the bulk 
magnetisation, M0 where T2<T1 
 
In addition to T2 relaxation, inhomogeneity in the applied field also gives rise to a 
T2
*
 process, which is defined as the characteristic time taken for the transverse 
magnetisation to decay to approximately 1/3 (37%) of its original magnetisation. 
T2
*
 process arise due to field inhomogeneities causing variations in the magnetic 
field experienced by individual nuclei which, in turn, cause them to move at 
different frequencies. This typically results in a more rapid decay of the bulk 
magnetisation than that observed in T2 processes. The manner in which the 
transverse magnetisation actually decays is by a combination of both T2 and T2
* 
processes, and can be summarised by Equation 1.18 below: 
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            Equation 1.20
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In an attempt to eliminate field inhomogeneity, a spin-echo pulse sequence (Hahn 
sequence) can be used to refocus the magnetisation back to equilibrium [59]. This 
process involves the application of a 90º pulse to initially dephase the 
magnetisation vector into the xy plane as a result of  both T2 and T2
*
 processes, 
followed by a 180º pulse after a time τ to refocus or rephase the spins, due to field 
inhomogeneities (i.e. due to T2
*
) allowing them to gain phase coherence. The 
transverse magnetisation is thus recovered, and an echo is produced at a time 2τ. 
As true T2 processes occur spontaneously in nature, dephasing of nuclear spins in 
this case cannot be reversed, and phase differences between the first and second 
fractions of the echo exist. This results in attenuation of the echo intensity 
according to T2, with a noticeable decay in the intensity of subsequent echoes 
evident at a rate of 1/T2. 
 
T2
T2
*
2
90o 180o
 
Figure 1.13: Spin echo pulse sequence and the attenuation of echo intensity after a single 180° 
pulse 
 
 
Meiboom and Gill [60] developed a modification of Carr and Purcell's multi-echo 
pulse sequence, more commonly referred to as the Carr-Purcell-Meiboom-Gill 
(CPMG) model, to compensate for diffusion effects and thus improve T2 
determination. The CPMG sequence involves the application of multiple coherent 
180º pulses and can be demonstrated by the following sequence diagram: 
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T2
*
Time  
Figure 1.14: CPMG pulse sequence with application of multiple 180° pulses 
 
In the model shown above, it can be seen that successive echoes are formed 
halfway between any two consecutive 180º pulses, with the amplitude of 
subsequent echoes decreasing with characteristic time T2 [61]. The application of 
multiple 180° pulses ensures that any errors that arise due to deviations of the exact 
angle of the applied pulse are rectified, thus improving measurement 
reproducibility. The CPMG pulse sequence was used throughout this thesis for 
measurement of T2. 
 
1.7 Fast-Field Cycling NMR (FFC-NMR) 
 
Fast-field cycling NMR (FFC-NMR) is a technique used to obtain the frequency 
(or magnetic field) dependence of longitudinal relaxation times, T1, or alternatively 
relaxation rates R1 (1/T1) for a given colloidal suspension over a particular 
magnetic field strength range (typically 10kHz to 10MHz).  Through this method, 
plots of R1 as a function of frequency are generated. These plots are more 
commonly referred to as nuclear magnetic dispersion profiles, or NMRD profiles, 
and are useful in the investigation of the molecular dynamics within a colloidal 
system and the properties of particles contained within it.  
 
The technique involves the polarisation of the sample magnetisation in a magnetic 
field with a high flux density. Relaxation of the magnetisation is permitted to take 
place by switching to the relaxation field for a time  and, following this, to an 
acquisition field (9.25 MHz) where the signal is acquired. This process is repeated 
a number of times for a range of  values, to measure T1, and then for a range of 
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Brlx values forming an NMRD profile. Longitudinal relaxation processes require a 
time-dependent magnetic field that fluctuates at a particular frequency, known as 
the Larmor frequency. The fluctuations that initiate the transitions driving 
relaxation arise due to modulation of the proton-proton (or proton-electron) dipolar 
interactions driven by dynamic processes over a time scale ω. NMRD profiles 
provide information in relation to the molecular motions of a system in the form of 
the spectral density function, J(). For a system where relaxation is driven by a 
single motion, the spin-lattice relaxation rate, R1, is given by: 
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where μ0 is the vacuum permeability, h is Planck’s constant, r is the distance 
between neighbouring 
1
H nuclei and J(ω) and J(2ω) are the spectral density 
functions evaluated at the Larmor frequency and twice the Larmor frequency 
respectively. These functions represent the only allowed frequencies for induced 
single- and double-spin flip transitions between the energy levels of the spin 
system. The efficiency of the local fluctuating fields to induce transitions is given 
by the spectral density function, which is defined by Equation 1.22.  
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Fluctuations of these local magnetic fields originating from random rotational, 
vibrational and diffusional motions of the particles present give rise to exponential 
functions of the form: 
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where τc is the correlation time which characterises the dynamic processes in 
suspension and is a decay constant of G (τ). Longer τc times indicate the presence 
of larger particles whereas shorter times represent those smaller in size. Fourier 
transforms of exponential functions give rise to Lorentzian spectral density 
functions where: 
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The rate of the random vibrational, rotational and diffusional motions mentioned 
above, represented by τc
-1
, can be derived from the half-width of the Lorentzian 
spectral function. Cosine Fourier transforms of the correlation function (spectral 
density function) are directly connected with relaxation (Equation 1.21). Thus the 
NMRD profile allows mapping of the spectral density.  
 
Figure 1.15: Correlation functions G(t)  for three different values of τc of 10 ns ( - ), 100 ns ( - ) 
and 1000 ns  ( - ) and their corresponding simulated spectral density functions J(ω) 
 
The spin-lattice relaxation time, T1 (and also the spin-spin relaxation time, T2) can 
also be expressed as a function of the correlation time at a particular Larmor 
frequency with the relationship outlined in Figure 1.16 below. Interaction with the 
small random fluctuating magnetic fields leads to spin-lattice relaxation with the 
most efficient relaxation effected by motions with τc = 1/(2πνo). Equally, these 
same random local magnetic fields are also necessary for spin-spin relaxation, with 
the difference being that the relaxation becomes more efficient as τc becomes 
longer, i.e. as the motions become slower and the local magnetic fields become 
more static. It follows that, as τc becomes larger, i.e., the molecular motion 
becomes slower, the value of T2 becomes smaller than T1. The literature outlines 
the typical correlation times for molecular motion, either rotational or translational, 
is 10
-12 
to 10
-11
 s for small molecules (e.g. water), 10
-9
 to 10
-6 
s for macromolecules 
of increasing size (or small molecules bound to macromolecules), and 10
-6
 to 10
-3
 s 
for some motions in membranes. 
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Figure 1.16: A typical plot of log T1 and log T2 as a function of log c mapping out the extreme 
narrowing and slow motion limit phases. 
 
 
It is evident from the plots presented in Figure 1.16 above, that three distinct 
ranges for ωτc exist. These can be categorised as follows: 
 
(i) Extreme narrowing phase ( ωc< 1):  In this range, the rate of fluctuations is 
much higher than the resonance frequency and is generally observed for small 
molecules in non-viscous solvents. The fast motions of the molecules averages 
out the interactions between them and T1 = T2 ≈ ~1/5Kc , where K is a constant 
equal to 30
2ħ24/1602r6, and the relaxation times are independent of frequency 
[62]. 
 
(ii) Point of T1 minimum ( ωc ≈ 1): This is where the relaxation is observed to be 
most efficient and is typical of medium sized molecules or viscous solvents. 
 
(iii) Slow-motion limit phase ( ωc > 1): The rate of fluctuations in this region is 
slow, and is generally characteristic of slowly tumbling molecules or 
macromolecules in viscous media. There is no strong spectral density contribution 
to the relaxation near the Larmor frequency, corresponding to the high frequency 
limit in Figure 1.16. Thus, the value for T1 is high.  
 
In conventional NMR, T1 is measured as a function of τc, e.g. by changing the 
temperature. Analysis of such data (Figure 1.16) requires a model for the 
dynamics. The most prominent advantage of field cycling methods over 
conventional NMR analyses is in the ability to study the dynamics of a system over 
a wide field frequency range, while keeping the temperature of the measurement 
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constant. This provides the scaled spectral densities, removing the need for a 
dynamic model. In addition to this, if a Lorentzian spectral density function is not 
inappropriate, e.g. for non-random motions, this will instantly be obvious from the 
shape of the profile. The use of NMRD in studying the dynamics of magnetic 
moments, e.g. of IONP in suspension, is a good example of these advantages, as 
will be discussed below. 
 
1.8 Magnetism and classes of magnetic materials 
 
All materials, regardless of whether they are magnetic or non-magnetic in nature, 
can be classified based on their response to the application of an external magnetic 
field. Five main types of behaviour exist and are as follows; diamagnetism, 
paramagnetism, ferromagnetism, antiferromagnetism and ferrimagnetism.  
 
The extent to which a given material becomes magnetized when in the presence of 
such a field is known as the magnetic susceptibility, as expressed by the following 
equation: 
 
H
M
               
Equation 1.25
 
 
where M represents the magnetisation and H is the applied magnetic field. As both 
M and H are measured in amperes per meter, χ is a dimensionless quantity.  
 
When a material is placed under the influence of a magnetic field, electromagnetic 
interactions take place which concentrate or disperse the lines of the magnetic 
field, resulting from the actions of orbital and delocalized electrons within the 
species. These interactions are then responsible for the induction of an internal 
magnetisation that either opposes or amplifies the applied magnetic field. When 
the direction of this field is opposite to that of the internal magnetisation of the 
material, it is said to be diamagnetic in nature [63]. In the opposite scenario, the 
material is categorized as paramagnetic [64]. 
 
Diamagnetic materials typically include organic molecules and some metals e.g. 
gold, copper, lead, water and biological tissue. They possess no net magnetic 
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moment in the absence of a magnetic field. This can be attributed to the absence of 
unpaired electrons within the orbital shells of such materials. Upon application of 
an external magnetic field, the magnetic dipoles within these materials align in a 
manner so as to oppose the direction of the applied field. The result is a small and 
negative bulk magnetic susceptibility as shown in Figure 1.17 below: 
 
H
H=0
 (a)       
H
M
slope = 
M= H
 < 0
(b) 
 
Figure 1.17: (a) Behaviour of dipole moments in the presence and absence of a magnetic field 
for a diamagnetic material and (b) direction and magnitude of magnetic susceptibility 
 
Paramagnetic materials exhibit behaviours that contrast those of their diamagnetic 
counterparts in terms of their alignment on application of a magnetic field. They 
also possess no net magnetisation in the absence of an external field but for a 
different reason. Paramagnetic materials are composed of small magnetic dipoles 
that are randomly oriented, resulting from the presence of unpaired electrons. In 
the presence of an applied field, these dipoles line up in parallel with the field and 
produce a net magnetisation. Magnetic susceptibilities in this instance are small 
and positive as shown in Figure 1.18. 
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Figure 1.18: (a) Behaviour of a paramagnetic material with increasing external field and (b) 
characteristic direction and magnitude of magnetic susceptibility 
 
On increasing the temperature of a paramagnetic material, however, the alignment 
of the moments in the applied magnetic field is compromised by thermal agitation 
of the atoms present, which causes them to lose alignment and results in an overall 
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decrease in the magnetisation of the material. This results in a temperature 
dependent susceptibility. 
 
 
The inverse relationship between the magnetic susceptibility and temperature can 
be described by the Curie Law, that states that the magnetisation in a paramagnetic 
material is inversely proportional to its temperature and can be described by 
Equation 1.26. 
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where C represents the Curie constant, H the applied magnetic field and T is the 
temperature of the material. The Curie Law only holds true for conditions of high 
temperature or low magnetic field strength, as at low temperatures and high field 
strengths, saturation of magnetisation occurs and dipoles align with the field to a 
point where further increase in field strength has a minimal effect.  
 
Ferromagnetic materials possess the property of acting as ‘permanent magnets’, in 
that they demonstrate bulk magnetisation in the presence and the absence of a 
magnetic field [63]. Ferromagnetic materials are composed of many small 
magnetic domains aligned in the same direction, usually due to quantum 
mechanical exchange coupling. This coupling results in either parallel or anti-
parallel alignment of moments of the material under the influence of the field. 
Ferromagnetic materials possess multiple magnetic domains in which all spins in a 
given domain will align with one another and become locked in one single 
orientation, as shown by Figure 1.19:  
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Figure 1.19: Behaviour of a ferromagnetic material in the absence and presence of a magnetic 
field 
 
 
Two principal phenomena exist that are characteristic of ferromagnetic materials; 
spontaneous magnetisation and a magnetic ordering temperature. In the absence of 
a magnetic field, the net magnetisation present will depend on the spin magnetic 
moments of the electrons present. On removal of an applied magnetic field, 
ferromagnetic materials retain a small fraction of the applied magnetisation. This 
phenomenon is more commonly referred to as magnetic hysteresis. A plot of the 
change in magnetisation with respect to the applied field is known as a hysteresis 
loop and is representative of the magnetic parameters of a given ferromagnetic 
material. When an alternating magnetic field is used, the resulting hysteresis loop 
adopts the shape shown in Figure 1.20. 
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Figure 1.20: Typical shape of a hysteresis loop outlining the relationship between the 
magnetisation of the sample (M) and the strength of the external magnetic field (H). 
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The first stage of hysteresis loop formation involves driving the material using an 
applied magnetic field to a state of magnetic saturation, Ms (Figure 1.20(a)), where 
all moments are locked and aligned along the same axis so as to oppose or align 
with the field. On removal of this field, the magnetisation does not return directly 
to zero, as some moments remain aligned with the field and so must be driven back 
by an applied field in the opposite direction. The remnance (Mr) (Figure 1.20(b)), 
of a material originates from the small population of magnetic domains that remain 
aligned with the field for some time upon the gradual reduction of the field back to 
zero and is essentially the residual magnetisation that remains in the sample 
following removal of that field. On reversal of the direction of the applied field, a 
fraction of the magnetic domains will change their direction of orientation or ‘flip’, 
resulting in an overall net magnetisation of zero (Figure 1.20(c)),. This is what is 
known as the coercive field (Hc), or coercivity, and the force required to overcome 
the remnance is known as the coercive force. The magnetisation is once again 
driven to saturation in the negative direction (Figure 1.20(d)), before driving it 
again in the positive direction by reversing the direction of H (Figure 1.20(e)). A 
final increase in the magnetic field in the positive direction then brings the sample 
magnetisation to zero (Figure 1.20(f)). The curve then adopts a path from this point 
back to the saturation magnetisation in the positive direction, thus completing the 
loop.  
 
Manipulation of the magnetisation of ferromagnetic systems can also be achieved 
through variations in temperature, where disorder can be generated within the 
material, creating a randomising effect on the exchange forces of the electrons 
present. The temperature at which this disorder is observed is known as the Curie 
temperature (Tc) and is an intrinsic property that provides an indication of the 
thermal energy required to perturb the ordering within the ferromagnet. Below, Tc 
the ferromagnet will appear ordered, whereas temperatures above Tc will result in 
disorder of the system where the material will exhibit normal paramagnetic 
behaviour once again. 
 
Antiferromagnetism arises from the coupling of adjacent moments which align 
themselves in an opposite or antiparallel manner with each other (opposite 
situation to ferromagnetism hence the term anti-ferromagnetic) [64]. In contrast to 
ferromagnetic materials, these exhibit a net overall magnetisation of zero in the 
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absence of an applied field. This alignment may be disturbed by thermal energy, 
and disorder can be generated within the material above a particular temperature, 
known as the Néel temperature (TN). Above this temperature, thermal agitation 
perturbs the alignment of the moments and the material exhibits paramagnetic 
behaviour.  
 
Ferrimagnetic materials are quite similar in nature to those which are 
antiferromagnetic, in that individual moments align themselves in an anti-parallel 
manner with the applied magnetic field but differ in the fact that the magnitude of 
the opposing magnetic sub-lattices are unequal in magnitude. This results in a 
small net magnetisation when such a material is placed in a magnetic field. 
Ferrimagnetic behaviour is commonly observed in ferrite materials, which include 
the iron oxides magnetite (Fe3O4) and maghemite (γ-Fe2O3).  
 
 
  (a)           (b) 
 
Figure 1.21: Illustration of dipole alignment in an (a) antiferromagnetic and (b) ferrimagnetic 
material 
 
In the case of magnetite, an inverse-spinel structure exists within the crystal, which 
can be separated into two distinct ferromagnetic sublattices; tetrahedral sites, 
occupied by trivalent iron ions (Fe
3+
), and octahedral site that contains both di- and 
trivalent iron ions (Fe
2+
 and Fe
3+
) [65]. The structural formula for arrangements of 
this type can be written as [Fe
3+
]A [Fe
2+
, Fe
3+
]B O4
2-
. In terms of the oxygen atoms 
present, Fe has 6 Oxygens as nearest neighbour at the octahedral site and 4 at the 
tetrahedral site. This arrangement is illustrated by Figure 1.22 below. Below the 
Curie temperature, the true magnetic sublattices are strongly exchange coupled, 
and oppose each other. 
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Figure 1.22: Crystal structure of Magnetite 
 
 
In the case of maghemite, or γ-Fe2O3, a similar crystal structure is observed. 
However, both the tetrahedral and octahedral sites are occupied by Fe
3+
 ions only, 
in addition to cation vacancies in some octahedral sites [65]. Similar exchange 
coupling is observed to Fe3O4 but the total magnetisation is much smaller. 
 
Oxygen, vacancies
Tetrahedral A site Fe 3+
Octahedral B site Fe 3+
 
 
Figure 1.23: Crystal structure of Maghemite 
 
One further type of magnetism can be observed for very small, single-domain 
crystalline particles, and it is known as ‘superparamagnetism’. In this case the 
magnetisation of the individual domains (particles) exhibit magnetisation due to 
the exchange coupling of electrons (ferrimagnetic for Fe3O4 and or γ-Fe2O3). When 
the diameter of ferro- or ferrimagnetic particles are decreased below their 
characteristic critical diameter, the formation of these individual domains becomes 
unfavourable due to an increased relative domain wall energy, and particles adopt a 
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single-domain arrangement as a result. This critical diameter, Dc, can be defined by 
the following equation: 
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where A is the exchange constant, Keff is the uniaxial anisotropy constant, μ0 is the 
constant of permeability and MS is the saturation magnetisation. For Fe3O4 and γ-
Fe2O3, Dc values have been determined at 128 nm and 166 nm respectively [66].  
 
On decreasing the size of the single domain particles further, a transition in the 
magnetisation of the particles from a ferromagnetic to a superparamagnetic state is 
observed to occur. Below the superparamagnetic size limit, DSPM, the thermal 
energy kBT is greater than that required to reverse the direction of the magnetic 
moments. The magnetisation can then spontaneously flip between two equivalent 
magnetic orientations about a particular axis, known as the ‘easy axis’, in either a 
parallel or anti-parallel fashion with the applied field. The energy required for this 
process is commonly referred to as the anisotropy energy and can be represented 
by the following equation: 
 
 2)( VSinKE effanis                
Equation 1.28
 
 
where keff is the anisotropy constant, V is the particle volume and θ denotes the 
angle between the magnetisation and the easy axis.   
 
A plot of the change in energy as a function of the magnetisation direction for a 
single domain particle is as shown in Figure 1.24. The resulting plot exhibits two 
energy minima at θ = 0 and θ = π, which correspond to magnetisation directions 
parallel and anti-parallel to the easy axis respectively.  
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Figure 1.24: (a) Illustration of anisotropy energy for a single-domain particle with uniaxial 
anisotropy. Eanis is the energy barrier for the rotation of the magnetisation, and  is the angle 
between the magnetisation, M, and the easy axis as illustrated by  1.27 (b). 
 
For an assembly of isotropic single-domain particles where no inter-particle 
interactions exist, values for kBT are much greater than those for the uniaxial 
anisotropy constant, Keff and the system behaves more like a paramagnet, with the 
exception that its magnetic moment is not just that of a single atom. Instead, the 
sum of the moments of all atoms present in the particle are accountable for the total 
magnetisation of each single domain particle, otherwise known as a 'super-spin' 
which fluctuates in an orderly fashion [67].  
 
In the absence of an applied field, the moments will readopt their random 
distribution in the domain and alignment in one particular direction is no longer 
observed, i.e. the material retains no net magnetisation.  
 
The time taken for this ‘flipping’ process or fluctuation to occur is represented by 
the Néel correlation time (τN) and is calculated using the following equation: 
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where kB is the Boltzmann constant, T is the temperature and τ0 is ~10
-9
 s. 
 
The rate at which this process occurs is, in turn, dependent on temperature, with 
the rate of fluctuation decreasing with decreasing temperature until the moments 
are static, where their motions and are said to be ‘blocked’. The temperature at 
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which this process occurs is known as the blocking temperature given by Equation 
1.30: 
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1.9 SPM theory for estimation of nanoparticle physical parameters  
 
 
An increasing interest has emerged in the use of SPM theory in fitting 
experimentally derived NMRD profiles using a model system that allows for 
estimation of several physical parameters of nanoparticles and nanoparticulate 
materials. These are the IONP size, saturation magnetisation (Ms), Néel correlation 
time (τn) and anisotropy energy (ΔEanis). Several studies into the superparamagnetic 
relaxation mechanism have been reported in the literature [68] validating its use in 
the determination of these parameters by SPM theory. The first theoretical 
approach, and the most generally accepted theory to date, was developed by Müller 
et. al [69], in an attempt to describe the magnetic interactions between 
superparamagnetic colloids and solvent molecules in aqueous suspension. It has 
since extended from the classical outer sphere theory of relaxation to include a 
high Curie component, associated with the high field fragment of the NMRD 
profile (>0.02 T), and the internal anisotropy energy of the crystal, responsible for 
the lower one. The theory is based on the interpretation of NMRD profiles that 
represent the dependence of 
1
H longitudinal relaxivity, r1, on the strength of the 
external magnetic field. 
 
The shape of the NMRD profiles for superparamagnetic nanoparticles possess 
common features, namely the occurrence of a low field plateau, followed by an 
observed increase in R1 at higher field to produce the high field dispersion before 
finally decreasing to zero at much higher fields [70].  
 
Both Néel and Brownian relaxation processes contribute to the overall resulting 
shape of the NMRD profile, with smaller particles exhibiting low field dispersion 
due to Néel relaxation processes. As the anisotropy, or indeed the particle size 
increases, fewer contributions are made from Néel process and Brownian 
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contributions dominate. This results in the attenuation of the low field dispersion 
until it vanishes. These effects are illustrated in Figure 1.25 overleaf. 
 
 
Figure 1.25: Néel and Brownian relaxation contributions to the shape of the NMRD profile for a 
superparamagnetic material [71]. 
 
The key parameters that determine the shape and relaxivity of the NMRD profile 
include the primary particle core size, which defines the frequency of the r1 
maximum in the NMRD profile (as the high frequency relaxation is driven by the 
diffusion of the solvent). Nanoparticles of larger core sizes will exhibit r1 maxima 
at lower frequencies. The relevant timescale is the characteristic diffusion time τD, 
defined by: 
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where d is the core diameter of the colloid and D is the diffusion coefficient. The 
dependence of the r1 maximum on particle size is shown in Figure 1.26. 
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Figure 1.26: Simulated relaxivity plots demonstrating the effect of increasing the particle 
diameter from 4 nm ( - ) to 5 nm ( - ) , 6 nm ( - ), 7 nm ( - )  and 8nm ( - ) All other parameters 
were kept constant at values of Ms = 40 emu.g
-1
, N = 2 ns,Eanis = 2 GHz and D=3.5x10
-5
 ns 
 
The relaxivity is also largely governed by the saturation magnetisation (Ms), and is 
defined as the maximum magnetisation achieved by a material in a magnetic field. 
Colloids possessing higher saturation magnetisation will exhibit profiles of higher 
amplitude than those of lower Ms values as demonstrated by Figure 1.27 . 
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Figure 1.27: Simulated relaxivity plots demonstrating the effect of changing the saturation 
magnetisation where Ms=17 emu.g
-1
( - ), and 56emu.g
-1
( - ). All other parameters were kept 
constant with , N = 2 ns, dSPM= 12 nm,Eanis = 2 GHz and DH2O= 3.5E-5 cm
2
s
-1 
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The relaxation at low fields is dependent on the fluctuations of the magnetic 
moments present and, hence on the Néel correlation time, τn. Simulations of the 
effect on changing τn are shown in Figure 1.28 below. 
 
Figure 1.28: Simulated relaxivity curves showing the effect of increasing the Neel correlation 
time where values for N were set at 4 ns ( - ), 6 ns ( - ), 8 ns ( - ) and 10 ns ( - ) with all other 
parameters kept constant at Ms = 40 emu/g, dSPM= 12 nm, E = 2 GHz,  and DH2O = 4.02e-
5cm
2
s
-1
 
 
 
Furthermore, modification of the diffusion coefficient can influence both the 
amplitude of r1 and also the position of the r1 maxima/minima. Upon reduction of 
the diffusion coefficient, D, from a value of 2.5x10
-5 
cm
2
/s to 1.5x10
-5 
cm
2
/s and 
further to 1.25x10
-5
 cm
2
/s for example, we observe an increase in the overall 
relaxivity of the NMRD profile, in addition to an increase in the amplitude of the 
peak at higher frequency. This increase in r1 may be attributed in the simulation to 
increasing the local viscosity of the water in the immediate vicinity of the magnetic 
nanoparticles, thus increasing D and driving the maximum r1 back to lower 
frequency. Increasing D is equivalent to increasing τc, which, in some sense, is 
equivalent to increasing particle size (Equation 1.31). This demonstrates that 
altering the water dynamics in the vicinity of the nanoparticles can have a 
significant effect on the relaxivity properties of the nanoparticles. 
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Figure 1.29: Simulated relaxivity curves showing the effect changing the diffusion coefficient, 
where D=3.5E-5 ( - ), 1.5E-5 ( - ) and 1.25E-5 ( - ). The remaining parameters were Ms = 40 
emu/g,  dSPM= 12 nm, N = 2 ns 
 
The final parameter that can be estimated by SPM plot simulations is the 
anisotropy energy, or ΔEanis, and is the effective activation energy required to 
invert the orientation of the particle spin. The depth of the dip at the mid-frequency 
region of the profile is dependent on this value which, in turn, is dependent on the 
diameter of the particles present. The anisotropy energy for single-domain particles 
is proportional to their volume, and will be observed to increase with increasing 
diameter.  
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Figure 1.30: Simulated relaxivity curves showing the effect of increasing the anisotropy energy 
ΔE. The values of E in these simulations were 1 GHz( - ), 2 GHz( - ), 3 GHz( - ) , 4 GHz ( - ) and 
5 GHz ( - ) the remaining parameters were Ms = 40 emu/g,  dSPM= 12 nm, N = 2 ns, DH2O = 4.02e-
5 cm
2
s
-1
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The SPM model approach has received much interest in the literature as it provides 
information on the magnetic properties of the colloid in situ, as sensed by the 
diffusing solvent molecules. Taboada et al, for example [68], report the efficacy of 
the model in studying the relaxometric behaviour of ultra-small nanoparticles of 
maghemite and estimating the potential of prepared dispersions for use as contrast 
agents for MR imaging [72].  
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CHAPTER 2 
Experimental 
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2.1 Objective 
 
The purpose of this chapter is to outline all experimental techniques that were used 
throughout the course of the work presented in this thesis. Each technique is 
described in terms of its general background and theory, including discussion of 
any relevant physical relationships involved, in addition to experimental conditions 
used and practical considerations to be considered during analysis. 
 
2.2 Photon Correlation Spectroscopy (PCS) 
 
2.2.1 Theory of PCS 
 
Photon Correlation Spectroscopy (PCS), or Dynamic Light Scattering (DLS) as it 
is otherwise known, is a light scattering technique used to determine the 
hydrodynamic size of dispersed, sub-micron sized particles by measuring the time-
dependent fluctuations in scattering intensity and subsequently determining the 
translational diffusion coefficient (D) and hydrodynamic diameter (dhyd) of the 
suspended nanoparticles giving rise to the scattering [73]. The fluctuation arises 
due to the random motion of sub-micron dispersed nanoparticles observed within a 
given solvent medium. This constant random motion, Brownian motion, occurs 
due to collisions of individual nanoparticles with the surrounding solvent [74]. 
 
A typical PCS measurement is conducted as follows; a laser light (typically 3 mW 
He-Ne laser), operating at a wavelength of 633 nm is passed through a cuvette 
containing the sample of interest. A fraction of this light is then scattered by the 
particles dispersed within the solvent the backscattered fraction of which is 
measured by a detector at an angle of 173˚. The signal intensity of the light is 
governed by the constant motion of the particles, and fluctuates as a function of 
time. A digital auto-correlator is used to process the resulting signal intensities at 
specific time intervals in order to determine the time scale of the fluctuations and 
thus the size of the particles present. Larger particles cause signal intensities to 
change more slowly due to their slower diffusion rates, whereas smaller particles 
move faster through the solvent leading to more rapid signal fluctuations. Smaller 
particles will therefore result in a more rapid reduction of the signal correlation, 
while larger particles will demonstrate a much more gradual decay. Particles that 
 51 
are monodisperse and are in random Brownian motion will thus give rise to an 
exponential correlation function (G), represented by Equation 2.1: 
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where τ is the sample time of the correlator and τc is the correlation time of the 
decay of G (τ). The correlation time is defined as the mean time between 
diffusional steps and the inverse of this correlation time gives the diffusional rate 
τc
-1
. 
 
 
 
Figure 2.1: Correlation functions and differences in the  intensity fluctuations of large and 
small particles [74] 
 
 
This time dependence of scattered light intensity can then be related to the particles 
diffusion coefficient, D, using Equation 2.2 below where k, representing the 
magnitude of the scattering vector, can in turn be represented by Equation 2.3: 
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The calculated diffusion coefficient can then be related to hydrodynamic size of the 
particles present using the Stokes Einstein equation (Equation 2.4): 
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                     Equation 2.4 
 
where kB is Boltzmann’s constant, T is the absolute temperature,  is the viscosity 
of the solvent medium and dhyd is the hydrodynamic diameter of the particle . 
 
The hydrodynamic diameter (dhyd) of an individual particle is defined as the 
diameter of the core of the nanoparticle plus any associated ligands or bound 
solvent molecules attached and is not the true size of the nanoparticle itself [73]. It 
can be observed from the Stokes-Einstein equation outlined above (Equation 2.4) 
that a number of factors exist that can have an impact on the measured dhyd of a 
given particle. It is evident, for example, that the hydrodynamic size of the particle 
is dependent on measurements carried out at a constant temperature (and therefore 
viscosity) as this governs the diffusion coefficient, D. The shape and surface 
characteristics of the particle also have an effect on the overall observed 
hydrodynamic size. 
 
dh  
 
Figure 2.2: Schematic of the hydrodynamic diameter of a particle 
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The correlation function contains the diffusion coefficient information required by 
the Stokes-Einstein equation for determination of the hydrodynamic size of a given 
particle in solution and the subsequent polydispersity index (PDI) of the dispersion 
in which it exists [75]. These coefficients are obtained by fitting the correlation 
function with one of two suitable algorithms; the cumulants analysis, which fits a 
modified exponential to the correlation function in order to determine a mean size 
and PDI, or the distribution analysis, which utilises Mie scattering simulations of 
trial particle distributions to model the exponential response. 
 
The cumulants analysis is defined in the International Standard on Dynamic Light 
Scattering ISO13321 (1996) [76] which states that a third order polynomial should 
be used in the determination of mean hydrodynamic size and PDI of the form 
shown in Equation 2.5 below: 
 
2
1]ln[  cbaG                   Equation 2.5 
 
where τ represents the delay time of the correlator. A plot of ln [G1] as a function 
of time can then be used to derive the z-average diffusion coefficient and the 
polydispersity index of the dispersion as the terms b and 2c/b
2
, respectively, as 
shown in Figure 2.3 below: 
 
 
 
Figure 2.3: Derivation of Z-Average and Polydispersity index from cumulants analysis [74] 
 
 
The polydispersity index (PDI) is essentially a representation of the distribution of 
size populations within a given dispersion. It typically ranges from values of 0.0 to 
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1.0, the latter suggesting a highly polydisperse dispersion with multiple particle 
sizes present. Values of 0.2 and below are most commonly deemed acceptable in 
practice, with some dispersions exhibiting PDI values of as low as 0.02 for 
polymer-based nanoparticle materials.  
 
The correlation function can also be fitted to a multiple exponential model to 
obtain intensity size distributions using the Multiple Narrow Modes algorithm 
based upon a non-negative least squares (NNLS) analysis [77] using commercially 
available software (Dispersion Technology Software, Malvern Instruments; 
Worcestershire, UK). Size distributions are displayed as a plot of the relative 
intensity of light scattered as a function of particle size. A typical intensity 
distribution is presented in Figure 2.4 below: 
 
           
 
 
Figure 2.4: Typical intensity histogram and distribution. 
 
 
2.2.2 Analysis Procedure 
 
PCS measurements were carried out on a High Performance Particle Sizer (HPPS) 
or a Zetasizer Nano ZS supplied by Malvern Instruments, UK. A 3 mW He-Ne 
laser operating at 633 nm was passed through the sample volume (typically 1 mL) 
within a suitably chosen cuvette (plastic for aqueous samples and quartz for non-
aqueous samples) at a constant temperature of 25ºC. A thermal equilibration time 
was first observed at the onset of all measurements to ensure this. The intensity of 
the scattered light was then detected at an angle of 173º to the incident beam 
(backscatter detection). This configuration results in an 8-fold increase in the 
detected scattering volume when compared to the classical 90º scattering detection 
method and, in turn, a similar increase in the count rate observed at the detector. 
This provides an opportunity to measure smaller nanoparticle sizes at lower 
concentrations, as the count rate is directly related to the sensitivity of the 
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instrument. The Z-Average (hydrodynamic diameter) and the PDI are then 
calculated from the cumulants analysis as defined in the International Standards 
ISO13321 (1996) [76] and ISO22412 (1998) [75]. A typical setup of a PCS 
instrument may be illustrated by Figure 2.5 below: 
 
 
Figure 2.5: General setup of a typical PCS instrument 
 
 
2.2.3 Practical Considerations 
 
Typically speaking, PCS is a widely used analytical technique in the determination 
of particle diameters within the nano to micron size range, the lower end of which 
is highly dependent on overcoming experimental obstacles such as thermal 
fluctuations, background noise contributions, any particle contaminants and 
environmental disturbances. It is therefore vital that a number of practical 
considerations are observed when performing dynamic light scattering 
measurements.  
 
In terms of sample preparation, an optimum nanoparticle concentration within the 
sample must be selected. This concentration should be low enough to avoid 
multiple scattering, which can often lead to overestimation of hydrodynamic size, 
but high enough to provide a sufficiently high number of particles for successful 
measurement. The particles must also be fully stable in the solvent medium in 
which they are dispersed so that the number of scatterers (particles) within the 
medium remains constant (i.e. no sedimentation can be seen to occur). 
Additionally, samples should be free from foreign particles (such as dust), as their 
presence will dominate the smaller, more weakly scattering particles of interest.  
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PCS, despite its limitations is, in comparison to other size-determination 
techniques, a fast, user-friendly method of determining particle size within the sub-
micron range which requires little sample preparation and is usually non-
destructive to the sample under analysis. It allows particles to be analysed in 
suspension without the need for drying or precipitation into their solid form (as is 
required with Transmission Electron Microscopy). Measurements are obtained 
within a number of minutes and slight changes in size and polydispersity can be 
observed in real time. This is a critical advantage for some of the work to be 
presented. 
 
2.3 Zeta Potential  
 
2.3.1 Principle of Zeta Potential 
 
As described in greater detail in Chapter 1 (Section 1.5), particles existing in a 
colloidal dispersion in polar solvents can carry their own characteristic surface 
charge or potential, otherwise known as the Zeta Potential, arising from the physics 
of the particles in the dispersion and any associated ligands that may be present. 
Zeta Potential can be defined as the electric potential in the interfacial double layer 
(DL) at the location of the slipping plane (i.e. the point at which the bulk fluid 
meets the particle surface) [58]. In other words, zeta potential is the potential 
difference between the dispersion medium and the stationary layer of fluid attached 
to the dispersed particle. Knowledge of the Zeta Potential of a given dispersion is 
useful in estimating the overall stability of a given colloidal dispersion against 
aggregation as particles with similar surface charges will easily repel each other 
and remain fully dispersed throughout the medium in which they exist. It is most 
favourable that all particles present possess highly positive or negative surface 
charges (usually in excess of ± 30 mV) in order to achieve complete dispersion 
stability.  
 
2.3.2 Analysis procedure 
 
Zeta Potential measurements were carried out on a Zetasizer Nano ZS instrument 
supplied by Malvern instruments (Worcestershire, UK) as illustrated by Figure 2.6 
(below). This system uses a technology known as M3-PALS, a second generation 
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form of the well-established phase analysis light scattering (PALS) technique 
combined with the patented mixed mode measurement (M3) technique [78]. PALS 
is essentially a variation of Laser Doppler Velocimetry (LDV), which involves the 
application of a potential to a dispersion and the measurement of the mobility of 
the particles present using the observed shift in frequency of the light moving 
throughout the cell. This shift is then related to the electrophoretic mobility which, 
in turn, can then be converted to zeta potential using established physical 
relationships. 
 
 
Figure 2.6: Zetasizer instrument setup [58] 
 
The M3 method is a relatively new technique in the measurement of zeta potential 
and involves the use of a technique known as fast field reversal (FFR) which 
greatly enhances the accuracy and resolution of the measurement process. 
Colloidal particles will respond much faster to the applied field as opposed to the 
surrounding liquid inside the capillary cell when this field reversal is rapid, thus 
suppressing any electroosmotic effects that may occur. This means that the 
mobility measured during this period is due to the electrophoresis of the particles 
only. More specifically, an M3 measurement involves the following steps; firstly, 
an FFR measurement is performed at the centre of the capillary cell to determine 
the mean distribution of the potential, followed by a slower field reversal (SFR) 
process which further enhances the resolution of the measurement [58]. The mean 
values for both processes are calculated and subtracted from one another to 
determine the electroosmotic flow of the particles dispersed within the medium. 
This value, in turn, is used to calculate the zeta potential. A representation of the 
FFR and SFR contributions to the resulting phase plot is as shown in Figure 2.7. 
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Figure 2.7: FFR and SFR contributions to Zeta Potential Phase Plot 
 
 
Combining PALS with the M3 technique ensures a much more accurate 
measurement of the Zeta Potential of the particles present within a given 
dispersion, particularly if the said particles exhibit tendencies of low mobility 
and/or high conductivity. Particle mobility measurements using PALS are made by 
comparing the phase of the detected signal of the scattered light with that of a 
reference beam or signal with a set frequency of 320 Hz. A plot of the phase 
difference as a function of time demonstrates a gradient dependent on the 
magnitude of this difference, which then is used to determine the value for the Zeta 
Potential. The sign of the potential (positive or negative) results from whether the 
observed frequency of the scattered light is in excess or falls below the frequency 
of the reference beam. 
 
2.3.3 Practical considerations 
 
As with PCS particle sizing experiments, the measurement of Zeta Potential is also 
dependent on a number of preparative and practical considerations involving both 
sample preparation and measurement. For example, nanoparticle stability and 
concentration within the dispersing medium are equally as important for the 
measurement of Zeta Potential as measurements are extremely sensitive to factors 
such as attractive and repulsive particle-particle interactions that are ultimately 
damaging to particle stability within their dispersed media. In addition to this, the 
nanoparticle concentration must fall within an acceptable range so as to allow for 
the laser beam to pass through the chamber and thus achieve a successful 
measurement.  
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The most important factor, however, for accurate Zeta Potential estimation is the 
pH of the dispersion under analysis. A Zeta Potential reported without its 
characteristic pH value is rendered as meaningless. Take, for example a positively 
charged particle in suspension. As a more alkaline solution is added to the 
dispersion, the particles present will acquire a more negative surface charge. If 
further alkali are added, the particles will eventually reach a point of neutrality 
(charge will be zero), before exhibiting a fully negative surface charge. This point 
of zero charge is known as the isoelectric point (IEP) and can be determined via 
titration and a plot of Zeta Potential versus pH. However, it is often found that 
rapid aggregation occurs close to the IEP.  
 
 
 
Figure 2.8: Schematic plot of Zeta Potential versus pH and IEP determination of a typical 
aqueous nanoparticle suspension [58] 
 
2.4 Fast Field-Cycling Nuclear Magnetic Relaxometry (FFC-NMR) 
 
2.4.1 Principles of FFC-NMR 
 
FFC-NMR involves the rapid switching of magnetic fields throughout the course 
of an experiment in order to measure the spin-lattice relaxation time, T1, over a 
range of magnetic fields, and hence Larmor frequencies, as νL = B0/2. Where  is 
the gyromagnetic ratio for 
1
H and B0 is the magnetic flux density of the applied 
field. The spin-lattice relaxation time is the time taken for the longitudinal 
component, Mz, of the nuclear spin magnetisation vector of an ensemble of 
1
H 
nuclei to recover fully to thermodynamic equilibrium. The field dependence of the 
spin-lattice relaxation rate R1 (1/T1) is represented by what is known as an NMRD 
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or Nuclear Magnetic Resonance Dispersion profile. NMRD profiles can provide a 
detailed insight into the molecular dynamics of a particulate system using spectral 
density functions; functions that describe the statistical distribution of motional 
frequencies in a given dynamic system. In the case of magnetic nanoparticle 
suspensions these profiles contain a wealth of information about the properties of 
the particles present, including their size, magnetisation and interaction with the 
solvent.  
 
In order to measure T1, one of two field-cycling sequences is performed; the pre-
polarised sequence (PP/S) and the non-polarised sequence (NP/S). The pre-
polarised sequence is used to measure T1 values below ~6 MHz and involves the 
polarisation of the 
1
H magnetisation of the sample at a high polarisation field, or 
BPol (usually in the range of 10-14 MHz). The field is then rapidly switched to one 
of a much lower value (known as Brlx, or the relaxation field) where the relaxation 
process is allowed to proceed for a time τ. A signal is then detected at a third field, 
known as the acquisition field, of 9.25 MHz (Bacq) following a 90º RF pulse which 
generates a free induction decay (or FID) [79, 80]. Equilibrium is then achieved 
following a time delay, or recycle delay (RD) which is typically of the order of 
5xT1. This process is repeated a number of times as a function of τ and generates 
values for T1 at the relaxation field observed. A typical pre-polarised sequence can 
be illustrated by the schematic shown in Figure 2.9. 
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Bpol Bacq
Brlx
π/2 
FID
Tpol
SWT SWT
Tx
Mxy
Time  
 
Figure 2.9: Schematic representation of a typical pre-polarised sequence. TPOL is the 
polarisation time, and BPOL is the polarisation magnetic field.  The switching time (SWT) is 
the time required by the field to switch between the different levels. Tx represents the 
transmitter output and Mxy is the magnetisation in the xy plane. Bacq is the 
detection/acquisition field. The multiple dotted lines drawn for BRLX represent various 
relaxation fields. 
 
 
At field frequencies in excess of 6 MHz, the non-polarised sequence is then 
applied, where the magnetisation is permitted to grow from zero as a fraction of τ. 
A polarisation field of zero is used in this instance, to allow for maximum 
difference between the polarisation and relaxation fields [80]. Sample 
magnetisation differences for short and long τ are therefore maximized, providing 
a more accurate estimation of T1. The basic non-polarised sequence can be 
illustrated as follows: 
 
Bpol
Bacq
Brlx
π/2 
FID
Tpol
SWT SWT
Tx
Mxy
Time
B= 0
 
Figure 2.10: The basic non-polarised sequence (NP/S). All parameters are as described in 
Figure 2.9 legend (above). 
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2.4.2 Analysis Procedure 
 
FFC-NMR measurements were performed on a Spinmaster FFC-2000 Fast Field-
Cycling NMR Relaxometer provided by Stellar (Italy) and Variable Temperature 
Controller (VTC, also Stellar). Samples (typically 0.3-1mL) were analysed at a 
constant temperature of 25ºC in addition to the following parameters:  
 
BPOL  = 12 - 14 MHz 
TPOL  = 0.3 - 0.5 s 
BACQ  = 9.25 MHz 
Slew rate  = 12 - 18 MHz/ms 
Switching time  = 0.0015 - 0.003 s 
TAU delay  = 0.001 s 
Block size  = 256 – 512  
Sweep width  = 1000000 Hz 
FLTR  = 270000 – 930000 Hz 
90° pulse duration  = 6 - 7 ms 
 
Table 2.1: Typical parameters used for NMRD profile acquisition 
 
The field strength range could be further extended in the region of 30 - 80 MHz 
using a stronger electromagnet external to the Stellar Relaxometer (Bruker WP80 
variable field electromagnet). This provided further information on the behaviour 
of a given dispersion’s magnetisation with increased field strength. 
 
2.4.3 Practical Considerations 
 
In addition to the boundaries set by the available measurable frequency range, 
NMRD analyses also have many associated practical considerations that one must 
observe prior to analysis. Firstly, sample concentration must be within a range that 
results in a measurable T1, so that does not fall short of nor exceed the 
experimental switching time of the measurement between changing field 
frequencies More dilute dispersions will result in a much longer T1  values 
(magnitudes of seconds) at any given field, while the opposite is observed for 
much more concentrated samples (orders of milliseconds). Particle dispersions 
must also be stable at all measured field strengths, and no sedimentation or 
precipitation should occur. 
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2.5 Inductively coupled plasma atomic emission spectroscopy (ICP-AES) 
 
2.5.1 General theory 
 
Inductively coupled plasma atomic emission spectroscopy (ICP-AES) is a well-
established analytical technique used in the detection and quantification of 
individual and/or multiple elements and their relative concentrations in a wide 
range of liquid media. This method exploits the fact that excited electrons emit 
energy at a particular wavelength characteristic of the element under analysis as 
they return to ground state [81]. The intensity of the light emitted is then related to 
concentration of ions present via the Beer-Lambert law and the use of a set of 
calibration standards of known concentration and their resulting standard curve. 
 
ICP-AES utilises a plasma source as the origin of ionisation and excitation during 
the analysis. The associated high temperatures of the plasma source (typically 
7,000-10,000 K) ensure that the analyte becomes fully nebulised into its aerosol 
form that, in turn, is composed of droplets of a variety of sizes. Larger droplets are 
disposed of to waste, and the smaller droplets are directed toward the Argon 
plasma source. It is in the plasma source that the transfer of energy occurs to 
promote the ions to a more excited state, shortly followed by the emission of 
electromagnetic radiation (light energy) as atoms return to their natural ground 
state. 
 
2.5.2 Analysis Procedure and Standard Calibration curve Preparation 
 
The role of ICP-AES in the work presented in this thesis was to determine the iron 
concentration of all nanoparticle dispersions and composite materials. This 
information was useful, for example, in the correction of NMRD profiles for iron 
content and in the determination of the amount of iron oxide nanoparticles being 
introduced prior to nanoparticle-polymer composite formation. 
 
Iron determination analyses for the purpose of the work presented in this thesis 
were carried out on a Varian Liberty 220 Inductively Coupled Plasma Atomic 
Emission Spectrometer, of which the typical instrument setup may be 
demonstrated as in Figure 2.11: 
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Figure 2.11: Typical setup of an ICP-AES instrument 
 
 
Prior to analysis, samples required subjection to an acid digestion process, in order 
to transfer all iron present in the sample into solution. To obtain the samples in this 
manner, approximately 0.5 mL of 6 N analar grade HCl and 1 mL of deionised 
water were added to a conical flask, followed by a known volume of the analyte. 
The solution was heated until 1-2 drops remained at the bottom of the flask. A 
small volume of water was then added and the resulting solution was brought to 
the boil. Following cooling, the solution was transferred to a volumetric flask and 
made to the mark with 1 M HNO3. It should also be noted that all glassware used 
in the digestion and analysis process was pre-rinsed with deionised water and 
HNO3 to ensure no ions were already present, thus affecting the detection of the 
iron in the solution of interest. 
 
For successful conversion of the resulting light intensities of all samples to their 
respective concentrations, it was necessary for a calibration curve to be constructed 
using a series of standards of known concentration. An iron standard solution (0.5 
M Fe(NO3) in HNO3 ; Merck, Germany) was diluted accordingly to prepare a 
series of standard solutions ranging from 0.05 mg/mL to 5 mg/mL Fe, with the 
range used depending on the estimated resulting intensities of the samples 
involved. From these standards, a calibration curve was generated and a linear fit 
to the data was used to extrapolate sample concentrations from the resulting 
equation of the fitted line using the obtained intensity values. A typical calibration 
curve is demonstrated below in Figure 2.12. An R
2
 value of 0.9995 indicates that 
the standards can successfully be used in the analysis and allow for an estimation 
of random error better than 1%. 
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Figure 2.12: A typical ICP-AES standard curve for Fe standards of the range 0.5-10 mg/mL 
 
 
2.5.3 Practical Considerations 
 
For successful ICP-AES measurement and accurate elemental analysis, it is vital 
that a number of considerations be met prior to any sample analysis. Firstly, the 
range of calibration standards used must be sufficient to cover the estimated 
concentration range of all analytes included in the measurement. It is suggested 
that all samples fall within 10 times the detection limit of the linear working range 
for Fe(0.006 μg/mL - 5 mg/mL [81]. 
 
In terms of sample preparation, it is vital that all samples for the purpose of use on 
this instrument were dispersed in 1 M HNO3 and exhibited no sedimentation or 
presence of any precipitate. This often requires the use of Triton X-100 for 
digestion of polymer-based samples, ensuring that the polymer did not generate a 
precipitate in solution that may result in blocking of the internal tubing of the 
instrument.  
 
2.6 Transmission Electron Microscopy (TEM) 
 
2.6.1 Principles of TEM 
 
Transmission Electron Microscopy (TEM) is a unique analytical microscopy 
technique used to characterise the structure of micro- and nano-materials using a 
combination of diffraction and imaging techniques. In a conventional Transmission 
Electron Microscope, an ultra-thin specimen is irradiated with an energised beam 
of electrons of a uniform current via an electron gun. This gun is connected to a 
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high voltage source (usually a tungsten filament) of ~100-300 kV and provides a 
beam source of high energy electrons via thermionic or field emission which 
illuminate the specimen through a two or three stage condenser lens system. 
Electrons are emitted from the gun source and are accelerated through the 
specimen towards an anode. The incident electrons interact with the specimen and 
are deflected from their path by direct collisions or electrostatic interactions with 
the surrounding electrons of the specimen. This results in a non-uniform 
distribution of electrons which provides structural information of the particles 
under analysis. The electron intensity distribution is then refocused and magnified 
via a three or a four objective lens system, which results in the formation of an 
image that can then be projected onto a fluorescent screen and processed by a 
computer/recording system. A typical setup of a Transmission Electron 
Microscope is as illustrated in Figure 2.13. 
 
 
 
Figure 2.13: Setup of a Transmission Electron Microscope 
 
 
As the incident electrons first pass through the specimen sample before reaching 
the imaging screen, they contain all structural information of that specimen. Image 
formation is therefore based on the principle of electron scattering. When the 
electrons come into contact with the sample, they can either ‘bounce off’ 
elastically (where the electrons change direction but not kinetic energy) or 
inelastically (incident electrons will change direction but also donate kinetic energy 
to the analyte). Scattered electrons are usually scattered in the forward direction, 
i.e. in parallel with the incident beam. These forward scattered electrons are 
responsible for image generation in TEM [82]. Scattering can be single, plural or 
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multiple (>20 times) in nature. The greater the amount of scattering, the more 
complicated the interpretation of the images and diffraction patterns become. It is 
therefore important that thin specimens are used for TEM analysis, as the number 
of backscattered electrons increases with increased sample thickness [82].  
 
Image contrast arises when there is interference between electrons coming from a 
range of diffraction angles. Electrons that interact with the sample are bent away 
from their original path, and interfere either constructively or destructively with the 
main electron beam. When a narrow objective aperture is used, electrons that get 
deflected at a greater angle are blocked, and the contrast of the image is enhanced. 
This however, is at the expense of electrons with a high deflection containing high 
resolution information being lost. It is therefore vital that a balance between good 
resolution and image contrast is met. This loss of electrons (and therefore 
amplitude) from the main electron beam is known as amplitude contrast, and is the 
main source of contrast in a TEM image. Amplitude contrast is dependent on two 
main factors; the sample thickness and the atomic number of the specimen under 
analysis. Elements with higher atomic numbers (and thus high electron densities) 
will exhibit a larger amount of scattering, leading to images of higher contrast (e.g. 
Au). It follows that elements with lower atomic numbers (e.g. Fe) will generate 
images of much lower contrast due to their decreased degree of scattering intensity.  
 
200nm
 (a)  (b) 
 
Figure 2.14: Contrast differences in TEM images of (a) Iron and (b) Gold nanoparticles 
 
 
2.6.2 Practical Considerations 
 
A number of practical considerations exist with TEM in order to obtain images of 
good resolution and contrast. Firstly, the specimen thickness, as mentioned 
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previously, must be very thin in order for the transmission of high energy electrons 
through the sample. It therefore follows that the concentration of particles in the 
dispersion introduced onto the TEM grid must be at an optimal level to avoid 
sample buildup over the surface of the grid. The drying process of the sample upon 
the grid is also important, as unwanted artefacts can often be introduced during this 
process. Other technical considerations include careful selection of the correct 
magnification and field of view during the analysis process.   
 
2.6.3 Experimental conditions 
 
TEM images were obtained using a JEOL 2000 FX TEM scan (at an accelerating 
voltage of 80 kV) for samples deposited on carbon-coated (400 mesh) copper 
grids. Access was courtesy of the Electron Microscopy Laboratory at University 
College Dublin. The preparation of samples involved depositing a drop (15 μL) of 
the diluted relevant dispersion in heptane onto the grids and allowing the solvent to 
evaporate, prior to imaging. 
 
2.7 Thermogravimetric analysis (TGA) 
 
2.7.1 Basics of TGA 
 
Thermogravimetric Analysis (TGA) is a useful analytical tool in the determination 
of many physical properties of a material such as purity, thermal stability, 
decomposition kinetics, composition (particularly for mixtures) and in the 
identification of many chemical processes such as desolvation, decomposition, 
chemisorption and oxidation.  
 
TGA is an analytical technique whereby the mass loss of a material is investigated 
as a function of temperature and/or time when subjected to a controlled 
temperature ramp [83]. When a substance is heated at a uniform, controlled rate, a 
continuous graph of mass change versus temperature is obtained and is known as a 
Thermogravimetric (TG) curve. TG curves can exhibit many stages of 
decomposition, each of which is composed of an initial (Ti) and a final (Tf) 
temperature value. Ti may be defined as the point at which decomposition begins 
to occur, and Tf as the point at which decomposition appears to be complete for 
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that particular stage. The difference between these times (Tf – Ti) is known as the 
reaction interval [84]. An example of this is shown in Figure 2.15. 
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Figure 2.15: Demonstration of a reaction interval in a TGA curve 
 
2.7.2 Instrumentation and Experimental setup 
 
The basic components of the TGA instrument are as follows; the sample balance, 
the heating furnace, a temperature control/measurement source and a recorder. The 
sample balance is composed of a sample pan that houses the analyte and resides in 
the furnace and is heated or cooled during the course of the experiment. The 
temperature gradient is controlled via use of a thermocouple and can range from 
approximately -150˚C to 1000˚C depending on the requirements of the experiment. 
A purge gas is also present in the chamber of the instrument and controls the 
environment for the analysis and is most commonly an inert gas such as Nitrogen. 
The mass change of the sample is then monitored on changing of the reaction 
temperature by a recording device (graphic recorder or X-Y recorder) and a plot of 
change in weight versus temperature is obtained. A typical setup of a TGA 
instrument is as shown in Figure 2.16 
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Figure 2.16: Setup of a typical TGA instrument 
 
 
TGA analyses were carries out on a Q Series Q-50 Thermogravimetric Analyser 
(TA Instruments, Delaware, USA) with Nitrogen gas pumped through the system 
at a rate of 50 mL/min to ensure an inert atmosphere for sample analysis. Samples 
were dried prior to analysis either by solvent evaporation or freeze drying, 
depending on the sample being analysed to ensure all moisture was removed from 
the material prior to measurement. 
 
2.7.3 Practical considerations and Sources of Error  
 
Factors such as the furnace heating rate, recording speed, furnace atmosphere and 
sensitivity of the recorder can greatly influence the accuracy of the results obtained 
[84]. Although no optimum heating rate can be suggested to give the best graphical 
resolution, a rate of approximately 3-10˚C/min is typically used, depending on the 
nature and number of decomposition stages present [85, 86]. In addition to this, it 
is suggested that for slower-decomposing samples, slower recording rates should 
be observed, as higher speeds may result in curve flattening and loss of resolution 
of the reaction interval(s). Sample quantity, packing, particle size and the nature of 
the material are among the many sample dependent factors that need to be 
considered prior to analysis. It is suggested that for most applications, 2-50 mg of 
sample is sufficient, where 50-100 mg may be necessary for more volatile 
materials. The sample must exhibit good coverage and packing upon the sample 
balance to ensure that controlled diffusion of evolved gases occurs throughout the 
course of the experiment. Samples of smaller particle sizes may be observed to 
exhibit a greater extent of decomposition, so it can also be important to check for 
ramp rate dependence of the particles under analysis prior to more accurate 
measurement. Finally, purity of the material will have an affect on the outcome of 
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the experiment and should also be taken into account during the experimental 
design. Purity should be confirmed by alternative means, where possible.  
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CHAPTER 3 
 
Synthesis of Charged Iron Oxide Nanoparticles 
and their Characterisation in Aqueous Media 
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3.1 Introduction 
 
The dispersion of iron oxide nanoparticles within a wide range of both aqueous and 
non-aqueous media has been successfully achieved and extensively reported in the 
literature [21, 44, 46, 49, 50, 87-92]. Their stabilisation in carrier liquids is of great 
importance, particularly as they are increasingly being considered for biomedical 
application. Nanoparticles developed for in vivo applications, for example, require the 
attachment of surfactants, or ligands, that will permit their dispersion and stability in 
aqueous biological media. The interpenetration of the ligands causes steric repulsion 
when two particles approach each other, reducing the probability of agglomeration. An 
additional benefit of coating with surfactants is that it inhibits air oxidation, to which 
the particles are susceptible [93]. 
 
Ligand attachment also provides electrostatic stabilisation to the dispersed 
nanoparticles which, in addition to generating colloidal stability, plays a significant 
role in the biokinetics and biodistribution of the nanoparticles and their associated 
drug delivery vehicles in vivo [44]. Coating nanoparticles with a wide range of 
materials such as gold [94], silica [95], polymers [96], antibodies [97] and proteins 
[98] can often assist in the binding of a variety of biological ligands at the nanoparticle 
surface, allowing for their attachment onto the cell membrane in addition to providing 
more extended blood circulation times and thus a greater probability of nanoparticle 
interaction with the tumour/cancer site of interest. This alternative targeting strategy 
has resulted in the formulation of a vast library of natural product-like molecules for 
use in many biomedical advances. 
 
Blood circulation times are determined by the process of opsonisation, which involves 
the removal of unrecognized foreign bodies from the body by the mononuclear 
phagocytic system (MPS) [99]. Macrophages present in the MPS, for example the 
macrophages of the Kupfer cells of the liver, possess the ability to remove unprotected 
nanoparticles and their carriers from the body within seconds of intravenous 
administration, rendering them ineffective in delivering therapeutics to their chosen 
targeted site [100].  
 
During opsonisation, foreign objects become covered by blood serum components 
known as opsonins, which aid in phagocytic recognition and eventual elimination 
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from the body. The rate at which this occurs is dependent on the surface properties of 
the nanoparticles which, if engineered correctly, can sometimes even avoid 
elimination for long periods of time. These nanoparticles, known as ‘stealth’ 
nanoparticles, have coatings composed of polymeric ligands such as polyethylene 
glycol (PEG) [99] .  
 
Studies into the dependence of surface coatings on the rate of opsonisation suggest 
that nanoparticles coated with hydrophilic ligands are less likely to be eliminated 
quickly as compared to their hydrophobic counterparts. A correlation between surface 
charge and opsonisation also exists [101], with research demonstrating that neutrally 
charged nanoparticles possessed much slower opsonisation rates than charged species, 
suggesting a mode of action for shielding groups such as the PEG moieties mentioned 
above. 
  
Nanoparticles intended for bioapplication must also be seen to exhibit a high degree of 
stability under a wide range of physiological and environmental conditions (e.g. 
changes in temperature, pH, magnetic environment etc.). It is therefore vital that 
nanoparticles are coated with appropriate ligands, while maintaining a reasonably 
small size (<100 nm) for transport within the body’s vasculature system.  
 
While aqueous coprecipitation syntheses would be more favourable for use in 
biomedical application (due to their ease of scalability and non-toxic reaction 
conditions), the moderate size control and poor crystallinity restricts their applicability 
for biomedical application (MRI, hyperthermia, MDT etc.) [102]. For this reason, high 
temperature thermal decomposition methods for nanoparticle formation have been 
widely employed in a range of organic mediaThermal methods involve the 
decomposition of a metal precursor at high temperature in the presence of a stabilising 
surfactant and have been demonstrated to produce highly crystalline nanoparticles of 
sizes less than 20 nm (dPCS) [46, 103]. In addition to this, syntheses of this type 
demonstrated potential for excellent size control, yielding highly monodisperse, 
crystalline nanoparticle dispersions of sizes tuneable from 5-12 nm which, in turn, 
contributes to their greater saturation magnetisation than IONP prepared by 
coprecipitation.  One disadvantage to this method, however, is that nanoparticles 
formed are not dispersible in aqueous media and require subsequent phase transfer 
and/or ligand exchange to achieve solubility.  
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The literature reports a wide range of transfer agents used to facilitate this process, 
extending from lipid bilayers to copolymers. The work of Yu et al. [104] demonstrates 
the successful transfer of iron oxide nanoparticles, coated initially with oleic acid and 
octadecene, to aqueous solution with full stability and successful dispersion using a 
PEG-ylated copolymer moiety, Poly(maleic anhydride-alt-1-octadecene) (PMAO-
PEG). The use of Pluronic F127 (PF127) has also been extensively utilised by many 
groups for functionalisation of oleic acid-stabilised nanoparticles that could be 
ultimately dispersed in water [89]. Quite often, however, addition of these ligands onto 
the IONP surface involve the use of bulky substituents, generating nanoparticles or 
nanoclusters in excess of 20-30 nm in diameter. For this reason, the use of short chain 
surfactants such as citric acid, as demonstrated by Sahoo [50] and DTAB, as used by 
Cao et al. [105] have proven to be beneficial as they can provide water dispersibility 
while maintaining a small (≤20 nm) hydrodynamic size, providing a source of highly 
biocompatible functionalized nanoparticles that can be used in the delivery of many 
potential drugs which can also be used as effective heating sources for the 
hyperthermia treatment of cancer. Another important application of magnetic IONPs 
of this nature is as contrast agents for MRI, as the presence of nanoparticles in the 
contrast medium can be used for enhancement (T1 agents) of the 
1
H NMR signal 
intensity, resulting in a positive (or bright) contrast in the MRI image. This signal 
enhancement relies on the nanoparticles being fully dispersed in the medium, hence 
the need for hydrophilic ligand attachment to the IONP surface [106]. Alternatively, 
suspensions of clustered IONP are used as T2 agents for signal suppression of the 
NMR signal. 
 
In the work presented here, we have utilised the methods, or modifications thereof, 
reported by both Sahoo et. al. and Cao et. al to produce citrate-stabilised IONP (Cit-
IONP) and DTAB-stabilised IONP (DTAB-IONP) respectively. Nanoparticles were 
synthesised with a view to their combination with n-(butyl cyanoacrylate) and poly-n-
(butyl cyanoacrylate) respectively as described in Chapter 4 to follow to produce 
nanocomposite materials for potential MRI and/or drug delivery applications. In the 
case of Cit-IONP, nanoparticles were prepared as per reported in the literature. For 
DTAB-IONP, the ligand exchange process was followed as outlined in the literature, 
with nanoparticles ultimately being dispersed in aqueous medium as opposed to the 
reported PVP/ethylene glycol mixture. 
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3.2 Experimental 
 
3.2.1 Synthesis of Citrate-stabilised Iron Oxide nanoparticles 
 
 
Materials 
 
Iron (II) chloride tetrahydrate (≥99.0%) was purchased from Fluka, Iron (III) chloride 
hexahydrate (puriss) was obtained from Riedel-de Haën and Citric acid (99+%) and 
Ammonium Hydroxide (28% NH3 in water, ≥99.99%) were purchased from Sigma 
Aldrich.  
 
Synthesis 
 
Citrate stabilised nanoparticles were prepared by coprecipitation of iron salts using a 
previously published method by Sahoo et al. [50]. In a typical synthesis a mixture of 
FeCl3.6H2O and FeCl2.4H2O in a 2:1 molar ratio was added to 40 mL deoxygenated 
water, in a three-necked round bottomed flask. The solution was purged with nitrogen 
for 15 minutes before heating to 80 ˚C with stirring under a constant flow of N2 in an 
oil bath. Once the solution had reached the required temperature, 5 mL of NH4OH was 
introduced dropwise into the reaction vessel, resulting in the formation of a black 
precipitate. A further 30 minutes heating at this temperature was applied, before the 
addition of 2 mL of citric acid solution (2.6 M) into the nanoparticle suspension. The 
temperature was then raised to 95 ˚C and the suspension was maintained at this 
temperature with magnetic agitation for 10 min. The nanoparticle suspension was then 
allowed to cool and it was dialysed against deionised water in an approximate 4:1 
volume ratio (H2O: IONP suspension) for 72 hours to remove any excess unbound 
citric acid. Following dialysis, nanoparticle suspensions were centrifuged for 30 min at 
13,200 RPM (16,100 RCF) to remove any large aggregates.  
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3.2.2 Phase transfer of iron oxide nanoparticles from organic to aqueous medium 
using Dodecyltrimethyl ammonium bromide (DTAB) as a transfer agent 
(Synthesis of DTAB-stabilised Iron oxide) 
 
Materials: 
 
Dodecyltrimethyl ammonium bromide (DTAB) (≥98 %), Iron (III) acetylacetonate 
(≥99.9 % trace metals basis) and Benzyl alcohol (anhydrous, 99.8 %) were purchased 
from Sigma Aldrich. All other reagents were used as required.  
 
Synthesis: 
 
Nanoparticles were synthesised using the non-hydrolytic surfactant assisted method as 
proposed by Pinna et. al. [55]. In a typical preparation 1.00 g of iron precursor, iron 
(III) acetylacetonate was placed in a three neck round-bottomed flask, followed by the 
addition of 20 mL benzyl alcohol. The solution was degassed using nitrogen for a 
period of 15 minutes, before bringing the reaction solution to reflux (195 ˚C) for a 
period of 7 hours. The dark brown/black suspension was then allowed to cool and 
stored at room temperature until further use was required.  
 
The solids were collected by centrifugation, washed twice with acetone and 
redispersed in chloroform using a small amount of oleic acid (50 μL/mL IONP 
suspension) as a stabilising agent. Chloroform suspensions of nanoparticles were then 
introduced in varying ratios to aqueous solutions containing the transfer agent, DTAB 
using vortex mixing. Suspensions were then allowed to stir for a number of hours 
under a nitrogen atmosphere to evaporate the chloroform present, resulting in stable 
aqueous suspensions of water-dispersible nanoparticles.  
 
3.2.3 Characterisation 
 
Nanoparticle dispersions were primarily characterised using PCS and NMRD, as 
described in Chapter 2. In addition to T1 measurements, the transverse relaxation time, 
T2 was recorded for a selection of nanoparticle dispersions at a field of 9.25 MHz 
using the Spinmaster FFC-2000 Field Cycling NMR Relaxometer (Stelar, Italy) and at 
fields between 40-60 MHz using a Bruker WP80 variable field electromagnet. The 
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Carr-Purcell-Meiboom-Gill (CPMG) pulse sequence was used in this instance with 
values for number of echoes and echo delay periods varied so as to reduce the % error 
of all measurements. For correction of all results obtained for iron content, ICP-AES 
was used, as described in Chapter 2.  
 
Visual imaging of nanoparticle dispersions was carried out using Transmission 
Electron Microscopy (TEM) imaging on a JEOL 2000 FX TEM scan (at an 
accelerating voltage of 80 kV) for samples deposited on carbon-coated (400 mesh) 
copper grids (courtesy of the Electron Microscopy Laboratory at University College 
Dublin).  
 
 
3.3 Results and Discussion 
 
3.3.1 PCS Characterisation  
 
Illustrated below is a typical particle size distribution plot for iron oxide nanoparticles 
stabilised by citric acid. Typical nanoparticle hydrodynamic diameters were in the 
range of 13-18 nm and all dispersions were relatively monodisperse (PDI 0.15-0.2) 
following centrifugation and dialysis steps. Citrate stabilised nanoparticles were stable 
for many months following synthesis. 
 
 
 
Figure 3.1: Size distribution of citrate-stabilised IONP (where citrate concentration=0.2M) (dhyd 
16.5 nm, PDI 0.15) ( - ) and a retest for stability (dhyd 16.7 nm, PDI 0.14) ( - ) 
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Sample Z-average(nm) PDI
Cit 2 15.8 0.18
Cit 3 13.6 0.20
Cit 4 16.5 0.15
Cit 4 (+2weeks) 16.7 0.15  
 
Table 3.1: Z-Average data (and PDI) for repeat Cit-IONP syntheses 
 
 
Stability of the citrate stabilised nanoparticles was also investigated within an 
observed pH and dilution range (See section 3.3.7 below).  
 
The size distribution plots shown below in Figure 3.2 are of iron oxide nanoparticles 
pre- and post-transfer using Dodecyltrimethyl ammonium bromide (DTAB) as a 
transfer agent (DTAB-IONP). It is interesting to observe that the hydrodynamic size 
distributions are almost unchanged following transfer from organic to aqueous 
medium. An increase in polydispersity was observed in some cases, however, with a 
small peak often presenting itself at the higher end of the distribution plot (omitted in 
Figure 3.2 below), which was difficult to remove by washing and/or centrifugation. 
This may be explained by the presence of excess transfer agent in the resulting 
dispersion, or slight aggregation of particles that were insufficiently coated (most 
likely the former). Nanoparticle sizes were generally reproducible across a range of 
syntheses, once the DTAB: Fe mole ratio was kept at 1:1 and suspensions were seen to 
remain stable over a period of weeks. 
 
 
 
Figure 3.2: Size distributions of Pinna IONP pre-transfer (dhyd, 20.4 nm PDI 0.18) ( - ) and post-
transfer (dhyd, 22.1 nm, PDI 0.11) ( - ) 
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3.3.2 Effect of reaction conditions on primary nanoparticle size 
 
 
It was observed for both the synthesis of citrate- and DTAB-stabilised iron oxide 
nanoparticles that moderate size control could be achieved on varying specific 
parameters throughout their synthesis. For citrate-stabilised IONP, nanoparticles of 
dhyd 13-18 nm (dTEM 10-13 nm) were prepared by ensuring that a sufficient 
concentration of surfactant (citric acid) was present throughout the synthesis and that 
dialysis and centrifugation was used following synthesis to remove any excess starting 
materials and large aggregates. For DTAB-stabilised IONP, good size control was 
facilitated by the use of a 1:1 ratio for the concentration of both the IONP and the 
transfer agent (DTAB) in the phase transfer medium, with typical sizes in the range of 
18-22 nm (dPCS) and 10-12 nm (dTEM).  
 
In the absence of surfactant molecules, nanoparticles are generally unstable and 
naturally form large aggregates or ‘clusters’ to reduce their surface free energy [107]. 
Inclusion of surfactant molecules during the synthesis of individual nanoparticles is 
therefore crucial if stable monodisperse suspensions of fully dispersed nanoparticles 
are to be achieved. The literature demonstrates a wide variety of uses of surfactant 
molecules, the choice of which depends on the envisaged properties of the 
nanoparticles and the medium in which they are to be dispersed. Oleic acid, for 
example is a commonly used surfactant for dispersion of iron oxide nanoparticles in 
non-aqueous media [46], whereas surfactants such as citric acid and Dodecyltrimethyl 
ammonium Bromide (DTAB) are often attached to the surface of nanoparticles to 
promote water dispersibility [50, 105]. 
 
The method of synthesis employed can also have a large impact on the size of the 
particles produced and the degree to which these sizes can be controlled. It has been 
extensively reported in the literature that moderate size control can be achieved for 
iron oxide nanoparticles prepared by the coprecipitation of iron salts in aqueous 
medium. Size control is typically dependent on factors such as the nature of the Fe 
salts used (chlorides, sulphates etc), the mole ratio (e.g. for Fe3O4 a ratio of 2:1 Fe
3+
 to 
Fe
2+
 is used), the pH and ionic strength of the medium, the presence of surfactants on 
the nanoparticle surface and the reaction temperature, with typical nanoparticle core 
sizes ranging from 3 to 20 nm (dTEM) depending on the reactions conditions used 
during the synthesis [102]. 
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For preparation of Fe3O4 nanoparticles coated with citrate, it appears that the citrate 
concentration used in the IONP synthesis plays an important role in determining the 
resulting hydrodynamic size of the nanoparticles produced. For citrate-stabilised 
nanoparticles synthesised for the purpose of this thesis, for example, it was found that 
at citrate concentrations of less than 0.2 M or in excess of 0.35 M produced 
nanoparticle dispersions of large hydrodynamic sizes, with efforts to centrifuge, 
precipitate or sonicate to recover nanoparticles of smaller sizes proving unsuccessful. 
At concentrations of approximately 0.2 M, however, success was demonstrated in 
preparing dispersed nanoparticles of approximately 20 nm (dPCS), with reproducibility. 
 
In a similar study, the work of Bee et al. [108] reports a relationship between 
concentration and core size control through XRD and TEM, where a noted decrease in 
crystallite size from 8.2 nm to 2.3 nm was observed with increased concentration of 
citric acid added during nanoparticle synthesis. It should be noted that, although the 
nanoparticles were claimed to be dispersed in aqueous medium, particle size analyses 
were only obtained with the particles in a dried state (i.e. no PCS analyses in their 
'dispersed' state). This size dependence may be attributed to either the enhancement of 
the nucleation rate and/or suppression of the growth during nanoparticle synthesis.  
 
Studies into the use of NaCl for similar size control of IONP have been also reported 
in the literature, in addition to those previously carried out in our group. Qiu et. al., for 
example, reported a reduction in size of ~1.5 nm (calculated by TEM) for IONP 
prepared in the presence of NaCl than those prepared at  lower ionic strength (i.e. in 
the absence of NaCl) [109]. It can also be noted that a decrease in saturation 
magnetisation on increasing the ionic strength of the IONP medium was observed.  
 
As mentioned previously in this chapter, nanoparticles synthesised via thermal 
decomposition methods are typically more favoured over those prepared by aqueous 
coprecipitation due to their much improved physical and chemical properties [110]. 
Nanoparticles prepared via these methods, however, require subsequent phase transfer 
for their dispersion into aqueous media. It is therefore vital that further steps are taken 
to ensure size and monodispersity are maintained on transfer, i.e. that no aggregation 
occurs during the transfer process. In addition to this the ligands, usually 
oleate/oleylamine, are chemisorbed onto the surface of the IONP and are difficult to 
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replace. Hence it is difficult to generate stable aqueous suspensions following phase 
transfer using ligand exchange. 
 
Phase transfer of Pinna-IONP to aqueous medium was achieved using 
dodecyltrimethylammonium bromide (DTAB). Prior to this, the temporary ligand 
(benzyl alcohol) of the prepared Pinna-IONP was replaced by a subsequent surfactant, 
oleic acid, ahead of the phase transfer process. DTAB-IONP formation was then 
driven by hydrophobic van der Waals interactions between the hydrocarbon chain of 
the IONP ligand (i.e. oleic acid) and the hydrocarbon chain of the surfactant (i.e. 
DTAB), encapsulating the IONP and allowing for dispersion in aqueous media. This 
can essentially be summarised as a ligand exchange process between the benzyl 
alcohol and oleic acid followed by encapsulation by the DTAB moiety. This method 
of DTAB-IONP formation was similar to that reported by Cao et. al., where a similar 
phase transfer process was carried out in order to disperse what they described as 
'colloidal super-particles' of approximately 190 nm ± 28 nm (dTEM) in a PVP/ethylene 
glycol medium [111] . 
 
The advantage of the simultaneous phase transfer/encapsulation method mentioned 
above is that the solvent acts as a temporary ligand only during nanoparticle 
synthesis, and provides a single-step ligand exchange process for IONP dispersion in 
aqueous media. The result is a relatively stable aqueous suspension of IONP with high 
relaxivity and a surface charge that allows for their electrostatic assembly with 
oppositely charged surfaces/particles for potential application in drug delivery.  
 
The mole ratio of transfer agent (DTAB) to iron oxide was found to have a drastic 
effect on the outcome of the transfer process, and much time was taken to achieve an 
optimum concentration of both species during the process. The initial concentration of 
the IONP pre-transfer was also important in achieving successful phase transfer, with 
concentrations of approximately 15-20 mg/mL necessary for the reaction to produce 
good dispersions, i.e. suspensions of individual nanoparticles of small hydrodynamic 
size with good PDI. 
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Figure 3.3: PCS size distribution data for different ratios of [Fe]: [DTAB] investigated for phase 
transfer. The colour-coding in the table to right of graph is representative to that in the size 
distribution plot. 
 
 
Figure 3.3 above illustrates the PCS hydrodynamic size distributions for three 
subsequent experiments with varied ratios of [Fe]: [DTAB] used during the phase-
transfer process. It is clear from this result that a 1:1 ratio was the most optimum for 
the reaction, as dhyd remained small in size and nanoparticles were most monodisperse. 
This ratio corresponded to approximately 1500 DTAB ligands per IONP present in the 
suspension, which meant that the DTAB was in great excess and ensured that all IONP 
were thoroughly coated following phase transfer. Given that the surface area of a 
typical DTAB-IONP is 6.2x10
-16
 m
2
, and assuming that each DTAB goes onto the 
second layer, this is equivalent to a DTAB a footprint of 4.1x10
-19
 m
2
, which is 
approximately 1.1 times that of oleic acid (with a footprint of 3.8x10
-19
 m
2
) [112]. This 
strongly suggests that a full DTAB monolayer, but no more, is required for IONP 
stabilisation.  
 
On observing the hydrodynamic diameters of both nanoparticle types over a period of 
weeks and, in some cases, months, it was noted that nanoparticles stabilised by citrate 
ligands were significantly more stable than those stabilised by DTAB (Figure 3.4). 
Citrate-IONP maintained hydrodynamic diameters identical to, or in close agreement 
with, the primary particle sizes measured initially following synthesis whilst 
maintaining good PDI values after periods of up to 9 to 12 months, where the DTAB-
IONP were seen to increase in both size and polydispersity within a number of days or 
weeks. This may be due to the fact that the DTAB encapsulates the particle by 
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physisorption as opposed to the citrate ligands that were more strongly chemisorbed 
onto the nanoparticle surface.  
 
(a) 
 
(b) 
 
Figure 3.4: PCS analyses of stability of (a) Cit-IONP over a period of 1 month and (b) DTAB-
IONP over a period of 3 days 
 
On subjecting both nanoparticle types to magnetic filtration at fields of 1.0-1.5 T, it 
was observed that the resulting retentate of any given Cit-IONP suspension 
demonstrated very similar hydrodynamic sizes to the same suspension prior to 
filtration. This was not the case for DTAB-IONP suspensions, which demonstrated 
signs of aggregation on exposure to the magnet. This observation may be due to partial 
loss of the physisorbed DTAB layer on the surface of the IONP. 
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(b) 
 
Figure 3.5: PCS analyses of (a) Cit-IONP and (b) DTAB-IONP pre- and post magnetic filtration 
at 
1.5 T 
 
3.3.3 Zeta Potential  
 
Iron oxide nanoparticles stabilised by citrate ligands exhibited a negative surface 
charge, typically in the range of -25 to -56 mV. Their negative charge is consistent 
with the long-term stability of the nanoparticles in solution, as it is generally found 
that particles that possess a surface charge in excess of ±30 mV will exhibit relatively 
good (if not excellent) stability in aqueous solution. It was found that zeta phase plots 
were of good quality for nanoparticle dispersions as presented in Figure 3.6 (inset). 
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Figure 3.6: Zeta potential distribution and phase plot (inset) of citrate IONP (Zeta Potential -
46mV for above sample) at pH 6.7 
 
In contrast to the citrate-stabilised iron oxide nanoparticles presented previously, 
nanoparticles stabilised using DTAB as a stabilising ligand exhibit a positive Zeta 
Potential, and values measured were typically in the range of +30 to +40 mV. Phase 
plots obtained were characteristic of positively charged nanoparticles (inverted phase 
as compared to the negatively charged citrate IONP) and were observed to 
demonstrate good shape (see phase plot (inset),Figure 3.7). 
 
 
 
Figure 3.7: Zeta Potential distribution and Phase Plot (inset) of DTAB-stabilised IONP (for a Zeta 
Potential of ~ +35mV at pH 7 
 
3.3.4 Effect of surfactant choice on the surface properties of nanoparticles (Zeta 
Potential)  
 
Cit-IONP were found to exhibit a negative surface charge due to the presence of non-
ligating carboxylate functionalities on the surface bound ligands. As stated previously, 
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Zeta Potential measurements for citrate-IONP varied between -25 mV at pH 3 to -56 
mV at pH 9 and were highly stable for long periods due to the strong negative charge. 
Note that the pKa values for citric acid are approximately 3.1, 4.8 and 6.4 [113]. In 
contrast to this, DTAB-IONP were found to be of opposite charge, with values in the 
region of +10 mV at pH 3 to +35mV at pH 7. This arises due to the positive charge on 
the quaternary nitrogen of the surfactant species arising from the pendant ammonium 
groups at neutral pH (pH7). 
 
On analysis of the phase plots for both nanoparticle species synthesised (Figure 3.8 
below), it is evident that nanoparticles of opposite charge produce phase diagrams of 
opposite frequency (or Doppler) shift, depending on their surface charge. This shift 
originates when the mobility of the nanoparticles in solution produce a characteristic 
shift away from that of a modulated, or reference, frequency (of the incident and 
reference beams) of 320 Hz. Positively charged nanoparticles possess beat frequencies 
in excess of this value, and thus generate an upward shift from the reference 
frequency. Alternatively, negatively charged nanoparticles will cause a shift in the 
opposite direction, causing a downward ‘dip’ in the phase plot diagram. 
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Figure 3.8: Typical Phase plots of (a) positively-charged IONP (in this case DTAB-IONP) and (b) 
negatively charged nanoparticles (citrate-IONP) measured at pH~7  
 
Apart from providing stability of nanoparticles in their dispersing solvent, surfactants 
are also a key aspect for functionalisation of the nanoparticles. For instance they can 
provide a location for ionic or covalent bonding of other functionalities [114]. They 
may also prove disadvantageous, however, as they may block the nanoparticle surface 
and/or reduce the interaction of the water with the moment of the particle. 
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3.3.5 Effect of pH on nanoparticle size and surface charge 
 
The pH of small aliquots of Cit-IONP was adjusted in the range of 3-9 using 1M NaCl 
or 1M NaOH, and individual samples were analysed for their changes in dhyd, PDI and 
their relative surface charge (Zeta Potential). The natural pH of Cit-IONP suspensions 
in the mM Fe range was found to be ~pH 6.7. Hydrodynamic sizes remained relatively 
stable (16-19 nm in diameter) over the pH range 3-7, beyond which the size and 
polydispersity were seen to increase as illustrated by Figure 3.9 below, due to particle 
aggregation at pH values of ~8 and above. Zeta Potential values were seen to increase 
in negativity on increasing pH as expected, and varied between -20 and -60 mV, 
illustrating good to excellent nanoparticle stability within the medium. It was not 
possible to identify the isoelectric point in the accessible pH range. 
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Figure 3.9: Size and Zeta Potential data as a function of pH for citrate-IONP 
 
 
A similar series of experiments was carried out for a suspension of DTAB-stabilised 
IONP within the pH range of 3-11. In this instance, hydrodynamic sizes were seen to 
be very unstable above pH 7, where noticeable aggregation was observed from both 
the Z-Average and PDI values. Due to this, Zeta Potential values at higher pH values 
could not be taken to be accurate and, in contrast with citrated-IONP suspensions, 
those at lower pH values were not seen to demonstrate a proportional change in 
surface charge. 
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Figure 3.10: Size and Zeta Potential data as a function of pH for DTAB-IONP 
 
 
 This observed instability of the DTAB-IONP may be explained by the fact that the 
encapsulating ligand in this instance is not chemisorbed to the surface of the IONP as 
is the case for Cit-IONP but is more weakly physisorbed and therefore is more prone 
to desorption or displacement from the IONP surface on changing pH. 
 
3.3.6 NMRD analysis 
 
The NMRD profiles below are representative of two subsequent syntheses of citrate-
stabilised iron oxide nanoparticles. Both profiles appear similar in shape, thus 
implying that they are reasonably reproducible in their measurement (within ~20% in 
the case of Figure 3.11 below), and that the properties of the nanoparticles produced 
by both syntheses were similar. 
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Figure 3.11: NMRD profiles of two separate citrate IONP syntheses 
 
 
The shape of the profiles shown is typical of superparamagnetic nanoparticle 
behaviour, in particular the maximum at a high frequency confirms the presence of 
small nanoparticles in the dispersion. The magnetisation of the nanoparticles was also 
apparently quite low, with an r1 plateau located at approximately 2.2-3.5 mM
-1
s
-1
. This 
observation is quite common in nanoparticles prepared by coprecipitation methods and 
suggests moderate crystallinity. This may be attributed to the rapidity and reduced 
control over nucleation and growth during IONP formation by coprecipitation methods 
as compared to those involving thermal decomposition.  
 
 
As in the case of the citrate nanoparticle NMRD profiles presented previously (Figure 
3.11), the shape of the profile for DTAB-IONP is typical of superparamagnetic 
nanoparticles in suspension (Figure 3.12). The maximum at a high frequency confirms 
the presence of small nanoparticles in the dispersion. However, the relaxivity of the 
DTAB-stabilised nanoparticles was found to be far greater, most probably due to their 
increased magnetisation. 
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Figure 3.12: NMRD profile of DTAB-stabilised IONP (dhyd  22.1nm, PDI 0.11) 
 
 
T2 measurements were made for both nanoparticle types at a field of 9.25 MHz and 
their relative r2/r1 ratios were calculated (Table 3.2). According to SPM theory, this 
ratio is predicted to increase with both an increase in the magnetisation of the entire 
particle and the particle size [70], which would account for the higher relaxivity ratio 
observed for the DTAB-IONP in comparison to that for Cit-IONP. 
 
 
Sample r1 r2 ratio
Cit-IONP 4.55E+01 7.32E+01 1.61
DTAB-IONP 4.61E+01 7.61E+01 1.83
mM
-1
s
-1
 
 
Table 3.2: Relaxivity data and r2/r1 ratios for Cit-IONP and DTAB-IONP at 9.25 MHz 
 
 
3.3.7 Effect of preparation method on the physical properties of the suspensions 
 
The results presented here show that the synthetic method chosen for nanoparticle 
formation can have a significant effect on other properties of the nanoparticles. In our 
case we monitor the nanoparticles’ magnetic properties through their effect on the 1H 
spin-lattice relaxation times of the solvating H2O molecules, which in effect act as a 
local reporter of the magnetic properties of the particles. The NMRD profiles 
presented previously are a clear demonstration of the difference in magnetic properties 
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between the nanoparticle types (see Figures 3.11 and 3.12). For example, the 
suspensions prepared by thermal decomposition (Pinna method) exhibit a much higher 
relaxivity than those prepared by aqueous co-precipitation (citrate stabilisation). This 
underlying cause can be studied using SPM theory [70], to simulate relaxivity profiles 
for comparison with experiment. 
 
 
Figure 3.13: NMRD profiles of Cit-IONP (○) and DTAB-IONP(□) and their SPM simulations 
included as solid lines. Calculated SPM parameters are listed in Table 3.3 below 
 
 
SPM simulations of the NMRD profiles for both citrate-IONP and DTAB-IONP were 
generated and are as outlined in Figure 3.13 (above). From these simulations, values 
for the estimated core size, saturation magnetisation, anisotropy energy and Néel 
Correlation time were extracted. These parameters, in addition to values for the 
estimated nanoparticle core diameters by PCS and TEM and the frequency of the r1 
maximum from NMRD, are given in Table 3.3. 
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Citrate-IONP DTAB-IONP
dPCS (nm) 13-18 18-22
dTEM (nm) 10-13 10-12
dSPM (nm) 11.6 10.4
νmax (MHz) 7.8 8.2
Ms (emu/g) 17 48
ΔE (GHz) 3 2.5
τN (ns) 28 10
NP Type
 
 
Table 3.3: Values of all estimated SPM parameters, in addition to further parameters determined 
by PCS, TEM and NMRD analyses. 
 
Analysis of Table 3.3 shows that the core size estimated by SPM theory is in close 
agreement with that measured by TEM analyses, suggesting that for both nanoparticle 
types, the water diffuses all the way to the core through the surface ligands, which is 
somewhat surprising. It has been found in the literature that SPM theory can 
overestimate particle size by 20 %. [68, 72], which is contrary to our findings. 
 
For both nanoparticle types, the primary particle size is very similar. For DTAB-
IONP, dPCS is slightly higher which could be consistent with some minor aggregation, 
possibly during the ligand exchange process. The νmax values are very similar and as a 
result the extracted dSPM values are also almost the same. This confirms that the NMR 
response is dictated in this case by the primary particle size. The relaxivity ratios are 
also very similar (as shown in Table 3.2). Taken together, these results strongly 
suggest that there is no appreciable aggregation for DTAB-IONP and the increased 
dPCS is due to the thicker ligand shell. 
 
SPM theory also provides an estimation of saturation magnetisation (Ms) values for 
fully dispersed nanoparticles [72]. It is clear from the fits and the table outlined above 
that the saturation magnetisation of the DTAB-IONP prepared by the Pinna 
decomposition method is much higher than that obtained for citrate-IONP prepared by 
coprecipitation. This may be explained by the fact that nanoparticles prepared by the 
Pinna method are of higher crystallinity due to extended particle annealing at elevated 
temp [55]. Confirmation of these findings, however, would require SQUID 
magnetometry analyses which were unfortunately unavailable to us. Finally, the 
anisotropy energies are low, as expected for superparamagnetic suspensions, values 
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for ∆Eanis of 2.5-3 GHz are as expected for individual particles of this size. Note that 
an energy barrier of 1 GHz is equivalent to ~6 kBT, at 298 K [103]. 
 
Further work could include the possible attachment of citrate ligands to nanoparticles 
prepared by the Pinna decomposition method, as the high magnetic properties 
combined with the long-term stability provided by the citrate ligand would produce a 
very interesting nanoparticulate system for potential biomedical applications. It will 
also provide a direct comparison to assess the effect of preparation method on the 
NMR properties.  
 
3.3.8 Effect of change in viscosity on Cit-IONP suspensions 
 
Table 3.4 (below) illustrates a series of additions of 1M sucrose solution to an aqueous 
dispersion of Cit-IONP. Small aliquots were introduced into the nanoparticle 
dispersion in 0.5-1 mL increments, and the corresponding viscosities were measured at 
on a A&D SV-10 Vibro Viscometer (Japan) supplied by Particular Sciences (Dublin, 
Ireland). Temperature control was achieved using a water bath maintained at 25°C 
using a Yellow Line MSC ceramic top hotplate stirrer (Lennox Laboratories, Dublin).  
 
Total vol sucrose soln(1M) added Total moles sucrose [sucrose] Viscosity
(mL) (moles) [M] (mPa.s@25oC)
0 (neat citrate IONP) 0 0 0.95
0.5 0.005 0.016 0.97
1.5 0.0015 0.016 1.05
2 0.002 0.017 1.06
3 0.003 0.018 1.26
4.5 0.0045 0.019 1.2
6.5 0.0065 0.02 1.75
8 0.008 0.023 2.04  
Table 3.4: Sucrose addition data for citrate-IONP viscosity studies 
 
 
Experimental viscosities were found to increase with sugar concentration, as expected. 
PCS measurements were taken for a small selection of the samples obtained in an 
attempt to determine the effect of sucrose addition on the hydrodynamic diameter and 
the PDI of the nanoparticles in suspension on changing the viscosity of the medium 
under the assumption that there is no aggregation. 
 
When the value for the viscosity of water was used for the PCS analysis, nanoparticle 
diameters appeared to increase on increasing the sucrose concentration within the 
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nanoparticle medium from 18 nm (primary NP size), to 22 nm and 25 nm for 
suspensions η=1.5 and η=1.8 respectively as expected. In addition to this, the PDI 
appeared to increase from 0.15 to 0.25 over the course of the sucrose addition, 
suggesting that aggregation may have occurred in the latter samples. On scaling the 
correlograms for each of the three samples seen in Figure 3.14 below, it is evident that 
the slope of the distribution becomes more gradual, indicating a slight increase in the 
hydrodynamic diameter of the particles present. 
 
On using the actual measured viscosities for both modified suspensions, a decrease in 
nanoparticle diameter was observed on increasing the viscosity, with calculated 
diameters of 15 nm and 12 nm for suspensions of η=1.5 and η=1.8 respectively (with 
primary nanoparticle sizes equal to 18 nm in diameter prior to sucrose addition).  
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Figure 3.14: Overplot and scaling of PCS correlograms for samples pre-sucrose addition and for 
samples of η=1.5 mPa.s-1 and η=1.8 mPa.s-1 
 
 
In a second experiment, two citrate nanoparticle dispersions were modified by 
addition of sucrose to yield solutions of different viscosity and their NMRD profiles 
were recorded (Figure 3.15). The observed result was a significant increase in the 
relaxivity (r1) on increasing the overall viscosity of the nanoparticle medium.  
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Figure 3.15: NMRD profiles of sucrose addition experiments to Cit-IONP where η = 0.99 mPa.s-1 
(i.e pre addition) (■),η = 1.5 mPa.s-1 (■) and η = 1.8 mPa.s-1 (■) 
 
 
 
Sample r1(mM-1s-1) r2 r2/r1ratio
Pre sucrose 14.74416 2.90E+01 1.97E+00
Viscosity=1.5 16.32547 3.46E+01 2.12E+00
Viscosity=1.8 37.52319 82.17247 2.19E+00  
 
Table 3.5: NMRD data at 9.25 MHz for Cit-IONP and η=1.5 and η=1.8 suspensions 
 
 
A slight shift of the r1 maximum to lower frequency on increasing the viscosity was 
also observed. This is more apparent on scaling the r1 values (Figure 3.16). That shift 
is consistent with a slight increase in nanoparticle size. The strong increase in r1 is 
difficult to explain. However, PDI values were also seen to increase, suggesting some 
possible particle aggregation. In addition to this, the r2/r1 ratios demonstrated a slight 
increase (Table 3.5).  
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Figure 3.16: Overplot and scaling of cit-IONP/sucrose sample NMRD profiles 
 
 
The literature presents a number of studies on the effect of sucrose addition on water 
mobility in aqueous suspensions. In one particular paper by Padua and Schmidt [115], 
an increase in the relaxation rate of the protons in pure H2O was observed on 
increasing the concentration of sucrose within an aqueous medium and was attributed 
to the increase in viscosity effects as a result. The rotational mobility of the water 
molecules in the medium was seen to decrease on introduction of the sugar molecules. 
The conclusions drawn were that the concentration of free water had become depleted 
and became associated with the added sucrose and that small clusters of sugar 
molecules had formed which moved at a much slower rotational rate than their 
individual counterparts. Note that this observation was made for aqueous sugar, 
solutions containing no nanoparticles, in the range of 0.5-2.0 g sucrose/g of water. For 
nanoparticle suspensions presented in this work, the concentration range was much 
lower at 0.1-0.2 g sucrose/g of water. Despite this fact, the experiments demonstrate 
that the effect of adding sucrose does not change the bulk water relaxation, but rather 
the relaxivity of the IONP. This may be explained by one of two possibilities; either 
the sucrose alters the viscosity of the bulk sample, or the rate of exchange with the 
citrated IONP surface. 
 
SPM theory was then used to investigate whether the change in the profile on adding 
sugar to the suspension could be due to changes in the diffusion coefficient of water. 
The fractional changes in the viscosity required to reproduce the primary nanoparticle 
size in PCS measurements were used to scale the diffusion coefficients in the SPM 
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simulations. For the 0.016 M sucrose sample (η = 1.5) for example, a 7% increase in η 
was required so that the DSPM value was scaled by 1/1.07. Similarly, for the 0.02 M 
sucrose sample (η = 1.8), a 18% increase in η was required to scale the DSPM value by 
1/1.18. 
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Figure 3.17: NMRD profiles for Cit-IONP (□) and Cit-IONP of modified viscosities of η=1.5 (▼) 
and η=1.8 (○) and SPM simulations as indicated by the solid lines for a decrease of 7 %(-) and 18 
% (-)  in DSPM in an effort to match the observed change in the NMRD response (r1 profiles) for 
the modified suspensions. 
 
It is apparent from the plot illustrated in Figure 3.17, that the appropriate modification 
of the diffusion coefficients in the SPM simulations (DSPM) in line with the 
expectations of Figure 3.15 was insufficient to reproduce the observed changes. This 
suggests that bulk viscosity changes are not the cause of the increase in r1 for this 
experiment.  
 
Cit-IONP suspension were then modified with respect to their pH over the range in 
which the nanoparticles were seen to be stable (i.e. pH 3-8) and the results are as 
presented in Figure 3.18. 
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Figure 3.18: NMRD data for Cit-IONP suspensions at pH 3(■), pH7(■) and pH 8/9 (■) 
 
 
It can be observed that, on modifying the pH of the suspension in either direction from 
its natural value, we see a noticeable increase in the r1 of the nanoparticles.  It 
therefore seems that, on altering the pH of the suspension or adding sucrose, the 
contact times in the vicinity of the nanoparticles are altered and a change in the 
environment about the IONP is sensed by the protons of the diffusing water. 
 
3.3.9 TEM imaging  
 
TEM analysis was also used to provide visual and structural information of 
nanoparticles in suspension. From measurement of particle size by TEM, we can 
observe that dTEM values are systematically lower than those obtained by PCS. This is 
due to the fact that PCS provides the total hydrodynamic diameter of the particles (i.e. 
the core particle plus any added surfactant), whereas TEM estimates the size of the 
core nanoparticle only. The discrepancy in both cases between dPCS and dTEM can be 
explained by the presence of surfactants on the surface of the nanoparticle. 
 
For Cit-IONP, the ~3 nm discrepancy between the TEM diameter (11.66 ± 1.5 nm) 
and the PCS diameter (13-18 nm) can be explained by the presence of the citrate 
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ligand attached to the surface (in agreement with citrate-stabilised VSOP-C184 
nanoparticles that have been reported to possess a dTEM of 4 nm and a dhyd of 7.0 ± 
0.15 nm) [102, 116]. 
 
100nm
 
 
 
Figure 3.19: TEM image of citrate IONP of dTEM ~10-13 nm. 
 
 
TEM imaging was also carried out on Pinna IONP pre- and post transfer with DTAB. 
It is evident from both images that size and monodispersity were generally maintained 
following the transfer process, with TEM diameters of 11.25 ± 1.3 nm pre- and post 
phase transfer. This suggests that all particles were successfully phase transferred. 
 
(a) (b) 
 
Figure 3.20: TEM images of Pinna IONP (a) pre-transfer in CHCl3 and (b) post-phase transfer in 
H2O  
 
For the DTAB-IONP, however, this increase between the observed diameters for TEM 
and PCS is much larger (~10nm). This, as mentioned earlier, is probably due to the 
thicker DTAB ligand shell, or that the DTAB is actually interacting with the oleic acid 
ligands already bound to the IONP surface as a result of hydrophobic Van der Waals 
interactions [117] (see Figure 3.21). Very strong evidence for this is provided by the 
measured r2/r1 for both nanoparticle types, which are very similar and typical for 
dispersed IONP in suspension (Table 3.2) 
 101 
DTAB
(a)
(b)
Oleic acid
γ
-F
e
2
O
3
O
OOH
OH
OO
O
O
O
O
H
O
H
O
O
O
O
O
OH
OH
O O
O
O
O
OH OH
O
O
O
O
O
O
H
O
H
O
O
O
Fe3O4
O
O
O
H
O
H
O
O
O
O
O
O
H
O
H
O
O
O
γ
-F
e
2
O
3
O
O
O
H
O
H
O
O
O
O
O
O
H
O
H
O
O
O
O
O
O
H
O
H
O
O
O
 
 
                 Figure 3.21: Chemical structures of (a) Cit-IONP and (b) DTAB-IONP 
 
 
 3.4 Conclusions 
 
 
The syntheses of iron oxide nanoparticles using both hydrolytic and non-hydrolytic 
methods and their successful stabilisation in aqueous medium by both ligand 
displacement and encapsulation methods are presented. Particle size information was 
indicative of well-dispersed individual nanoparticles of reproducibly small 
hydrodynamic diameters. The Zeta Potential measurements confirmed the expected 
characteristic surface charges associated with the ligands. NMRD analyses 
demonstrated that suspensions prepared using thermal decomposition methods 
exhibited higher relaxivity than those prepared by coprecipitation methods possibly 
due to improved crystallinity. It was also encouraging to observe that these observed 
higher r1 values were maintained in the case of nanoparticles prepared by 
decomposition methods on their transfer into aqueous medium.  
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CHAPTER 4  
 
Synthesis and Characterisation of Polymer-
Nanoparticle Composite Materials for 
Potential Biomedical Application 
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4.1 Introduction  
 
The therapeutic application of composite materials including magnetic 
nanoparticles in the development of drug delivery vehicles (DDVs) for a wide 
range of purposes has gained a significant amount of interest. The development of 
magnetic targeted carriers (MTCs) for use in magnetic drug targeting (MDT), for 
example, is particularly attractive for the treatment of solid tumours where 
surgical eradication or radiation is not possible. MDT therapies offer many 
benefits over more conventional non-specific methods such as chemo- and 
radiotherapies, as they allow for maximum drug efficacy while using the lowest 
possible dose and, in turn, reducing the potential toxicity and side effects usually 
associated with increased drug concentration in vivo. With magnetic drug 
targeting, drugs can be incorporated into the core of a delivery vehicle, or 
adsorbed via ionic or covalent linkage onto its surface. The latter is more 
favourable as it allows for a much lower required drug dose while maintaining 
efficacy of that drug. Once transported to the site of interest, drug release can be 
facilitated via many methods such as pH dependent cleavage [118], irradiation 
[44] or the use of elevated temperature (hyperthermia) [42]. 
 
In addition to this, the magnetic properties of these delivery vehicles may be used 
to provide a platform for monitoring the efficacy of drug delivery through MRI 
[119]. Conjugation of a chemotherapeutic drug to magnetic DDVs enables 
simultaneous monitoring of drug delivery with MRI imaging, allowing physicians 
to quantify the amount of drugs taken up at the tumour site and monitor response 
to treatment in real time [120]. 
 
This chapter focuses on the use of poly (alkyl-cyanoacrylate) nanoparticles 
(PACA) as potential drug delivery vehicles which, when combined with 
magnetic iron oxide nanoparticles, form ‘composite materials’. These materials 
possess one of two types of iron oxide nanoparticles; either positively charged 
dodecyltrimethyl ammonium bromide (DTAB) stabilised IONP (forming DTAB-
IONP/PACA), or negatively charged citrate stabilised IONP (Cit-IONP/PACA), 
depending on the formulation of the composite material in question. Composite 
materials formulated using DTAB IONP were proposed to form a ‘surface-
decorated’ structure, where the IONP were attached to the surface of the polymer 
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nanoparticles (Figure 4.1). Those prepared using citrate-stabilised IONP were 
expected to form a ‘core-shell’ structure, where the nanoparticles were 
incorporated into the internal matrix of the PACA spheres (Figure 4.1). Strong 
evidence of the former appeared to present itself, with all PCS, Zeta and NMRD 
data accounting for the formation of the proposed decorated structure. 
Difficulties arose when attempting to prove successful formation of the Cit-
IONP/PACA composite, nonetheless a series of interesting observations were 
made such as the overall increase in r1 across the NMRD profile and the increase 
in dhyd while maintaining a low PDI, suggesting a high degree of size 
monodispersity within the suspension. 
 
Figure 4.1: Proposed structure for both (a) decorated and (b) core-shell composite materials 
 
 
4.2 Experimental 
 
4.2.1 Synthesis of Poly-n-butyl cyanoacrylate (PACA) nanoparticles 
 
 
Materials 
 
Monomer, n-butyl cyanoacrylate (medical grade), was obtained from Henkel 
Loctite Corporation, Ireland. Citric acid (99+%) and Dextran 40 (Fluka, mol. Wt. 
40 kDa) were purchased from Sigma.  
 
Synthesis 
 
Poly(n-butyl-cyanoacrylate) nanoparticles were prepared via an open anionic 
polymerisation of n-butylcyanoacrylate monomer (20 mg/mL) in aqueous 
medium, acidified using citric acid (0.2% w/v) and in the presence of a steric 
colloidal stabiliser, Dextran 40 (0.8% w/v). Polymerisation was carried out for a 
 105 
period of 3hr at ambient temperature with magnetic agitation, after which the 
resulting suspension was adjusted to pH 7 using 1M NaOH.  
 
4.2.2 Synthesis of Citrate-stabilised IONP/PACA nanocomposites 
 
 
Citrate-stabilised IONP for use in Cit-IONP/PACA nanocomposite syntheses (as 
described below) were prepared as described previously in Chapter 3. 
 
Nanocomposite materials of citrate-stabilised IONP and Poly-(n-butyl-
cyanoacrylate) nanoparticles were prepared via the following method; an aqueous 
suspension of citrate-stabilised IONP was used as the polymerisation medium for 
PACA nanoparticle formation, where all necessary reagents for the synthesis were 
added to the IONP dispersion (as opposed to an equal volume of water). The 
polymerisation was carried out as described previously. The aim of this 
experiment was to attempt encapsulation of the IONP in a polymer matrix, 
forming a core-shell nanostructure containing a magnetic core.  
 
4.2.3 Synthesis of DTAB-stabilised IONP/PACA nanocomposites 
 
 
The formation of DTAB-IONP/PACA composite materials relied on electrostatic 
interaction of two particles of opposite charge; the DTAB-stabilised IONP 
exhibiting a highly positive charge and the PACA nanoparticles possessing an 
opposite negative one. Dispersions of DTAB-stabilised IONP and PACA 
nanoparticles were combined using overnight agitation at room temperature. 
Composite materials were then centrifuged or filtered accordingly depending on 
the results of initial PCS measurements. 
 
4.2.4 Characterisation 
 
As with the nanoparticle dispersions discussed in Chapter 3, composite materials 
were primarily characterised by PCS and NMRD analysis. ICP-AES was used as 
described in Chapter 2 of this thesis to determine the iron content contained 
within the composites formed. Zeta Potential measurements were also carried out 
on a Zetasizer Nano ZS (Malvern Instruments, UK) following composite 
preparation. Finally, Transmission Electron Microscopy was used in an attempt to 
confirm the outcome of IONP-PACA combination.  
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4.3 Results and Discussion 
 
4.3.1 PCS Characteristation 
 
The synthesis of PACA nanoparticles is known to be one of great success and 
extremely high reproducibility, with nanoparticles in the range of 110 to 140 nm 
(dhyd) being formed with ease and a high level of monodispersity, with PDI values 
of 0.04 to 0.1 obtained in syntheses in this work [30]. Nanoparticles formed are 
stable for a number of months particularly when refrigerated, and at pH 3-7.  
 
    
 
 
   Figure 4.2: Size distribution of PACA NP (dhyd 114nm, PDI 0.08) 
 
 
It is evident from the size distribution plot below that the hydrodynamic size of 
the Cit-IONP/PACA composite material had increased significantly compared to 
that of the pure PACA (dPCS (PACA) 114 nm, PDI 0.08) and indeed the value is 
far greater than that of the citrate-stabilised IONP (dPCS (citrate) 16.5 nm, PDI 
0.15). One interesting observation, however, is that the PDI (0.09) had not 
increased significantly from those characteristic of PACA nanoparticle 
dispersions. This suggests that a very different monodisperse structure had been 
formed.  
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Figure 4.3: Comparison of hydrodynamic diameters of all species involved in citrate-
IONP/PACA composite formation; citrate-IONP (----) dPCS 16.5nm (0.15), PACA (----) dPCS 
114nm (0.08) and IONP-PACA composite (----) dPCS 300nm (0.09) 
 
 
Figure 4.4 (below) demonstrates PCS size distribution data for a dispersion of 
DTAB- IONP/PACA nanoparticles. The hydrodynamic diameters of the DTAB-
IONP, PACA, and nanocomposite material were ~20 nm, 100-110 nm and 115-
120 nm respectively, suggesting the formation of a composite material. The 
presence of a faint peak in the higher end of the size distribution for both the 
DTAB-IONP and the composite indicates that some larger aggregates were 
present in both suspensions, which, in turn, would have contributed to the larger 
PDI values obtained as opposed to that of the PACA.  
 
 
 
Figure 4.4: Comparison of hydrodynamic size distribution of all nanoparticles involved in 
DTAB-IONP-PACA composite formation; DTAB-IONP (----) dPCS 19.2 nm (0.20), PACA (---
-) dPCS 119 nm (0.07) and IONP-PACA composite (----) dPCS 151 nm (0.18) 
 
4.3.2 Zeta potential 
 
 108 
 
Zeta potential measurements were also performed to confirm the characteristic 
negative charge of the polymer nanoparticles. Within a suitable concentration 
range (approx 0.2-1.0 mg/mL PACA), phase plots and zeta distributions met all 
the quality criteria of the Zetasizer software. 
 
 
 
Figure 4.5: Zeta Potential distribution and Phase Plot (inset) for PACA NP (for Zeta 
Potential of -21mV) 
 
 
In the case of the Cit-IONP/PACA composite, however, it is difficult to determine 
from the Zeta Potential data whether a composite material was formed, as both 
species involved are individually negatively charged, with values typically of the 
same order of magnitude as those observed for the composite material. We can, 
however, deduce that the species is still highly negatively charged, with zeta 
potential values typically in the region of -5 to -30 mV, depending on dilution. 
 
 
     
 
Figure 4.6: Zeta Potential distribution and phase plot (inset) for citrate-IONP/PACA 
composite (-21 mV) 
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The Zeta Potential data obtained for the DTAB-IONP/PACA suspension (Figure 
4.7) also supported the hypothesis of a composite material being formed, as 
opposed to a co-suspension. Distributions were typically monodisperse and had 
values ranging from +2 to +11 mV, suggesting reasonable short term stability of 
the composite materials produced. These values were between those obtained for 
very positively charged DTAB-stabilised IONP (~+35 mV) and the negatively 
charged PACA nanoparticles (~ -30 mV) (see Figure 4.8).  
 
 
 
Figure 4.7: Zeta Potential distribution of composite (Zeta Potential 11.2mV) 
 
 
 
 
Figure 4.8: Phase plots of all nanoparticles involved in DTAB-IONP/PACA composite 
formation; DTAB-IONP( - ) (+35mV), PACA ( - ) (-21mV) and DTAB-IONP-PACA( - ) 
(+11mV).  
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4.3.3 Effect change in pH on nanoparticle/nanocomposite properties 
 
Figure 4.9 below illustrates the data obtained following pH titration of small 
aliquots of water-dispersed PACA nanoparticles over the pH range of 3-10 using 
1M NaOH and 1M NaCl. The natural pH of the suspensions were typically pH 7-
7.5. Hydrodynamic diameters varied from 105 nm to 125 nm over the observed 
pH range for the chosen sample and PDI values remained within an acceptable 
range for monodisperse suspensions. Zeta Potential values remained negative 
throughout the course of the experiment, with values ranging between -8.5 and -
25 mV and phase plots maintaining good shape the pH range demonstrating the 
acceptable quality of the data obtained. PACA NP dispersions were observed to 
remain stable at neutral pH for a period of months when refrigerated.  
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Figure 4.9: Size/Zeta versus pH for PACA nanoparticles 
 
 
The pH dependence of hydrodynamic size and zeta potential was also investigated 
for a representative citrate-IONP/PACA composite material, (Figure 4.10 below). 
In this instance, hydrodynamic sizes remained relatively unchanged within the pH 
range of 3-9, beyond which the suspended material appeared to disassemble, and 
a sharp decrease in the particle size was observed.  
 
Zeta potential values fell between -19 mV and -35 mV and corresponding phase 
plots were good for the majority of the measurements. This was with the 
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exception of the measurement at pH 11 where the phase plot was very noisy. This 
value can therefore not be taken as an accurate estimation of the surface charge at 
that pH. This problem may have arisen due to accumulation of ions about the 
electrode due to an increased base concentration, causing degradation of the 
electrodes and/or sample within the cell. The latter explanation may be supported 
by the sharp decrease in the hydrodynamic size of the particles present in the 
medium from approx 200 nm to 150 nm, suggesting degradation of the structure 
of the composite at this pH. 
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Figure 4.10: Size/Zeta versus pH for citrate-IONP/PACA composite 
 
 
When compared to the pH titration plot of the unloaded PACA NP (Figure 4.9), 
Cit-IONP/PACA suspensions appeared to have similar stability; both dhyd and 
Zeta Potential values were stable over a reasonably broad pH range, with the 
exception of pH 11 for the composite. 
 
Finally, the pH dependence of the DTAB-IONP/PACA was investigated (Figure 
4.11 below). Hydrodynamic size was again maintained over the majority of the 
pH range with good PDI associated with these measurements, with the exception 
of a particle size of ~750 nm observed at pH 11 with a PDI value of 0.6. Zeta 
potential measurements were made on all samples demonstrating good particle 
sizes, and were observed to become more negative on increasing the 
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concentration of the base in the nanoparticle medium, as expected. This was the 
first instance over the course of the three titration experiments outlined in this 
chapter that an isoelectric point was observed, and was present for the DTAB-
IONP composite material at pH~3.5. 
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Figure 4.11: Size/Zeta versus pH for DTAB-IONP/PACA composite 
 
 
 
The pH range over which the composite was seen to remain stable was much 
narrower in this instance, compared to PACA and Cit-IONP/PACA, with a 
gradual increase in dhyd for DTAB-IONP/PACA dispersions below pH 4-5 and 
also above pH 9.   
 
 
4.3.4 TEM imaging  
 
PACA nanoparticles were also viewed under a Transmission Electron 
Microscope. The images obtained demonstrated good nanoparticle 
monodispersity as was also observed by PCS analysis. Particles appeared to be 
highly spherical and measured particle diameters by both techniques were similar 
(dpcs 110 nm (PDI 0.08), dTEM 102 ± 8.1 nm) confirming the highly monodisperse 
nature of the material.  
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500nm  
 
 
Figure 4.12: TEM image of PACA NP 
 
 
Figure 4.13 below demonstrates a typical TEM micrograph of a citrate-
IONP/PACA composite. Large aggregates seemed to dominate the surface of the 
grid, with particles of two different levels of contrast present. For comparison, a 
micrograph of Cit-IONP is presented (Figure 4.13 (a)), which presents the IONP 
in a more dispersed manner, as opposed to the more 'clustered' fashion observed 
in Figure 4.13(b). 
 
Electron microscopy was used in an attempt to determine whether a composite 
material (i.e. one that is intimately mixed on the nanoscale), or a co-suspension, 
was formed from the combination of the particles. Unfortunately, little structural 
information could be obtained from any of the images obtained. Drying the 
sample onto the grid may be a contributing factor, as clearly the high 
monodispersity apparent from PCS was not preserved. 
 
100nm
(a)  
Two levels of 
contrast due to 
presence of 
both Cit-IONP 
and PACA
(b)                  
 
Figure 4.13: TEM image of Cit-IONP and Cit-IONP/PACA  
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The TEM micrograph presented in Figure 4.14 below represents a typical DTAB-
IONP/PACA composite dispersion. At a first glance it appears that there are 
larger nanoparticle spheres present (PACA) that are decorated on the surface with 
particles of a much darker contrast (DTAB-IONP). On looking at the size bar 
beneath the image however, we see that these apparent polymer nanospheres 
(brighter spheres) are far in excess of 500nm. This is not in agreement with PCS 
measurements where dPCS=151 nm. This discrepancy may be due to disruption of 
the composite during the drying process onto the grid. Thus we cannot decipher 
from imaging techniques whether composite materials were successfully 
prepared. However it does appear that there is a significant fraction of free 
DTAB-IONP on the grid, although again these may have been released during 
drying. 
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Figure 4.14: TEM of DTAB-IONP/PACA composite 
 
 
4.3.5 NMRD studies 
 
 
As with the NMRD profile (Figure 3.11) for the citrate-stabilised IONP prior to 
combination with the n-butyl cyanoacrylate monomer, a typical 
superparamagnetic shape is evident from the profile for Cit-IONP/PACA (Figure 
4.15). In comparison to the profile for the dispersed particles, however, the 
observed relaxivity of the composite has essentially doubled. Note that the 
position of the r1 maximum has also shifted to slightly lower frequency, which is 
usually taken to be indicative of increased nanoparticle size for dispersed 
particles. Note that this observation is similar to that observed on changing the pH 
of Cit-IONP in suspension (Figure 3.18). 
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Figure 4.15: NMRD profiles of citrate-stabilised IONP (CoP 3) (dhyd 15.8 nm, PDI 0.15) and 
Cit-IONP/PACA composite (CoP 3_PBCA) (dhyd 300 nm, PDI 0.09).  
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4.3.6 Effect of dilution on R1 of citrate composite 
 
Figure 4.16 below represents relaxation (R1) measurements made at three 
different fields (16, 6 and 0.1MHz) for a series of dilutions performed on a single 
citrate-IONP/PACA composite material. From the graph, we can see that the 
relationship between R1 and concentration was proportional at all frequencies. 
This experiment provides the relaxivity and also shows that the suspension is 
stable over this dilution range. 
 
 
Figure 4.16: R1 as a function of Fe concentration on dilution of citrate composite at the lower 
frequencies 
 
 
 
 
4.3.7 Effect of nanoparticle concentration on citrate composite formation  
 
The increase in the measured r1 is observed on composite formation using citrate-
stabilised IONP, irrespective of the r1 on forming the composite was confirmed by 
a series of replicate experiments as illustrated in Figure 4.17 and Figure 4.18.  
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Figure 4.17:  NMRD profiles for a series of replicate experiments of citrate-IONP/PACA 
composite formation with [cit-IONP] of (a) 12.5 mM and (b) 20 mM respectively. Monomer 
concentration was kept constant at 20 mg/mL 
 
 
It can be noted, however, that the observed change in r1 was not by the same 
factor in all cases of composite formation. A common citrate-stabilised IONP 
source was therefore used for a further experiment in which composite materials 
were prepared by varying the cit-IONP concentration, to investigate the cause of 
the r1 enhancement. From the data shown in Figure 4.18 below, we can conclude 
that the r1 enhancement increases as the quantity of citrate-nanoparticles 
introduced into the polymerisation medium increases (see Figure 4.18 below). 
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Figure 4.18: NMRD profiles for composites of varying cit-IONP concentrations using the 
same cit-IONP source. For the purpose of these experiments, the PACA concentration was 
kept constant at 20 mg/mL 
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4.3.8 SPM Modelling of citrate-IONP composites 
 
The increase in r1 on forming the Cit-IONP/PACA composite is interesting as any 
enhancement of relaxivity could be of use in magnetic resonance imaging. The 
physiochemical basis for the effect could also be of fundamental interest. It is 
clear that the primary nanoparticles have not changed size and the absence of a 
larger r1 enhancement at low frequency suggests the absence of nanoparticle 
aggregation within the composite which would increase the magnetocrystalline 
anisotropy [121]. 
 
In the first instance, the effect of viscosity on relaxivity was investigated through 
SPM simulations using a similar approach to that described in Chapter 3. It should 
be noted that the observed increase in r1 in that case was significantly greater. It 
was possible to generate good agreement with the data by taking the successful 
simulation for Cit-IONP and reducing the diffusion coefficient (DSPM), while 
keeping all other parameters fixed. In the case shown in Figure 4.19, a reduction 
in DSPM of 36% was sufficient. Physically, this situation could be interpreted as 
the polymer matrix reducing the local diffusion coefficient of the water in the 
immediate vicinity of the magnetic nanoparticles, i.e. within the polymer shell. 
This, however, does not confirm the formation of a core-shell composite, with the 
citrate-IONPs encapsulated within larger polymer spheres. 
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Figure 4.19:  Manipulation of diffusion coefficient of Cit-IONP SPM fit  in an attempt to 
match composite NMRD profile data (Δ) where DSPM= 3.5E-5 cm
2
/s  ( - ), 2.5E-5 cm
2
/s ( - ), 
1.5E-5 cm
2
/s  ( - ), and 1.25E-5 ( - ), which was the best fit for the Cit-IONP/PACA NMRD 
data (a 36% decrease in DSPM) . The other parameters for Cit-IONP were as follows: τN 28 
ns,  Ms 17emu.g
-1
, dSPM 13.6 nm. 
 
 
To further investigate the effect of viscosity, we attempted to simulate the profiles 
of other Cit-IONP/PACA suspensions. A typical example is shown overleaf. In 
this case application of a 7% and 18% decrease in DSPM, was unsuccessful in 
matching the NMRD data. On experimenting further with changing the value for 
DSPM, we estimated that a 30% decrease would be necessary to make the 
simulations agree with experiment in this particular case (Figure 4.20). 
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Figure 4.20: Manipulation of diffusion coefficient of a cit-IONP SPM fit (○, - ) where r1 of 
the IONP was higher than those represented by Figure 4.19. The diffusion coefficient of the 
Cit-IONP (DSPM=3.5E-5 cm
2
/s) was decreased in this case by 7 %, ( - ) and 18 %,( - ) in an 
attempt to explain the r1 increase on forming Cit-IONP/PACA due to viscosity effects (as 
was observed in Chapter 3, Figure 3.17). In this instance a  30% decrease in DSPM was 
required to fit the composite NMRD data (□, -) 
 
 
From the data presented in Figure 4.19 and Figure 4.20 above, we conclude that a 
30-36% decrease in D from the value used for Cit-IONP was required in order to 
generate a good fit with the NMRD data for Cit-IONP/PACA. On measurement 
of the actual viscosity for Cit-IONP and Cit-IONP/PACA suspensions (Table 
4.1), it was observed that the bulk viscosity does not change by more than 5% 
upon formation of the composite. Given that the measured viscosities of the Cit-
IONP/PACA suspensions were close to 1 mPa/s (Table 4.1), we can conclude that 
the change in r1 is not solely due to a change in viscosity of the medium. 
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Table 4.1 Measured viscosity ranges for  Cit-IONP and Cit-IONP/PACA suspensions 
 
 
We have previously shown in Chapter 3 that even a 18% increase in the viscosity 
is insufficient to account for changes in r1 for dispersed particles. The simulations 
represented by the solid green and black lines for increases of 7% and 18% 
respectively in Figure 4.19 and Figure 4.20 confirm that this is also the case for 
Cit-IONP/PACA. We can therefore conclude that the change relaxivity arises at 
least in part from altered local viscosity about the Cit-IONP, perhaps within the 
soft PACA shell. 
 
4.3.9 NMRD of DTAB-IONP/PACA  
 
In comparison to the NMRD profile obtained for the DTAB- IONP, a 4-fold 
reduction is observed in the relaxivity of the composite material. Similar to 
citrate-IONP/PACA, the r1 maximum shifted from higher frequency (~8 MHz) to 
lower frequency for the composite (~4 MHz). This suggests potential formation of 
a ‘current-bun’ type composite material (Figure 4.1), where the PACA 
nanoparticles are decorated by the iron oxide on the surface, given that the 
hydrodynamic size of the resulting material (151 nm) has increased by a value 
comparable to that obtained for DTAB-IONP prior to composite formation (19.2 
nm) when compared to the size of the PACA (119 nm). 
Sample Viscosity (mPa/s)(@25˚C) 
Cit-IONP 0.99-1.00 
Cit-IONP/PACA 1.03-1.04 
PACA 1.31-1.32 
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Figure 4.21: NMRD of DTAB-IONP (dPCS 19.2 nm, PDI 0.20) and composite (dPCS 151 nm, 
PDI 0.18) 
 
 
4.3.10 Effect of polymer concentration on DTAB composite formation and 
SPM modelling 
 
Figure 4.22 below illustrates NMRD data obtained for a number of DTAB-
IONP/PACA composite materials of varying polymer concentration. It can be 
observed that on increasing the polymer concentration while keeping IONP 
concentration constant, the relaxivity of the resulting composites decreases 
accordingly. This result was repeated a number of times and in all cases, 
irrespective of the initial r1 of the DTAB-IONP, on formation of the composite r1 
was reduced. 
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Figure 4.22: NMRD profiles for DTAB-IONP (■) and DTAB-IONP/PACA composites of 
varying [PACA] where [PACA] = 1 mg/mL(■), 2 mg/mL(■) and 20 mg/mL (■) respectively 
 
 
Simulations using SPM theory of all DTAB-IONP-PACA composites presented 
above were conducted and are represented in Figure 4.23 below. These 
simulations provide a good reproduction of experimental data, with all calculated 
parameters as shown in Table 4.2. 
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Figure 4.23: NMRD profiles and SPM simulations of DTAB-IONP (▼, - ) and DTAB-
IONP/PACA of [PACA] = 20 mg/mL) (○, -) ,  2 mg/mL (□, -), 1 mg/mL (▽, - )   
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Sample τ n (ns) Ms (emu.g
-1
) d SPM (nm) dPCS (nm) ΔE (GHz)
DTAB-IONP 10 56.0 10.4 22.4 2
DTAB-IONP/PACA ( [PACA] =1 mg/mL) 3 38.0 15.6 138.8 2.75
DTAB-IONP/PACA ( [PACA] =2 mg/mL) 3 30.5 16.4 148 2.5
DTAB-IONP/PACA ( [PACA] =20 mg/mL) 3 23.5 16.4 138.3 2
 
 
Table 4.2: Calculated SPM parameters for DTAB-IONP and all DTAB-IONP/PACA 
 
 
The NMR size, dSPM is found to increase from 10.4 nm for the DTAB-stabilised 
IONP to 15.6-16.4 nm for the composite materials. A substantial decrease in 
saturation magnetisation, Ms, from 56 to 23.5-38 emu.g
-1
 is also observed.  
 
Concerning the size, dSPM, it should be noted that the size obtained from NMR is 
really an indirect measure; the high frequency part of the profile is particularly 
sensitive to the diffusional correlation time, D for the solvent molecules in the 
vicinity of the particle. This dependence on τD is the basis for the dSPM values 
obtained. Note that D = d
2
/4D, where d is the particle size and D the diffusion 
coefficient [102].  An increase in particle size or an increase in the local water 
viscosity could have the same effect on the profile; increasing D and driving the 
maximum in r1 back to lower frequency. Hence, the presence of the polymer may 
alter the local water mobility in the vicinity of the nanoparticle, so altering the 
NMRD profile. 
 
We suggest, that the decrease in Ms, as sensed by the water, may be due to partial 
physical shielding of one whole side of the IONP surface from the diffusing 
1
H 
nuclei in the H2O due to its adsorption onto the solid polymer, as shown in Figure 
4.24. 
 
Limited interaction of 
H2O with  surfaces of 
IONP
H20 free to interact with 
all surfaces of IONP
 
Figure 4.24:  Schematic representation of the diffusion of water about IONP (left) and IONP 
electrostatically bound to a surface (right). 
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The systematic decrease in r1 on increasing the amount of PACA NP introduced 
during composite formation may potentially be due to a decrease in the surface 
coverage of the PACA by the DTAB-IONP as shown in Figure 4.25 below. As 
the DTAB-IONP concentration was kept constant throughout all composite 
syntheses (15 mg/mL) and the amount of PACA NP present increased, the 
probability of all PACA NP becoming either partially or completely decorated by 
the DTAB-IONP will decrease. It follows that, as the water diffuses past the 
composite, the 
1
H nuclei would come into contact with fewer IONP and thus a 
much lower relaxation enhancement will be observed.  
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Figure 4.25: Possible explanation for r1 decrease on increasing PACA concentration while 
keeping the DTAB-IONP concentration constant (15 mg/mL)  
 
 
4.4 Conclusions and Future Work 
 
 
In this chapter, data for composite materials derived from both citrate and DTAB-
stabilised IONP (Cit-IONP/PACA and DTAB-IONP/PACA respectively) has 
been presented. With respect to the formation of the DTAB-IONP/PACA, the 
results obtained from PCS, zeta potential and NMRD analyses strongly support 
the formation of the proposed surface-decorated structure, where the iron oxide 
nanoparticles are electrostatically bound to the surface of the PACA nanospheres. 
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For example, the observed increase in hydrodynamic size of the composite 
material was almost comparable to the approximate dhyd of a typical DTAB-
stabilised IONP, and zeta potential measurements suggesting the formation of a 
near neutral material following coupling. The decrease in the observed r1 for 
DTAB-IONP/PACA in the NMRD profile also strongly suggests successful 
attachment of the IONP onto the PACA surface. TEM imaging was not as 
successful in supporting the proposed structure. This, however, seemed to have 
been due to degradation of the materials during drying onto the grids for analysis. 
 
The electrostatic interaction between the DTAB-IONP and the PACA, however, 
was not as strong as hoped. The PCS size distribution plot shown in Figure 4.26 
below suggests that the magnetic nanoparticles could be easily separated from the 
polymer using magnetic capturing methods with high fields, where a reduction in 
hydrodynamic size of ~15-20 nm was observed. This may be explained by the 
IONP being retained in the magnetic field, while the non-magnetic material 
(PACA) passed through and was collected in the eluent. This suggests the need 
for stronger binding chemistries at the IONP-PACA interface. 
 
 
 
 
Figure 4.26: Magnetic filtration of DTAB-IONP/PACA composite where a reduction in the 
hydrodynamic size from 130 nm ( - ) to 111 nm ( - ) was observed. Note that the dhyd of 
DTAB-IONP and PACA are approx. 20 nm and 110 nm respectively. 
 
 
In the case of Cit-IONP composites, an increase in r1 was observed as compared 
to the data obtained for Cit-IONP. This increase was far greater than can be 
attributed to bulk viscosity changes within the composite medium. This 
observation is consistent with the formation of a composite that is water 
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permeable, wherein the water retention times are considerably altered as 
compared to Cit-IONP. It is unlikely, therefore, that a co-suspension has been 
formed in which both citrated-IONP and PACA co-exist in the same aqueous 
medium without any direct interaction 
 
One major issue encountered on attempts to image the composite materials by 
TEM was the drying of the sample onto the TEM grid. In an effort to overcome 
this obstacle, cryo-electron microscopy could be used in future analyses in place 
of conventional TEM analyses, as this would remove any problems experienced 
during the drying process, thus resulting in more clear and conclusive images for 
determination of the actual structure of the nanomaterials. Cryo-SEM studies are 
planned with Dr. Twamley (Chemical Sciences, DCU) for the coming months. 
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CHAPTER 5 
 
Non-aqueous Iron Oxide Nanoparticle Cluster 
Assembly    
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5.1 Introduction  
 
In Chapters 3 and 4, the many benefits of using electrically charged IONP and their 
composite materials for biomedical application were outlined. For example, 
nanoparticle dispersions composed of small, individual IONP have presented 
themselves as good heat mediators for potential use in hyperthermic application 
[21, 27, 38, 42], whereas their larger composite counterparts are engineered more 
toward specific targeting and drug delivery [24, 122]. The one disadvantage of 
these larger composite materials that we have observed, however, is that the 
nanocomposite size cannot be easily controlled over a wide range of sizes. For this 
reason, iron oxide nanoparticle clusters, or IONPCs, have been extensively 
developed in the areas of specific site targeting and drug delivery.  This is 
essentially due to their size-dependent magnetic properties and the ability to 
control the particle and cluster size. Overall size is a major determinant of bio-
distribution of the IONPC-based agents in vivo [123]. 
 
It has been reported in the literature that the nature of the clusters formed strongly 
influences the magnetic anisotropy arising from interparticle interactions [49]. In 
addition to this, studies have shown a marked increase in the low field relaxivity on 
increasing the particle size [124]. The dependence of the magnetic properties on 
primary particle size also provides the potential to generate the maximum magnetic 
effect of the IONPCs while minimising the particle concentration to be introduced. 
The characteristic high r2 values (and higher r2/r1 ratios) of these materials provides 
the possibility for their use as T2 agents in a wide range of molecular imaging 
applications [102].  
 
One major discovery leading to more successful targeted antitumor therapy was the 
discovery of the EPR effect by Matsumura and Maeda in 1986 which demonstrated 
that most solid tumors have a defective or 'leaky' vasculature that is highly porous 
and permeable, which facilitates a sufficient supply of nutrients and oxygen to 
tumor tissues for their rapid growth [125]. The advantage of the EPR effect is that 
it can be exploited for tumor-targeting chemotherapy in the delivery of 
macromolecular agents such as genes, antibodies, micelles, liposomes, and 
protein–polymer conjugates to the tumour site in addition to contrast agents for 
MRI imaging purposes [126]. 
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The EPR effect is a molecular weight-dependent phenomenon where molecules or 
particles larger than 40 kDa, i.e. the threshold of renal clearance, demonstrate a 
prolonged circulation time and a much increased half life, resulting in a more 
gradual clearance from the body [127]. These molecules/particles gradually 
permeate tumors in a size-selective fashion. This provides the possibility of using 
IONPCs and Au-IONPCs as mentioned in this thesis for application for in vivo 
imaging and drug delivery applications.  
 
A method to size-selectively produce IONPCs has been recently reported by our 
group through a process known as competitive stabiliser desorption (CSD) [128]. 
This process involves the exposure of IONP dispersed in heptane to a substrate of 
cyanopropyl-modified silica particles (CN-modified silica) which, over time, 
results in the gradual and continuous assembly of the IONP due to depletion of the 
surfactant ligands. As desorption of the surfactants from the surfaces is ongoing, 
aggregation or clustering proceeds gradually with time and the clusters increase in 
size, but critically size monodispersity of the clusters is maintained. This process is 
shown in Figure 5.1.  
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Figure 5.1: Schematic representation of the mechanism for NPC assembly by competitive 
stabiliser desorption as proposed by Stolarczyk et. al. [128] 
 
The cause of IONPC assembly is the presence of the competing silica substrate (as 
shown in Figure 5.2), which, over time, partially depletes the NP of their 
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stabilising surfactant at their defect sites, generating 'activated NP', or NP
*
, that 
possess open sites allowing for NP
*
-NP
*
 interaction. It should be noted that the 
substrate acts indirectly on the NPs by depleting the heptane of any free oleic acid, 
thus altering the equilibrium between NP-bound surfactant and that present in the 
assembly medium. A sample setup of a cuvette containing IONP for assembly in 
the presence of a silica substrate is as shown below. 
 
                                      
IONP suspension
CN-modified silica
 
Figure 5.2: Typical setup of a cuvette for an IONPC assembly 
 
The main advantages of this method are that the monodispersity of the cluster size 
is well preserved during the assembly process. Furthermore, upon removal of the 
suspension from exposure to the silica substrate, the assembly process can be 
stopped at a specific size. The resulting clusters have been observed to remain 
stable for extended periods of time. This allows engineering of clusters of an exact 
size that can be tuneable to the envisaged application of the material, although 
phase transfer is required.  
 
The addition of gold nanoparticles in the CSD experiments to follow were made 
for the purpose of attenuating iron oxide nanocluster assembly, by blocking NP* 
sites formed as a result of exposure to the CN-silica substrate. The introduction of 
Au NPs is also advantageous as many biomedical advantages of AuNP and AuNP-
coated IONPs have been reported in the literature [41, 94, 129, 130]. The well 
established surface chemistry of AuNP provides potential surface tunability for 
improved aqueous stability and biocompatibility of magnetic IONP [131]. The 
optical properties of AuNP, in combination with the magnetic properties of the 
IONP could allow for simultaneous optical and magnetic resonance imaging in 
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vivo. Furthermore, Au-coated IONP have been exploited for other biomedical 
applications such as thermoabalation and thermosensitive drug delivery [131, 132]. 
This is due to the fact that, when exposed to optical radiation, the electrons within 
the AuNP resonate with the electromagnetic field, causing them to absorb and 
scatter light. This phenomenon is commonly known as surface plasmon resonance 
(SPR), it is also associated with the conversion of light energy to heat, making Au-
functionalised IONP attractive candidates for heat-mediated drug release [133]. 
The optimal resonance wavelength is determined by the physical parameters of the 
nanoparticles (e.g. size, shape, surface coverage and surface area) making the 
engineering of their many physiochemical properties critical [131].  
 
Previous studies involving the use of AuNP both during and post cluster assembly 
have previously been reported by the group [94]. These studies involved the use of 
AuNP to stop IONPC assembly, producing magnetic plasmonic mixed 
nanoparticle clusters of controlled size. In addition to this, attempts were made for 
the dispersion of IONPs in aqueous medium by polymer-mediated phase transfer 
with some success. 
 
The aim of the work presented in this chapter was to assess the colloidal stability 
of Au-stabilised IONPCs in an attempt to understand the impact of AuNPs on the 
cluster assembly and redispersion, with a view to optimising the composites for 
eventual phase transfer into aqueous medium. In the first part of this chapter, we 
present the synthesis of iron oxide nanoparticles by thermal decomposition, in 
addition to the synthesis of gold nanoparticles for NPC assembly attenuation. 
IONP stabilised by oleic acid/oleylamine and oleylamine only were synthesised, 
and the kinetics of their assembly were compared.  The second part of this chapter 
then focuses on the assembly of IONPCs and the effects of further surfactant 
and/or AuNP additions on the colloidal stability of the suspensions. 
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5.2 Experimental 
 
5.2.1 Synthesis of Iron Oxide nanoparticles by thermal decomposition of Iron 
precursors 
 
Materials 
 
Iron(III) acetylacetonate (≥99.9% trace metals basis), 1,2-hexadecanediol 
(Technical grade, 90%), oleic acid (≥99.0%), oleylamine (≥70% GC, Fluka), 
diphenyl ether (99%) and ammonium hydroxide (28% NH3 in water, ≥99.99%) 
were purchased from Sigma Aldrich. All other bench solvents were used as 
required. 
 
Synthesis 
 
In a typical synthesis, the required amount of oleic acid and oleylamine (depending 
on the desired surfactant to iron precursor ratio) was weighed into a three-necked 
round bottomed flask. Iron (III) acetylacetonate (2 mmol) and 1,2-hexadecanediol 
(10 mmol) were then weighed out and transferred into the reaction vessel, along 
with 20 mL of diphenyl ether. All reagents, once combined, were purged with 
nitrogen for a period of 15 minutes before the pipette was raised from the solution 
and heating under reflux was commenced. A heating mantle was used to provide 
the heat required for the reaction, and the dial was turned to maximum to achieve 
an approximate reflux temperature of ~262˚C. Once this temperature had been 
reached, reflux for an additional 15 minutes was observed. The solution (now a 
dark brown colour) was allowed to cool to room temperature before adding 60 mL 
of ethanol, shaking the flask, and allowing the particles to precipitate over a bar 
magnet. Precipitation times were often slow and required to be left over night in 
some cases. Once precipitation was complete, the upper solvent layer (a 
transparent orange colour) was removed, leaving behind a dark brown (almost 
black) precipitate. One fifth of the initial amounts of oleic acid and oleylamine 
were then weighed out and mixed with a 20 mL volume of heptane. This solution 
was added to the reaction flask and was shaken and left to settle. After a period of 
15-20 minutes, a further 60 mL of ethanol was added to the flask, and the washing 
process was repeated as carried out previously.  The final precipitate was 
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redispersed in 10-15 mL heptane (SZ-IONP) and centrifuged at 13,200 RPM 
(16,100 RCF) to remove large aggregates. 
 
The above synthesis was also carried out in the absence of oleic acid, with twice 
the typical amount of oleylamine to facilitate surface coverage of the IONP 
produced  (SZ-OAm IONP).  
 
5.2.2 Synthesis of Dodecanethiol (DDT)-stabilised Gold Nanoparticles 
 
Materials 
 
Hydrogen tetrachloroaurate (≥ 99.9%), dodecanethiol (DDT; ≥ 98%), and sodium 
borohydride (NaBH4 ;≥ 98.5%), were purchased from Sigma-Aldrich. 
Tetraoctylammonium bromide (TOAB ≥ 98%) was obtained from Fluka. 
 
Synthesis 
 
Dodecanethiol-derivatised gold NPs were synthesised in a two-phase liquid-liquid 
synthesis as reported by Brust and co-workers [134]. Prior to nanoparticle 
synthesis, it was vital that all glassware was primed with aqua regia, a concentrated 
mix of nitric and hydrochloric acids in a volume ratio of 1:3 respectively to ensure 
no residual materials existed on the walls of the glassware from prior syntheses. A 
typical nanoparticle synthesis was then conducted as follows; a solution of TOAB 
in toluene (32 mL, 50 mM) was first prepared and subsequently added to a 100 mL 
round-bottomed flask and stirred with a magnetic stir bar under gentle heating to 
completely dissolve the solid material into solution. Following this, an aqueous 
solution of hydrogen tetrachloroaurate (10 mL, 30 mM), appearing bright yellow in 
colour, was added in a dropwise manner to the organic phase in the flask under 
vigorous stirring. The stirring was continued until the tetrachloroaurate was 
completely transferred into the organic layer (~30 min). The mixture turned from a 
yellow to red-brown colour during mixing, and separated into two phases on 
discontinuation of stirring, when it was observed that the mixture separated into a 
toluene phase (red-brown in colour) and a colourless aqueous phase. The mixture 
was placed into a 250 mL separating funnel, and the lower aqueous layer was 
removed. The toluene layer was then released into a 100 mL conical flask, and, on 
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continuation of magnetic stirring, a 100 L aliquot of dodecanethiol was 
introduced to the mixture. A freshly prepared aqueous solution of sodium 
borohydride (10 mL, 0.4 mM) was then added dropwise to the flask with vigorous 
stirring. The colour changed from red-brown to dark purple upon reduction. The 
two phase mixture was covered and stirred at room temperature for 2-3 hours. The 
stirring was then discontinued, upon which the two phases separated, and the dark 
purple organic phase was removed and transferred to a separate glass flask. A 25 
mL aqueous solution of H2SO4 (1 drop conc. H2SO4 in 25 mL H2O) was added to 
bring the pH to 4, after which the lower aqueous layer was removed using a 
separating funnel. 25 mL of H2O was then added, and the separation process was 
repeated. This step was carried out 4 further times before drying the organic layer 
over anhydrous MgSO4. The resulting solution was filtered using a Buchner 
filtration apparatus and the suspension of TOAB-Au nanoparticles was collected in 
the conical flask. Ethanol (~ 50 mL) was added to the flask to precipitate the gold 
nanoparticles. This required the mixture to be kept in the freezer at -20°C 
overnight. This resulted in the formation of a dark purple-brown precipitate had 
settled to the bottom of the flask. The precipitate was once again filtered under 
reduced pressure using a Buchner funnel, washed with ethanol, and suspended in 
40 mL heptane to produce the final suspension, which appeared dark purple in 
colour. The suspension was centrifuged a number of times for periods of 30-45 
minutes at 13,200 RPM (16,100 RCF)  using a tabletop centrifuge (Eppendorf 
5415 D) to remove any larger or aggregated particles. The dark purple supernatant 
was collected, characterised by PCS, and utilised for nanocluster assembly 
experiments.  
 
5.2.3 Nanoparticle Cluster (NPC) assembly experiments 
 
Iron-oxide NP cluster assembly 
 
Prior to all assembly experiments, cyanopropyl (CN)-modified silica (30-70 μm, 
Alltech Associates; 50.2 mg) was placed in a quartz cuvette and spread evenly to 
form a thin layer at the bottom. A small aliquot (3-4 drops) of heptane was then 
carefully dripped down the side wall of to ‘fix' the silica to the base of the cuvette 
in order to prevent aggregation when the nanoparticle suspensions were later added 
on top of the silica. A 1.2 mL aliquot of appropriately diluted iron-oxide 
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nanoparticle dispersion was carefully placed in the cuvette over the thin silica 
layer, taking care not to agitate the silica at the bottom. This was usually performed 
by adding two successive 600 μL aliquots. /the hydrodynamic characteristics of the 
suspension was then observed using PCS analyses (High Performance Particle 
Sizer (HPPS), or a Zetasizer NanoZS, Malvern Instruments; Worcestershire UK) 
where the average hydrodynamic diameter was continuously monitored). On 
removal of the cuvette from the instrument following assembly experiments, it was 
observed that the nanoparticles had deposited themselves on the surface of the 
silica due to them being stripped of their stabilising surfactants. All measurements 
recorded in the software were then exported and studies of change in the dhyd, PDI 
and derived count rate over time were conducted and plotted as shown in the 
results section below.  
 
Attenuation of IONPC assembly by addition of further surfactants  
 
Iron-oxide nanoparticle dispersions stabilised by oleic acid/oleylamine 
(OAc/OAm-stabilised IONPCs) or oleylamine only (OAm-IONPCs) were 
subjected to the assembly process as described above. Cluster assembly was 
allowed to proceed for varied periods of time, after which, the measurement was 
temporarily terminated and the cuvette was carefully removed from the instrument. 
A small volume (typically 50 L) of oleic acid, oleylamine or gold nanoparticle 
suspension was then slowly and carefully added to the suspension of iron-oxide 
clusters. The cuvette was replaced in the instrument, and the light scattering 
measurements were resumed for an additional 2 – 20 hours with selection of the 
same attenuator position and measurement positioning to ensure that comparable 
count rates were obtained once the measurement was continued.  
 
5.3 Characterisation 
 
For correction of all results obtained for iron content, ICP-AES was used as also 
described. Thermogravimetric curves were also obtained on a Q Series Q-50 
Thermogravimetric Analyser (TA Instruments, Delaware, USA) for IONP 
stabilised by either a mixture of oleic acid/oleylamine or oleylamine only, in a 
further attempt to understand the binding chemistry of the ligands on the surface.  
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5.4 Results and Discussion 
 
5.4.1 Kinetics of assembly for OAc/OAm IONPCs (mixed surfactant IONPCs) 
 
Figure 5.3 below outlines the first of a number of experiments for determining the 
optimum conditions for assembly of OAC/OAm-IONPCs (i.e. clusters formed 
from IONPs prepared using a mixture of OA and OAm). The IONP concentration 
was approximately 2 mM in this case, or a 1:20 dilution of the neat suspension 
(where Fe = 41 mM). In this figure, the dhyd values, derived count rate and PDI are 
presented. The dhyd, is found to increase over time. The derived count rate is a 
measure of the backscattered light intensity and the observed gradual increase in 
the count rate is a result of an increase in the number of larger particles, i.e. 
IONPCs, in the suspension. PDI values remained within an acceptable range of 
0.18-0.22 indicating that controlled assembly processes had been achieved.  
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Figure 5.3: Typical assembly data obtained by PCS for the formation of OAc/OAm-IONPCs 
in heptane in the presence of silica. Fe concentration was approximately 2 mM. Included in 
the plot are values for the dhyd ( □ ), derived count rates ( ● ) and the PDI values (□) 
 
 
The growth rate in this instance, however, was very slow, with cluster sizes 
reaching approximately 17 nm (from a primary NP size of 8 nm) after a period of 
18 hours. A more dilute nanoparticle suspension (0.8 mM Fe) was then used for 
the assembly process. The resulting assembly plot is as shown in Figure 5.4. 
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Figure 5.4:  Typical assembly data obtained by PCS for the formation of OAc/OAm-IONPCs 
in heptane in the presence of silica. Fe concentration was approximately 0.8 mM. Included in 
the plot are values for the dhyd ( □ ), derived count rates (■) and the PDI values (□) 
It can be noted that, at a lower IONP concentration, a more controlled and 
successful assembly was achieved, with clusters growing to approximately 50 nm 
over a 24 hour period. This increase in the observed growth rate can be attributed 
to the increase in the occurrence of  NP
*
- NP
*
 collisions as a result of a lower 
population of IONPC in the medium as compared to that used in Figure 5.3. This 
strongly suggests the presence of a NP
*
 de-activation process driven by the 
interaction of NP
*
 with NP. PDI values for the IONPCs improved from an average 
value of 0.20 in the initial experiment, to 0.18 in the case of the dilution used in 
Figure 5.4. This preservation of monodispersity, in addition to a steady increase in 
the dhyd and derived count rate, throughout the course of the experiment is 
indicative of controlled NPC assembly. Nanoparticle concentrations within this 
range were therefore used for all subsequent assembly experiments. 
 
 
5.4.2 Redispersion of OAc/OAm IONPCs using additional surfactant. 
 
Figure 5.5 illustrates the assembly of OAc/OAm-stabilised IONPCs in heptane, 
with further addition of oleic acid to the growing clusters at dhyd of approximately 
45 nm. The observed effect was a partial yet rapid dispersion of the IONPCs to a 
hydrodynamic size of 34 nm, with no further decrease occurring (i.e. a plateau) in 
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the dispersion of the nanoparticles. In addition to this, a drop in the derived count 
rate is evident, which can be explained by a reduction in particle size. PDI values 
remained consistent throughout the course of the experiment, indicating that the 
observed particle size was a true representation of the entire nanoparticle 
suspension.  
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Figure 5.5 : Assembly of OAc/OAm-IONPCs in heptane with addition of oleic acid following 
cluster assembly. Included in the plot are values for the dhyd ( □ ), derived count rates ( ■ ) and 
the PDI values (■) 
 
 
The introduction of oleic acid into the assembly medium stops the cluster assembly 
process, and a decrease in the hydrodynamic size and derived count rate is 
observed. We interpret this as being due to the oleic acid diffusing into the clusters 
and binding to the vacant sites. This increases the colloidal interparticle repulsions 
and the clusters partially disperse due to random thermal fluctuations. 
 
In an attempt to observe a trend in the extent of dispersion as a function of 
concentration of oleic acid, the experiment represented in Figure 5.5 was repeated 
for three different concentrations of surfactant (Figure 5.6). Surfactant addition 
times varied as a result of different rates of cluster growth in all three cases. As the 
cluster sizes were all different, we calculated the percentage dispersion for each of 
the three assembly experiments. In this instance, it was observed that, as the 
concentration of oleic acid added to the growing clusters was decreased, the 
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percentage of dispersion increased from 64% for the highest concentration of oleic 
acid (6 mM), to 86% and 91% for the 4 mM and 2 mM solution additions 
respectively.  
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Figure 5.6: Addition of oleic acid in a range of concentrations to growing  
OAc/OAm-IONPCs 
 
 
Due to the difference in cluster size at the time of surfactant addition, the three 
plots were scaled to a common value (so that the point of addition was at ~65 nm) 
in an effort to visually observe the effect of surfactant addition on each IONPC 
suspension (Figure 5.7). 
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Figure 5.7: Scaled plot of oleic acid addition experiments (Figure 5.6) All sets of data were 
scaled to a common hydrodynamic diameter at the point of surfactant addition for the 
purpose of comparison. 
 
This shows that the plateau in the size was reached more quickly at lower 
concentrations of oleic acid addition. As the cluster sizes upon surfactant addition 
in this experiment were all different, however, we cannot use this as a true 
representation of the relationship between surfactant addition and rate of 
dispersion. 
 
A second series of experiments with varied concentrations of oleic acid were 
performed for three separate IONPC assemblies of similar size. The percentage 
dispersion (i.e. the percentage by which the clusters reduced in size following 
addition of oleic acid) was calculated for each experiment and the results are 
presented in Figure 5.8 below. It was observed that, for the highest concentration 
of oleic acid added (6 mM), the calculated percentage of dispersion was 
significantly higher (76%) than those calculated for the more dilute oleic acid 
additions; 44% and 55% for 3 and 2 mM OA, respectively. This suggests that the 
rate of dispersion is somewhat dependent on the concentration of oleic acid. We 
did not, however, observe proportionality between the concentration of oleic acid 
added and the percentage of dispersion in these experiments. 
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Figure 5.8: Second experiment for the addition of oleic acid in a range of concentrations to 
growing  OAc/OAm-IONPCs 
 
  
Finally, the effect of oleylamine addition to oleic acid/oleylamine stabilised NPCs 
was also investigated (Figure 5.9). Once again, rapid dispersion of the clusters was 
evident, with dhyd values decreasing from 50 nm to 30 nm within 2-3 hours of 
surfactant addition. It should be noted again that dhyd values comparable to the 
initial primary particle sizes were not achieved upon redispersion for both of the 
above addition experiments. This may have been due to an insufficient amount of 
surfactant being added to the suspension to encourage total cluster dispersion. 
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Figure 5.9: Assembly of OAc/OAm-IONPCs in heptane with addition of oleylamine following 
cluster assembly. Included in the plot are values for the dhyd ( □ ), derived count rates ( ■ ) and 
the PDI values(■) 
 
It should be noted that concentration dependence experiments were only carried 
out for oleic acid additions to IONPCs, Future work could extend to similar studies 
of oleylamine addition in a number of different concentrations to IONP assemblies. 
 
5.4.3 Attenuation of OAc/OAm-IONPC assembly by addition of gold NPs with 
addition of further surfactant following assembly. 
 
 
 OAc/OAm-IONPCs were then assembled to a given size and DDT-stabilised 
AuNPs were added prior to subsequent addition of oleic acid. In the experiment 
shown in Figure 5.10, 50 μL of AuNP suspension was added to 55 nm IONPCs.  
On addition of the AuNP to the IONPCs in heptane, a cessation (or plateau) in the 
assembly was evident for a period of approximately 4 hours. This shows that the 
presence of the AuNP stabilises the IONPCs, presumably by occupying the vacant 
sites on the cluster surface preventing further assembly.  
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It is apparent that the presence of the AuNPs had a significant effect on the rate of 
decrease in both the hydrodynamic size and the derived count rate following 
further oleic acid addition. In the absence of AuNP, both dhyd and count rate 
decreased rapidly (12 nm/hr) (Figure 5.5), whereas a more gradual decrease was 
evident in this case (7 nm/hr). This may once again be attributed to increased 
stability of the clusters due to the presence of AuNP and the partial shielding of the 
surface with a non-desorbing ligand, DDT in this case. 
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Figure 5.10: Attenuation of assembly by addition of AuNP followed by oleic acid to facilitate 
nanoparticle dispersion. Included in the plot are values for the dhyd ( □ ), derived count rates ( 
■ ) and the PDI values (■) 
 
The experiment shown in Figure 5.10 was then repeated for a number of 
concentrations of oleic acid addition, and the results are as presented in Figure 
5.11. As before, the addition of AuNP (50 μL) stopped any further assembly and 
addition of oleic acid resulted in partial dispersion of the IONPCs. The result was a 
fairly similar percentage reduction in the size as the oleic acid concentration was 
reduced with decreases of 69%, 62% and 79% for oleic acid concentrations of 6, 4 
and 2 mM, respectively. Once again, on reducing the amount of oleic acid, we 
observe that the plateau is reached earlier, as was the case in the absence of AuNP 
(Figure 5.6). 
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Figure 5.11: Second experiment on the addition of AuNP prior to oleic acid to growing 
OAc/OAm-IONPCs. Note once again that the volume of AuNP added was kept constant while 
the concentration of oleic acid added was varied and surfactant addition times were different 
as a result of varied growth rates 
 
Similarly, the effect of AuNP on further oleylamine addition to OAc/OAm-
IONPCs was also investigated (Figure 5.12). On addition of AuNP, a plateau in the 
size was observed (inset). However, on addition of the oleylamine, the size 
increased dramatically and was then observed to decrease once again. In addition 
to this, the PDI doubled, and the count rate was seen to decrease, suggesting that 
aggregates had rapidly formed and subsequently precipitated from the suspension. 
This suggests that some of the oleylamine becomes bound to the IONPC surface, 
rather than diffusing into it as in the case for oleic acid, so disrupting the colloidal 
stability. 
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Figure 5.12: Addition of AuNP prior to oleylamine addition to growing OAc/OAm-IONPCs. . 
Included in the plot are values for the dhyd ( □ ), derived count rates ( ■ ) and the PDI values 
(■) 
 
 
5.4.4 Kinetics of assembly for OAm-IONPCs (single surfactant IONPCs) 
 
For the purpose of comparison, nanoparticles stabilised by oleylamine only were 
also prepared using the approach of Sun et. al. but with twice the amount of 
oleylamine (i.e. no oleic acid was used). The kinetics of their assembly was also 
studied, as shown in Figure 5.13 and Figure 5.14.  
0 10 20 30 40 50 60
-10
-5
0
5
10
15
20
25
30
35
40
PDI=0.8PDI~0.25
Cumulative Time(h)
Z
-A
v
e
ra
g
e
(d
n
m
)/
P
D
I
1000
2000
3000
4000
5000
6000
7000
D
e
ri
v
e
d
 C
o
u
n
t 
R
a
te
(k
c
p
s
)
 
Figure 5.13: Typical assembly data obtained by PCS for the formation of OAm-IONPCs in 
heptane. Fe concentration was approximately 2 mM. Included in the plot are values for the 
dhyd ( □ ), derived count rates ( ● ) and the PDI values (□) 
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Figure 5.13 shows typical assembly data for a suspension of OAm-IONP (Fe = 2 
mM) in heptane. On assembly of the IONPCs at this nanoparticle concentration, 
we observe an increase in both the dhyd and the derived count rate over time. This 
suggests that a gradual assembly had been achieved with IONPCs of 
approximately 35 nm being formed. The PDI values were seen to increase, 
however, indicating that the increase in the dhyd is associated with uncontrolled 
aggregation. Despite the drawbacks, this experiment does suggest that oleylamine 
is subject to desorption. 
 
A second dilution was performed at a lower nanoparticle concentration (where 
[Fe]=1 mM) for the OAm- IONP and the kinetics of the assembly are as shown in 
Figure 5.14 (below). Once again, a more dilute IONP suspension resulted in more 
controlled assembly, with clusters reaching approximately 60 nm while observing 
a steady increase in counts and PDI values of approximately 0.22 throughout the 
course of the experiment. It should be noted, however, that this was achieved over 
a period of 2 hours, indicating that the assembly was very rapid. It was concluded 
that, under the conditions shown here at least, the assembly of oleylamine-
stabilised IONP could not be controlled as easily as their oleic acid/oleylamine 
stabilised counterparts. However, this is the first observation of CSD for a different 
ligand and it suggests the possible generality of the method.  
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Figure 5.14: Typical assembly data obtained by PCS for the formation of OAm-IONPCs in 
heptane. Fe concentration was approximately 1 mM. Included in the plot are values for the 
dhyd ( □ ), derived count rates ( ■ ) and the PDI values (scaled by a factor of 100) (□) 
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5.4.5 Redispersion of OAm IONPCs using additional surfactant. 
 
Further experiments similar to those carried out for OAc/OAm-IONPCs discussed 
in Section 5.4.2 above were carried out on a series of OAm-IONPC suspensions 
for comparison of the effect of further surfactant on the assembly process for 
clustered materials stabilised by a single surfactant. These studies would provide 
insight as to whether the method of IONP (and thus IONPC) stabilisation would 
impact the redispersion behaviour of the clustered materials upon further surfactant 
addition. It should be noted that similar Fe and surfactant concentrations were used 
for both mixed surfactant and single surfactant IONP experiments.  
 
Figure 5.15 illustrates the addition of oleic acid to IONPCs stabilised using 
oleylamine only (OAm-IONPCs). The result was a gradual and partial dispersion 
of the clusters from 38 nm to 23 nm. It can be noted that the redispersion was not 
as rapid as previously observed for IONPCs stabilised by both oleic acid and 
oleylamine (Figure 5.5). This may be due to a lower affinity of the added oleic acid 
for the silica substrate, as compared to OA/OAm-IONPCs,  as in the latter case the 
substrate has been exposed to OAc during the assembly stage. This could result in 
a slower desorption of oleylamine from the IONPC surface. Another possible 
explanation is that the difference is due to the process of oleic acid diffusion 
through the NPCs being slower for OAm-IONPCs than for the mixed surfactant 
IONPCs. It is difficult to explain this on the basis of the difference in headgroup as 
in both cases that group is bound to the NP surface. This suggests different NP 
surface morphology, e.g. phase defects or a different surface coverage for OAm 
stabilised NP, i.e. the nature of the NP* may be different.  
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Figure 5.15: Addition of oleic acid to assembling OAm-IONPCs.  Included in the plot are 
values for the dhyd ( □ ), derived count rates ( ■ ) and the PDI values (■) 
 
The above experiment was then repeated for the addition of oleylamine to the 
nanoparticle clusters following assembly (Figure 5.16). The result was a very rapid 
dispersion from 42 nm to 20 nm, after which a plateau in the hydrodynamic size 
was observed. It should be noted that again the original dispersed IONP size was 
not recovered. A similar trend was observed for the mean count rate and the PDI 
was also observed to remain consistent throughout the experiment. In this instance, 
as there is no oleic acid to reduce the affinity of the oleylamine for the silica 
substrate, we observe a much more dramatic decrease in the measured dhyd to a 
diameter much closer to the initial primary particle size. 
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Figure 5.16: Addition of oleylamine to growing OAm-IONPCs.  Included in the plot are 
values for the dhyd ( □ ), derived count rates ( ■ ) and the PDI values (■) 
 
 
5.4.6 Attenuation of OAm-IONPC assembly by addition of AuNPs 
 
Similar experiments to those presented in Section 5.4.3 were then repeated for 
OAm-IONPCs to which AuNP had been added (Figure 5.17). It should be noted 
that, for OAm-IONPCs, AuNP addition failed to fully attenuate assembly and, in 
some cases, cluster assembly appeared to continue at the same rate as was the case 
in Figure 5.17. In this particular experiment, 50 μL of AuNP suspension was added 
to the IONPC suspension in heptane at approx. 40 nm and the assembly continued 
at a similar rate to before AuNP addition. This could be due to an insufficient 
concentration of AuNPs added to attenuate the assembly, but as the same 
concentration was used as for the OAc/OAm-IONPC experiments, it is more likely 
that this observation arises due to the nature of the OAm-IONPC surface. The 
question remains as to whether the AuNPs have physisorbed onto the surface. 
 
Upon oleic acid addition to Oam-IONPCs at a cluster size of ~50 nm, we do 
observe dispersion of the assembling IONPCs, albeit a gradual one (~2 nm/hr) 
similar to that observed for OAm-IONPCs in the absence of AuNP (~3 nm/hr) 
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(Figure 5.15). Once again, this gradual dispersion may be due to the oleic acid 
diffusing through the IONPCs (or Au-IONPCs).  
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Figure 5.17: Addition of AuNP prior to oleic acid addition for growing OAm-IONPCs. 
Included in the plot are values for the dhyd ( □ ), derived count rates ( ■ ) and the PDI values 
(■) 
 
 
The addition of oleylamine to Au/OAm-IONPCs, as shown in Figure 5.18 below, 
however, resulted in a different behaviour to that observed for OAm-IONPCs 
(Figure 5.16). On addition of AuNP, the assembly process was not fully attenuated, 
but a noticeable decrease in the growth rate was apparent, in addition to a more 
gradual dispersion following oleylamine addition. This may be attributed to partial 
stabilisation of the clusters by AuNP prior to surfactant addition, resulting in 
slower desorption of the surface-bound surfactant from the surface of the IONPCs, 
strongly suggesting the formation of Au/OAm-IONPCs as opposed to a mixture of 
AuNPs and OAm-IONPCs.                                                                                                                                                                                                                                                  
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Figure 5.18: Addition of AuNP prior to oleylamine addition for growing OAm-IONPCs. 
Included in the plot are values for the dhyd ( □ ), derived count rates ( ■ ) and the PDI values 
(■) 
 
 
5.5 Summary and Conclusions 
 
The work presented in this chapter outlines the colloidal behaviour of mixed and 
single surfactant IONP and their assembly in organic medium in the presence of a 
competing substrate; CN-modified silica. In addition to this, studies on additional 
surfactant and/or AuNP additions were also investigated, in an attempt to 
understand the surface chemistry of the IONPCs, and the way in which the 
adsorbed surfactants were removed from their surfaces.  
 
For mixed IONPCs, the addition of oleic acid to the clusters resulted in their 
dispersion, with a reduced percentage dispersion in addition to an earlier plateau 
observed for decreased concentrations of surfactant. Similarly, cluster dispersion 
was also observed upon oleylamine addition to the IONPCs, suggesting that 
oleylamine can diffuse into the clusters and bind to vacant sites in the absence of 
AuNP. On replicating these surfactant addition experiments in the presence of 
AuNP, the rate of dispersion was somewhat reduced upon oleic acid addition, 
suggesting that the AuNP act as a shield to the added surfactant attempting to bind 
to the IONPC surface. Further addition of oleylamine, however, resulted in further 
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aggregation of the clusters, possibly due to the retention of some additional 
oleylamine on the IONPC surface, due to the presence of surface AuNP. 
For single surfactant IONPCs stabilised by oleylamine only, the addition of oleic 
acid resulted in a slower dispersion than observed for the mixed surfactant IONPCs 
with the same concentration of surfactant added in both cases. Upon oleylamine 
addition to OAm-IONPCs, a rapid dispersion was evident, possibly due to a 
difference in the nature of the activated nanoparticles (surface defects)  in this case. 
Interestingly the TGA curves for both OAc/OAm-IONPs and OAm-IONP are 
identical (Figure 5.19), which supports this interpretation as opposed to the 
alternative; that there is a difference in the surface NP ligand density prior to 
initiating assembly. 
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Figure 5.19: TGA curves outlining the % weight losses for both mixed surfactant (OAc/OAm) 
IONP and single surfactant (OAm) IONP 
 
 
In the presence of AuNP, additional surfactant addition to OAm-IONPCs resulted 
in a reduced rate of re-dispersion in all cases which, once again, may be attributed 
to shielding and partial stabilisation of the IONPC surface. This, presumably, 
occurs by occupation of the vacant sites present on the cluster surface, thus 
preventing further assembly and resulting in a slower surfactant desorption from 
the surface of the IONPCs. This resulted in the production of Au-IONPC 
composite materials of controlled size by the addition of gold nanoparticles to 
growing IONPCs. 
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Several attempts were also made to complete NMRD analyses on the IONPCs 
shown in this chapter. Unfortunately, in each case, the colloidal stability of these 
materials on exposure to the magnetic field was insufficient for us to reach any 
firm conclusions on the magnetic order and relaxivities of the assemblies formed.  
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CHAPTER 6 
 
NMRD Analysis in the Development of 
Composite Magnetic Nanomaterials 
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6.1 Introduction 
 
In Chapter 4, we presented the formation of nanocomposite materials consisting of 
individually stabilised IONP and polymer nanoparticles, forming 'core-shell' 
structures, or 'surface decorated' materials, where NMRD studies demonstrated a 
noticeable increase (core-shell) or decrease (surface decorated) in the measured r1 at 
all frequencies in comparison to that measured for the dispersed IONP. This chapter 
presents an NMRD and DLS study into the properties of two further types of IONP-
based nanocomposite materials; lipid-stabilised IONPCs, or 'magnetoliposomes', and 
fatty acid bilayer stabilised IONPCs, or BPCs, in an attempt to understand their 
magnetic resonance properties and to investigate their potential as magnetic 
nanomaterials/drug carriers for in vivo imaging and cancer therapy.  
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Figure 6.1: General structures for (a) surface decorated IONP/PACA (b) core-shell IONP/PACA (c) 
magnetoliposome and (d) fatty-acid bilayers 
 
Liposomes, aqueous compartments formed by a lipid bilayer, were first applied in 
biomedicine by Bangham et. al. in 1965 [135]. Since then, their use in the fields of 
diagnostic imaging, drug delivery and hyperthermia have been extensively reported 
in the literature owing to numerous beneficial attributes such as their colloidal 
stability, biocompatibility, encapsulation potential and surface characteristics [99, 
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102, 136, 137]. A significant advantage of these materials is that they offer the 
capability to encapsulate both contrast agents and therapeutics in the same delivery 
vehicle, thus allowing for simultaneous diagnostic imaging and treatment. In 
addition, their membrane dynamics can be exploited for triggered drug release, 
allowing more efficient delivery of therapeutics to target tissues [138]. More 
interesting, for the present work, are the recently described 'magnetoliposomes' 
which, as the name suggests, possess a magnetic material (i.e. IONPs) in the interior 
of the liposome structure, with or without an aqueous lumen. The characteristic high 
magnetic moments of these materials suggests possible applications for T2-weighted 
cellular imaging [52]. Bruns et. al., for example, have previously demonstrated the 
use of IONP-containing nanosomes of different functionalities (quantum dots, 
radiolabels and lipoproteins) for real-time MRI imaging and quantification of 
lipoprotein kinetics in vivo [139]. 
 
The term 'magnetoliposome' was first introduced by De Cuyper and coworkers 
[140], to describe structures where the interior of the phospholipid vesicle was 
entirely packed with magnetic nanoparticles. The phospholipids are thought to 
displace the surfactant molecules and arrange in a bilayer configuration around the 
iron-oxide core (Figure 6.1 (c)), with the inner phospholipid layer adsorbed directly 
onto the nanoparticle surface and form solid magnetoliposome, or SML, structures 
[141]. 
 
Alternatively, the solid nanoparticles may be contained within the aqueous 
compartment of a conventional liposome, forming what we will refer to as aqueous 
magnetoliposomes, or AMLs [52]. The advantage of the AML structure is that it 
allows for encapsulation of multiple materials (magnetic NP, therapeutics, contrast 
agents etc.) into the aqueous core, as shown in Figure 6.2 overleaf. 
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Figure 6.2: General structure for the arrangement of a lipid bilayer in an aqueous magnetoliposome 
structure 
 
For the purpose of the work presented in this thesis, IONPCs were encapsulated by a 
bilayer of 1,2-Dioleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (sodium salt) 
(DOPG) (18:1) as illustrated by Figure 6.3 below, to form SMLs [52]. 
DOPG
DOPG lipid bilayer
Iron oxide nanoparticle 
cluster (IONPC)
 
             Figure 6.3: General structure for IONPCs stabilised by a DOPG bilayer 
 
The second type of nanocomposite presented in this chapter are magnetic IONPCs 
stabilised by fatty acid bilayers, or BPCs. These materials are stabilised with a 
primary fatty acid layer that is chemisorbed onto the surface of the nanoparticle or 
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nanocluster, through the carboxylate groups, and a secondary physisorbed layer 
whose alkyl chains interpenetrate the primary layer with the hydrophilic head groups 
pointing outward. This provides for successful aqueous dispersion of BPCs. 
Materials of this type have been extensively reported in the literature as effective 
diagnostic T2 contrast agents in MRI imaging as a result of their increased r2 values 
(and the associated r2/r1 ratios) due to IONP clustering [123, 141]. The extent of this 
clustering has a noted effect on the magnetic properties of the material, in particular 
on their magnetic anisotropy [49], and is therefore critical to their efficacy for 
biomedical application. BPCs synthesised in the work presented here were stabilised 
by a primary layer of decanoic acid (C10:0) and a secondary layer of lauric acid 
(C12:0) [49], as illustrated by Figure 6.4 below. 
 
Iron oxide nanoparticle 
cluster (IONPC)
C
H
3
O O
C
H
3
C
H
3
C
H
3
O
O
C
H
3
C
H
3
CH3 O
O
C H3
C H3
CH
3
O
O
C
H
3
C
H
3
CH3
O
O C
H3
C
H3
C
H 3
O
O
C
H 3 C
H 3
CH3
O
O
CH3
CH3
C
H
3
OO
C
H
3C
H
3
CH3
O
OH
C
H
3
O
O
H
C
H
3
OO
H
CH
3
O
OH
CH
3
O
OH
C
H 3
O
O
H
C
H
3
O O
H
CH
3
O
OH
Primary layer (Decanoic acid)
Secondary layer (Lauric acid)
C
H
3
O O
C
H
3
C
H
3
C
H
3
OO
C
H
3C
H
3
C
H
3
O O
C
H
3
C
H
3
C
H
3
OO
C
H
3C
H
3
 
Figure 6.4: General structure for the arrangement of a BPC nanocomposite with IONPCs stabilised 
by decanoic acid(primary layer) and lauric acid (secondary layer) 
 
The aim of this chapter is to present these two additional methods for controlled 
assembly formation, and to contrast the effect of nanocomposite structure on the 
materials relaxivity in the clinical ranges and on the NMRD profiles for the full 
range of nano-composite materials discussed in the thesis. Note that, unlike the 
PACA based nanocomposites, SMLs and BPCs are dense clusters of IONPs. 
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6.2 Experimental 
 
6.2.1 Preparation of solid magnetoliposomes (SMLs) by alkaline coprecipitation 
of iron salts 
 
Materials 
 
1,2-Dioleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (sodium salt) (DOPG) (18:1) 
was purchased as a lyophilised powder (> 99%) from Avanti Polar Lipids 
(Alabaster, AL, USA) and stored at -20°C. Iron (II) chloride tetrahydrate (> 99%) 
was purchased from Sigma-Aldrich (Ireland) and Iron (III) chloride-6-hydrate (> 
99%) was purchased from Riedel-de-Haën (Seelze, Germany). All reagents were 
used without further purification. 
 
Synthesis 
 
The method used is a modification of that described by Meledandri et. al., [52]. Iron 
salts (FeCl3•6H2O and FeCl2•4H2O) in a 2:1 molar ratio were added with stirring to 
20 mL deoxygenated H2O in a 3-neck round-bottomed flask and the solution was 
slowly heated to 80°C under strong magnetic agitation. After 30 minutes at this 
temperature, one fifth of the total phospholipid to be added (0.85 mM dissolved in 
0.5 mL methanol) was added to the reaction mixture, immediately followed by the 
addition of 1.5 mL of 33% ammonia to precipitate the metal ions. A black precipitate 
was immediately observed, indicating the formation of magnetite nanoparticles. The 
remaining DOPG (3.41 mM dissolved in 1 mL methanol) was then slowly added to 
the mixture over 5 minutes, after which crystal growth was allowed to proceed for a 
further 15 minutes with vigorous stirring. The suspension was then cooled to room 
temperature prior to subjecting the suspension to a washing cycle five times using a 
50/50 v/v solution of acetone/methanol, and the flask containing the DOPG-coated 
IONP was placed over a bar magnet to isolate the nanoparticles. During the final 
wash cycle, the sample was resuspended in 10 mL DI H2O in preparation for 
magnetoliposome formation through the addition of a secondary, physisorbed DOPG 
layer. In order to achieve this, the IONP temporarily dispersed in H2O were heated to 
65°C under a steady stream of N2 with vigorous stirring in a 3-neck round-bottomed 
flask fitted with a water-cooled reflux condenser. After 30 minutes at 65°C, 10 mM 
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ammoniated DOPG was slowly added to form a secondary phospholipid layer 
around the nanoparticles, and the suspension was stirred for an additional 30 
minutes. Upon cooling to room temperature, the suspension was sonicated for 30 
minutes in a sonication bath, and was then placed over a bar magnet for 20-30 
minutes. The supernatant was then decanted and retained for further characterisation.  
 
6.2.2 Preparation of bilayer fatty acid-stabilised IONP clusters (BPCs) 
 
Materials 
 
Iron (II) chloride tetrahydrate (> 99%) was purchased from Sigma-Aldrich (Ireland) 
and Iron (III) chloride hexahydrate (> 99%) was purchased from Riedel-de-Haën 
(Seelze, Germany) and were used without further puriﬁcation. Fatty acids (decanoic 
acid and lauric acid) were also obtained from Sigma-Aldrich (purity >99.9%), and 
again were used without further puriﬁcation. 
 
Synthesis 
 
The method used is a modification of that described by Gosh, Clarke et. al., [49]. A 
mixture of iron (III) chloride hexahydrate and iron (II) chloride tetrahydrate, in a 
molar ratio of 2:1 (typically 0.5 and 0.25 mmol), was dissolved in 20 mL 
deoxygenated water, heated slowly to 80°C with strong magnetic stirring and 
maintained for 30 min at that temperature. Following this, one ﬁfth (0.08 mmol) of 
the total amount of primary surfactant (decanoic acid C10:0) was added to the 
reaction solution followed by immediate addition of the required volume 0.5 mL of 
33% ammonia to facilitate IONP precipitate the IONP. The remaining surfactant 
(0.32 mmol) was then added to the mixture in ﬁve parts over a 5 minute period, after 
which vigorous stirring was continued for a further 15 min at 80°C. The suspension 
was then cooled to room temperature and precipitated in one step using a 50:50 v/v 
mixture of acetone and methanol and a strong bar magnet. This process was repeated 
five times to remove any excess surfactant that was not bound to the IONP surface. 
The washed particles disperse readily in non-polar organic solvents to produce 
concentrated non-aqueous dispersions.  
 
In order to successfully disperse the IONP in aqueous media a secondary surfactant 
layer of the same or different surfactant is required. The decanoic acid-coated IONP 
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were re-dispersed in water and the suspension was heated to 60°C with strong 
stirring. The second surfactant, lauric acid (C12:0) (0.25 mmol), as its ammonium 
salt (pH ~10), was then added drop-wise to the suspension. The suspensions were 
then sonicated at 50°C for 15-20 minute cycles until a suspension of magnetite 
nanoparticles stabilised against agglomeration was achieved. The nanoparticle 
suspensions were then characterised by PCS and NMRD. 
 
6.3 Results and Discussion 
 
6.3.1 Solid magnetoliposome (SML) suspensions 
 
PCS analyses of a typical SML suspensions demonstrated that suspensions of 
monodisperse nanoclusters were formed, with sizes ranging from 95-110 nm, PDI 
values of 0.22-0.24. It should be noted that these values are slightly higher than those 
observed for fully-dispersed individual IONP dispersions. This increase may be 
explained by the presence of some larger aggregates within the SML suspension, 
which could possibly be removed by centrifugation, sonication or magnetic 
filtration. Note that the fraction of these larger aggregates was very small in most 
cases and the NMR results are as expected, so further size selection was deemed not 
necessary in these instances. Size distributions for the most part were unimodal, an 
example is shown in Figure 6.5 below. 
 
 
 
Figure 6.5: Typical PCS size distribution for a SML suspension of 104 nm, PDI 0.24 
 
 
Figure 6.6 presents the NMRD profile obtained for a typical SML suspension of dhyd 
~104 nm (PDI 0.24). The overall shape of the profile suggests a superparamagnetic 
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material had been formed, with the frequency of the r1 maximum at ~1 MHz 
suggesting a primary particle size of  less than 20 nm [70]. In comparison to the 
NMRD profiles obtained for the Cit-IONP/PACA and DTAB-IONP/PACA 
presented in Chapter 4 (re-presented in Figure 6.9 below, the profile obtained for the 
SML suspension presents a much broader peak in the high frequency region, this 
probably arises from the broader size distribution. Significantly higher r1 values were 
found across the entire frequency range and a higher r1 plateau in the low frequency 
region was also observed. The former is consistent with higher Ms, associated with 
improved crystallinity, and the latter with greater magnetic anisotropy (see Chapter 
1, Figure 1.33) for SMLs due to increased inter-particle interactions (resulting in 
longer Néel correlation time, see Chapter 1, Figure 1.31. for re-orientation of the 
magnetic moments of the dispersed IONPCs as compared to individual IONP. [121]. 
The expected NMRD response of a dispersed IONP suspension of core size and Ms 
typical for aqueous co-precipitation particle synthesis is included solid line in Figure 
6.6 below, for the sake of comparison. The major difference is an increase in r1 at 
low frequency of forming the clusters.  
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Figure 6.6: NMRD data for a typical SML suspension (■),  stabilised by a DOPG lipid bilayer. 
A simulated profile for dispersed IONP (solid red line) is included [52]. The parameters used in 
the SPM simulation were MS = 27 emu/g, dSPM=20 nm,  τN = 24 ns, ΔEanis = 2.2 GHz 
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Although T2 data was not collected for magnetoliposome suspensions in the work 
presented in this chapter, previous studies in the group, and also in the literature in 
general, reported high r2 values (and thus high r2/r1 ratios) for materials of this type 
[52, 141, 142]. This allows for their consideration as potential T2 negative contrast 
agents for MRI imaging.   
 
6.3.2 Fatty-acid bilayer stabilised IONPCs (BPCs) 
 
Turning to fatty-acid bilayer stabilised IONPCs (BPCs), in the case of 
decanoic/lauric acid PCS analyses indicated the formation of unimodal size 
distribution, with measured hydrodynamic sizes of 85-100 nm following adequate 
sonication of the suspensions post synthesis. PDI values varied from 0.19-0.24, 
indicating that fairly monodisperse suspensions were achieved. 
 
 
Figure 6.7: PCS data for a typical BPC suspension of 93 nm (PDI 0.24) 
 
 
The NMRD profile of the BPC suspension is shown in Figure 6.8. Once again, 
measured r1 values were high for all frequencies across the range, with the 
occurrence of a low field r1 plateau, a prominent maximum in the low frequency 
range (~1 MHz) and a rapid decrease in r1 at higher frequencies also evident, 
suggesting that the material was also composed of superparamagnetic particles in the 
sub 20 nm range. The simulated curve for dispersed IONP (identical to that used in 
Figure 6.6) is again included for comparison. The BPC profile is similar to that 
presented for SML suspensions. Both show much higher r1 values across the entire 
frequency range than those obtained for Cit-IONP/PACA and DTAB-IONP/PACA, 
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in addition to a higher r1 plateau in the low frequency region and this effect is 
stronger for BPCs. This, again, suggests higher Ms, and magnetic anisotropy for 
BPCs as compared to Cit-IONP/PACA and DTAB-IONP/PACA nanocomposites.  
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Figure 6.8: NMRD data for a typical BPC suspension (■), stabilised by a decanoic acid/lauric acid 
bilayer. A simulated profile for dispersed IONP (solid red line) is included [49]. The parameters used in 
the SPM simulation were MS = 27 emu/g, dSPM = 20 nm,  τN = 24 ns, ΔEanis = 2.2 GHz 
 
 
6.4 Conclusion 
 
From the work presented in this chapter, it has become apparent that by forming 
dense IONP clusters with fatty acids or lipid bilayers, an increase in the low 
frequency relaxivity, as compared to SPM simulations of the expected profile for 
dispersed IONP was observed. This is in contrast with that observed for the change 
in r1 for more 'open' Cit-IONP and DTAB-IONP nanocomposites, where an overall 
increase or decrease in the r1 across the entire profile was observed, when compared 
to that for dispersed IONP (illustrated in Figure 6.9 below). We interpret the former 
observation as being due to stronger inter-particle interactions for the IONP dense 
nanocomposites (SMLs and BPCs), giving rise to greater magnetic anisotropy and 
longer Néel correlation times. The contrast in the observed changes in r1 upon 
composite formation between both dense and open IONPC materials provides the 
potential for engineering the NMRD response through modification of the composite 
architecture. This, in turn, presents the potential of such materials as next-generation 
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diagnostics, or as image-guided hyperthermically-actuated delivery vehicles for 
biomedical application. 
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Figure 6.9: NMRD profiles for (a) Cit-IONP and Cit-IONP/PACA and (b) DTAB-IONP and 
DTAB-IONP/PACA as described in Chapter 4 
 
In previous studies carried out within the group [52], IONP-dense clustered materials 
(SMLs and BPCs) such as those presented here have also exhibited elevated r2 
values and hence are applicable for potential T2-weighted imaging applications.  
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CHAPTER 7 
 
Thesis Summary and Conclusions 
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Despite the challenges presented in producing stable nanocomposites throughout the 
work presented in this thesis, NMRD analysis has allowed us to probe the magnetic 
order within soft magnetic materials in situ, thus providing direction to the 
development of related (second generation) materials. NMRD analysis of the 
composite materials presented identifies the possibility of systematically altering r1 
at some or all frequencies across the measured range. By formation of composites 
including PACA, namely Cit-IONP/PACA and DTAB-IONP/PACA, wherein inter-
particle interactions within the clusters are minimised, r1 was altered at all 
frequencies. Alternatively, by forming dense IONP clusters with fatty acids or lipids, 
it proved possible to drive up the low frequency relaxivity only, by controlling the 
effective magnetic anisotropy through the extent of interparticle interactions.  
 
NMRD comparisons between both citrate and DTAB-stabilised IONP and their 
corresponding composite materials demonstrate that a change in the IONP 
environment could also have an impact on the NMRD response. In the case of the 
Cit-IONP versus Cit-IONP/PACA, for example, an increase in r1 across the 
frequency range was observed. SPM modelling of the of the effect of  viscosity of 
the dispersion medium, suggested that the effect is probably attributable to a change 
in the local environment about the IONP, as opposed to a change in the bulk 
viscosity of the medium, which supports formation of the nanocomposite. In the 
case of the DTAB-IONP and their corresponding composite materials, the observed 
decrease in the relaxivity was explained by a reduced interaction of the diffusing 
H2O protons with the IONP surface following their attachment to the surface of the 
PACA nanospheres.  
 
The NMRD response of these composite materials was also shown to be effectively 
engineered through careful selection of the IONP type used in their construction. It 
was found that IONP prepared by different methods have very contrasting magnetic 
properties, with those prepared by non-hydrolytic methods demonstrating 
significantly higher relaxivity than those prepared by conventional coprecipitation 
methods. This is because thermal decomposition produces IONP of excellent 
crystallinity, resulting in increased saturation magnetisation.  
 
For biomedical application the stability of the composite materials is vital. It was 
found that this was essentially a consequence of the relative stability of the 
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individually dispersed IONP. In the case of citrate-stabilised IONP, it was observed 
that both particles and composites remained colloidally highly stable (hydrodynamic 
size, PDI and zeta potential) for extended periods of time over a relatively broad pH 
range, or when exposed to elevated field strengths during magnetic filtration. This 
stability was closely related to the surface coverage of the IONP by the citrate 
ligands, with a minimal surface ligand coverage required. It followed that, the 
majority of the composite materials prepared using these nanoparticle dispersions 
demonstrated similar stability, with those exhibiting more negative Zeta Potential 
values maintaining their hydrodynamic size and PDI values for longer periods of 
time, as expected.  
 
In contrast to this, IONP stabilised by DTAB did not exhibit the same degree of 
stability both temporally and on exposure to a strong magnetic field. The dispersion 
obtained and its colloidal stability were found to be strongly dependent on the 
quantity of DTAB ligand used in the phase transfer process. The lack of long-term 
stability is most likely due to the fact that the DTAB moieties are physisorbed onto 
the particles and so are relatively easily displaced, as compared to the chemisorbed 
citrate ligands of the Cit-IONP materials. Future work could involve attachment of 
ligands with stronger binding chemistries, improving long-term stability for 
positively charged IONP used in nanocomposite formation.  
 
Several attempts were also made to complete NMRD analyses on the IONPCs 
presented in Chapter 5 of this thesis. Unfortunately, in each case, the colloidal 
stability of these materials on exposure to the magnetic field was insufficient for us 
to record reliable data. Hence the magnetic order and relaxivities of the assemblies 
of this type remain an open question. Despite this obstacle, some insight was gained 
into the nature of the activated IONP, formed by partial removal of surfactant from 
the IONP surface (which were previously stabilised by two different ligand types) 
and their corresponding clustered materials. Future work could involve the 
preparation of more colloidally stable materials in order to determine their NMRD 
response, so that they may be compared to the other composites described in this 
thesis. Furthermore, their eventual phase transfer into water for their consideration 
in biomedical application would also be a key step. 
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We have noted that large assemblies (dhyd >100 nm) of either open (porous) or dense 
(non-porous) IONPC architecture are both potentially effective T2-agents for MRI 
applications. An alternative approach suggested by the work presented in this thesis 
on Cit-IONP/PACA and DTAB-IONP/PACA composite materials is the use of 
composites with drastically reduced inter-particle interactions (incorporating PACA, 
or perhaps a more stable equivalent) for developing improved agents with T1-
weighting properties for MRI.  
 
The contrast in the NMRD behaviour between the composite materials presented in 
this thesis, and the manner in which their architecture can be used to engineer this 
response, presents potential for the development of a variety of next-generation 
diagnostics, in particular, for image-guided hyperthermically-actuated delivery 
vehicles. The principle challenge in the development of these advanced vehicles is in 
preparing colloidally stable composites, that are stable under a wide range of 
physiological conditions, while optimising their magnetic properties and thus their 
MRI/hyperthermic potential. Although much effort and some progress towards this 
goal has been shown in the work presented in this thesis, the challenge of preparing 
nanocomposites with both excellent physical properties and long-term colloidal 
stability remains.   
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